1	The	DT	O	the	det	4	SENT_1	[p1l715t81r752b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l764t83r845b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l859t83r1034b102],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_1	[p1l1048t83r1214b109],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_1	[p1l1228t81r1444b108],

1	surgical	JJ	O	surgical	amod	4	SENT_2	[p1l12t305r345b405],
2	and	CC	O	and	_	0	SENT_2	[p1l368t305r525b383],
3	medical	JJ	O	medical	conj_and	1	SENT_2	[p1l549t304r882b383],
4	treatments	NNS	O	treatment	nsubj	14	SENT_2	[p1l907t321r1360b383],
5	directed	VBN	O	direct	partmod	4	SENT_2	[p1l1387t304r1727b383],
6	at	IN	O	at	_	0	SENT_2	[p1l1750t321r1830b383],
7	removal	NN	O	removal	prep_at	5	SENT_2	[p1l1849t330r2147b384, p1l10t433r81b511],
8	or	CC	O	or	_	0	SENT_2	[p1l102t458r192b511],
9	dissolution	NN	O	dissolution	prep_at	5	SENT_2	[p1l211t432r686b512],
10	of	IN	O	of	_	0	SENT_2	[p1l708t432r810b511],
11	clots	NNS	O	clot	prep_of	7	SENT_2	[p1l812t432r1008b511],
12	are	VBP	O	be	cop	14	SENT_2	[p1l1030t459r1157b511],
13	also	RB	O	also	advmod	14	SENT_2	[p1l1178t433r1346b511],
14	likely	JJ	O	likely	_	0	SENT_2	[p1l1367t432r1595b533],
15	to	TO	O	to	aux	16	SENT_2	[p1l1612t449r1691b511],
16	be	VB	O	be	xcomp	14	SENT_2	[p1l1714t432r1810b511],
17	of	IN	O	of	_	0	SENT_2	[p1l1832t432r1934b511],
18	great	JJ	O	great	amod	19	SENT_2	[p1l1936t449r2153b533],
19	beneﬁt	NN	O	beneﬁt	prep_of	16	SENT_2	[p1l11t560r310b639],
20	in	IN	O	in	_	0	SENT_2	[p1l325t561r407b638],
21	the	DT	O	the	det	22	SENT_2	[p1l429t561r559b639],
22	treatment	NN	O	treatment	prep_in	16	SENT_2	[p1l582t577r999b639],
23	of	IN	O	of	_	0	SENT_2	[p1l1017t560r1117b639],
24	this	DT	O	this	det	28	SENT_2	[p1l1121t561r1275b639],
25	common	JJ	O	common	amod	28	SENT_2	[p1l1300t586r1682b639],
26	and	CC	O	and	_	0	SENT_2	[p1l1704t560r1860b639],
27	devastating	JJ	O	devastating	conj_and	25	SENT_2	[p1l1883t560r2147b640, p1l11t689r262b789],
28	disease	NN	O	disease	prep_of	22	SENT_2	[p1l285t689r614b767],
29	.	.	O	.	_	0	SENT_2	[p1l285t689r614b767],

1	From	IN	O	from	dep	6	SENT_3	[p1l15t869r178b924],
2	the	DT	O	the	det	4	SENT_3	[p1l216t864r320b924],
3	Stroke	NNP	O	Stroke	nn	4	SENT_3	[p1l358t864r566b924],
4	Program	NNP	O	Program	pobj	1	SENT_3	[p1l608t869r906b943],
5	,	,	O	,	_	0	SENT_3	[p1l608t869r906b943],
6	University	NNP	ORGANIZATION	University	_	0	SENT_3	[p1l951t869r1280b943],
7	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l1315t863r1387b924],
8	Michigan	NNP	ORGANIZATION	Michigan	nn	10	SENT_3	[p1l1418t864r1718b943],
9	Health	NNP	ORGANIZATION	Health	nn	10	SENT_3	[p1l1765t864r1978b924],
10	System	NNP	ORGANIZATION	System	prep_of	6	SENT_3	[p1l2019t868r2148b943, p1l8t971r154b1031],
11	,	,	O	,	_	0	SENT_3	[p1l2019t868r2148b943, p1l8t971r154b1031],
12	Ann	NNP	PERSON	Ann	nn	13	SENT_3	[p1l179t964r309b1019],
13	Arbor	NNP	PERSON	Arbor	dep	6	SENT_3	[p1l334t960r531b1020],
14	.	.	O	.	_	0	SENT_3	[p1l334t960r531b1020],

1	1	LS	NUMBER	1	_	0	SENT_4	[p1l12t1070r61b1121],
2	.	.	O	.	_	0	SENT_4	[p1l12t1070r61b1121],

1	Mayer	NNP	ORGANIZATION	Mayer	nn	2	SENT_5	[p1l137t1068r335b1138],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_5	[p1l364t1067r464b1134],
3	,	,	O	,	_	0	SENT_5	[p1l364t1067r464b1134],
4	Brun	NNP	PERSON	Brun	nn	5	SENT_5	[p1l497t1068r654b1122],
5	NC	NNP	O	NC	appos	2	SENT_5	[p1l682t1067r804b1134],
6	,	,	O	,	_	0	SENT_5	[p1l682t1067r804b1134],
7	Begtrup	NNP	O	Begtrup	nn	8	SENT_5	[p1l837t1068r1091b1138],
8	K	NNP	O	K	appos	2	SENT_5	[p1l1122t1068r1187b1134],
9	,	,	O	,	_	0	SENT_5	[p1l1122t1068r1187b1134],
10	et	FW	O	et	nn	11	SENT_5	[p1l1222t1075r1280b1121],
11	al.	FW	O	al.	appos	2	SENT_5	[p1l1305t1063r1377b1122],
12	.	.	O	.	_	0	SENT_5	[p1l1305t1063r1377b1122],

1	Recombinant	JJ	O	recombinant	amod	4	SENT_6	[p1l1409t1063r1845b1125],
2	activated	VBN	O	activate	amod	4	SENT_6	[p1l1870t1063r2149b1123],
3	factor	NN	O	factor	nn	4	SENT_6	[p1l10t1158r196b1218],
4	VII	NN	O	vii	_	0	SENT_6	[p1l216t1164r311b1218],
5	for	IN	O	for	_	0	SENT_6	[p1l335t1158r428b1218],
6	acute	JJ	O	acute	amod	8	SENT_6	[p1l451t1171r616b1219],
7	intracerebral	JJ	O	intracerebral	amod	8	SENT_6	[p1l642t1159r1048b1218],
8	hemorrhage	NN	O	hemorrhage	prep_for	4	SENT_6	[p1l1073t1159r1483b1235],
9	.	.	O	.	_	0	SENT_6	[p1l1073t1159r1483b1235],

1	N	NN	O	n	nn	2	SENT_7	[p1l1512t1164r1568b1219],
2	EnglJ	NN	O	englj	nsubj	3	SENT_7	[p1l1591t1159r1783b1235],
3	Med	VBD	O	med	_	0	SENT_7	[p1l1805t1159r1946b1218],
4	2005	CD	DATE	2005	dobj	3	SENT_7	[p1l1971t1163r2147b1231],
5	;	:	O	;	_	0	SENT_7	[p1l1971t1163r2147b1231],
6	352:777	CD	NUMBER	352:777	num	7	SENT_7	[p1l10t1261r392b1317],
7	-85	CD	NUMBER	-85	dep	4	SENT_7	[p1l10t1261r392b1317],
8	.	.	O	.	_	0	SENT_7	[p1l10t1261r392b1317],

1	2	LS	NUMBER	2	_	0	SENT_8	[p1l8t1360r61b1411],
2	.	.	O	.	_	0	SENT_8	[p1l8t1360r61b1411],

1	Qureshi	NNP	PERSON	Qureshi	nn	2	SENT_9	[p1l139t1353r394b1427],
2	AI	NNP	O	AI	_	0	SENT_9	[p1l412t1358r502b1424],
3	,	,	O	,	_	0	SENT_9	[p1l412t1358r502b1424],
4	Tuhrim	NNP	O	Tuhrim	nn	5	SENT_9	[p1l525t1353r766b1413],
5	S	NNP	O	S	appos	2	SENT_9	[p1l789t1357r841b1424],
6	,	,	O	,	_	0	SENT_9	[p1l789t1357r841b1424],
7	Broderick	NNP	PERSON	Broderick	nn	8	SENT_9	[p1l865t1353r1181b1413],
8	JP	NNP	O	JP	appos	2	SENT_9	[p1l1191t1358r1269b1424],
9	,	,	O	,	_	0	SENT_9	[p1l1191t1358r1269b1424],
10	et	FW	O	et	nn	11	SENT_9	[p1l1295t1365r1353b1411],
11	al.	FW	O	al.	appos	2	SENT_9	[p1l1370t1353r1441b1412],
12	.	.	O	.	_	0	SENT_9	[p1l1370t1353r1441b1412],

1	Spontaneous	JJ	O	spontaneous	amod	3	SENT_10	[p1l1469t1357r1882b1428],
2	intracerebral	JJ	O	intracerebral	amod	3	SENT_10	[p1l1905t1353r2147b1411, p1l10t1449r196b1508],
3	hemorrhage	NN	O	hemorrhage	_	0	SENT_10	[p1l214t1449r624b1524],
4	.	.	O	.	_	0	SENT_10	[p1l214t1449r624b1524],

1	N	NN	O	n	nn	2	SENT_11	[p1l646t1454r702b1508],
2	EnglJ	NN	O	englj	nsubj	3	SENT_11	[p1l718t1449r904b1524],
3	Med	VBD	O	med	_	0	SENT_11	[p1l920t1449r1060b1508],
4	2001	CD	DATE	2001	dobj	3	SENT_11	[p1l1079t1453r1683b1520],
5	;	:	O	;	_	0	SENT_11	[p1l1079t1453r1683b1520],
6	344:1450	CD	NUMBER	344:1450	num	7	SENT_11	[p1l1079t1453r1683b1520],
7	-60	CD	NUMBER	-60	dep	4	SENT_11	[p1l1079t1453r1683b1520],
8	.	.	O	.	_	0	SENT_11	[p1l1079t1453r1683b1520],

1	3	LS	NUMBER	3	_	0	SENT_12	[p1l10t1552r61b1604],
2	.	.	O	.	_	0	SENT_12	[p1l10t1552r61b1604],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_13	[p1l138t1545r345b1621],
2	LF	NNP	O	LF	_	0	SENT_13	[p1l358t1550r446b1617],
3	,	,	O	,	_	0	SENT_13	[p1l358t1550r446b1617],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_13	[p1l464t1550r675b1621],
5	]	NNP	O	]	appos	2	SENT_13	[p1l464t1550r675b1621],
6	,	,	O	,	_	0	SENT_13	[p1l464t1550r675b1621],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_13	[p1l695t1550r879b1621],
8	Z	NNP	LOCATION	Z	appos	2	SENT_13	[p1l892t1550r951b1617],
9	,	,	O	,	_	0	SENT_13	[p1l892t1550r951b1617],
10	et	FW	O	et	nn	11	SENT_13	[p1l973t1557r1031b1604],
11	al.	FW	O	al.	appos	2	SENT_13	[p1l1043t1545r1115b1604],
12	.	.	O	.	_	0	SENT_13	[p1l1043t1545r1115b1604],

1	Proportion	NN	O	proportion	_	0	SENT_14	[p1l1135t1546r1483b1621],
2	of	IN	O	of	_	0	SENT_14	[p1l1501t1544r1577b1604],
3	different	JJ	O	different	amod	4	SENT_14	[p1l1581t1544r1858b1604],
4	subtypes	NNS	O	subtype	prep_of	1	SENT_14	[p1l1872t1545r2148b1621],
5	of	IN	O	of	_	0	SENT_14	[p1l10t1641r86b1701],
6	stroke	NN	O	stroke	prep_of	1	SENT_14	[p1l92t1642r288b1702],
7	in	IN	O	in	_	0	SENT_14	[p1l306t1643r367b1701],
8	China	NNP	LOCATION	China	prep_in	1	SENT_14	[p1l386t1642r593b1701],
9	.	.	O	.	_	0	SENT_14	[p1l386t1642r593b1701],

1	Stroke	NNP	O	Stroke	_	0	SENT_15	[p1l617t1642r820b1702],
2	2003	CD	DATE	2003	num	1	SENT_15	[p1l838t1646r1363b1714],
3	;	:	O	;	_	0	SENT_15	[p1l838t1646r1363b1714],
4	34:2091	CD	NUMBER	34:2091	number	5	SENT_15	[p1l838t1646r1363b1714],
5	-6	CD	NUMBER	-6	dep	1	SENT_15	[p1l838t1646r1363b1714],
6	.	.	O	.	_	0	SENT_15	[p1l838t1646r1363b1714],

1	4	LS	NUMBER	4	_	0	SENT_16	[p1l8t1746r61b1797],
2	.	.	O	.	_	0	SENT_16	[p1l8t1746r61b1797],

1	Brott	NNP	PERSON	Brott	nn	2	SENT_17	[p1l138t1744r302b1798],
2	T	NN	O	t	_	0	SENT_17	[p1l318t1743r374b1810],
3	,	,	O	,	_	0	SENT_17	[p1l318t1743r374b1810],
4	Broderick	NNP	PERSON	Broderick	nn	5	SENT_17	[p1l399t1739r716b1799],
5	J	NNP	PERSON	J	appos	2	SENT_17	[p1l727t1744r772b1810],
6	,	,	O	,	_	0	SENT_17	[p1l727t1744r772b1810],
7	Kothari	NNP	PERSON	Kothari	nn	8	SENT_17	[p1l798t1739r1039b1800],
8	R	NNP	PERSON	R	appos	2	SENT_17	[p1l1060t1744r1125b1810],
9	,	,	O	,	_	0	SENT_17	[p1l1060t1744r1125b1810],
10	et	FW	O	et	nn	11	SENT_17	[p1l1152t1751r1210b1797],
11	al.	FW	O	al.	appos	2	SENT_17	[p1l1228t1739r1299b1798],
12	.	.	O	.	_	0	SENT_17	[p1l1228t1739r1299b1798],

1	Early	RB	O	early	advmod	3	SENT_18	[p1l1325t1739r1486b1814],
2	hemorrhage	NN	O	hemorrhage	nn	3	SENT_18	[p1l1505t1739r1898b1814],
3	growth	NN	O	growth	_	0	SENT_18	[p1l1920t1739r2149b1814],
4	in	IN	O	in	_	0	SENT_18	[p1l9t1835r71b1893],
5	patients	NNS	O	patient	prep_in	3	SENT_18	[p1l88t1836r341b1910],
6	with	IN	O	with	_	0	SENT_18	[p1l358t1835r501b1894],
7	intracerebral	JJ	O	intracerebral	amod	8	SENT_18	[p1l519t1835r926b1894],
8	hemorrhage	NN	O	hemorrhage	prep_with	3	SENT_18	[p1l944t1835r1355b1910],
9	.	.	O	.	_	0	SENT_18	[p1l944t1835r1355b1910],

1	Stroke	NNP	O	Stroke	_	0	SENT_19	[p1l1379t1835r1582b1895],
2	1997	CD	DATE	1997	num	1	SENT_19	[p1l1603t1839r2004b1906],
3	;	:	O	;	_	0	SENT_19	[p1l1603t1839r2004b1906],
4	28:1	CD	NUMBER	28:1	number	5	SENT_19	[p1l1603t1839r2004b1906],
5	-5	CD	NUMBER	-5	dep	1	SENT_19	[p1l1603t1839r2004b1906],
6	.	.	O	.	_	0	SENT_19	[p1l1603t1839r2004b1906],

1	5	CD	NUMBER	5	_	0	SENT_20	[p1l10t1938r61b1989],
2	.	.	O	.	_	0	SENT_20	[p1l10t1938r61b1989],

1	Becker	NNP	PERSON	Becker	nn	3	SENT_21	[p1l138t1931r356b1991],
2	K	NNP	O	K	nn	3	SENT_21	[p1l374t1936r462b2002],
3	]	NNP	O	]	_	0	SENT_21	[p1l374t1936r462b2002],
4	,	,	O	,	_	0	SENT_21	[p1l374t1936r462b2002],
5	Baxter	NNP	ORGANIZATION	Baxter	nn	6	SENT_21	[p1l486t1936r690b1989],
6	AB	NNP	ORGANIZATION	AB	appos	3	SENT_21	[p1l705t1936r817b2002],
7	,	,	O	,	_	0	SENT_21	[p1l705t1936r817b2002],
8	Bybee	NNP	PERSON	Bybee	nn	9	SENT_21	[p1l841t1931r1028b2006],
9	HM	NNS	O	hm	appos	6	SENT_21	[p1l1048t1936r1188b2002],
10	,	,	O	,	_	0	SENT_21	[p1l1048t1936r1188b2002],
11	Tirschwell	NNP	ORGANIZATION	Tirschwell	nn	12	SENT_21	[p1l1210t1931r1546b1991],
12	DL	NNP	ORGANIZATION	DL	appos	6	SENT_21	[p1l1565t1936r1675b2002],
13	,	,	O	,	_	0	SENT_21	[p1l1565t1936r1675b2002],
14	Abouelsaad	NNP	ORGANIZATION	Abouelsaad	nn	15	SENT_21	[p1l1697t1931r2071b1991],
15	T	NN	ORGANIZATION	t	appos	6	SENT_21	[p1l2089t1935r2144b2002],
16	,	,	O	,	_	0	SENT_21	[p1l2089t1935r2144b2002],
17	Cohen	NNP	PERSON	Cohen	nn	18	SENT_21	[p1l10t2027r218b2086],
18	WA	NNP	O	WA	appos	6	SENT_21	[p1l244t2032r375b2086],
19	.	.	O	.	_	0	SENT_21	[p1l244t2032r375b2086],

1	Extravasation	NN	O	extravasation	nsubj	8	SENT_22	[p1l407t2028r836b2087],
2	of	IN	O	of	_	0	SENT_22	[p1l865t2026r942b2086],
3	radiographic	JJ	O	radiographic	amod	4	SENT_22	[p1l956t2027r1366b2103],
4	contrast	NN	O	contrast	prep_of	1	SENT_22	[p1l1395t2039r1657b2086],
5	is	VBZ	O	be	cop	8	SENT_22	[p1l1682t2028r1730b2086],
6	an	DT	O	a	det	8	SENT_22	[p1l1761t2047r1836b2086],
7	independent	JJ	O	independent	amod	8	SENT_22	[p1l1865t2027r2148b2103, p1l10t2124r153b2183],
8	predictor	NN	O	predictor	_	0	SENT_22	[p1l165t2124r459b2200],
9	of	IN	O	of	_	0	SENT_22	[p1l475t2123r551b2183],
10	death	NN	O	death	prep_of	8	SENT_22	[p1l555t2124r729b2183],
11	in	IN	O	in	_	0	SENT_22	[p1l746t2125r807b2183],
12	primary	JJ	O	primary	amod	14	SENT_22	[p1l823t2125r1077b2200],
13	intracerebral	JJ	O	intracerebral	amod	14	SENT_22	[p1l1090t2124r1498b2183],
14	hemorrhage	NN	O	hemorrhage	prep_in	10	SENT_22	[p1l1514t2124r1924b2200],
15	.	.	O	.	_	0	SENT_22	[p1l1514t2124r1924b2200],

1	Stroke	NN	O	stroke	_	0	SENT_23	[p1l1947t2124r2149b2184],
2	1999	CD	DATE	1999	num	1	SENT_23	[p1l12t2225r573b2292],
3	;	:	O	;	_	0	SENT_23	[p1l12t2225r573b2292],
4	30:2025	CD	NUMBER	30:2025	number	5	SENT_23	[p1l12t2225r573b2292],
5	—	CD	NUMBER	—	dep	1	SENT_23	[p1l12t2225r573b2292],
6	32	CD	NUMBER	32	dep	5	SENT_23	[p1l12t2225r573b2292],
7	.	.	O	.	_	0	SENT_23	[p1l12t2225r573b2292],

1	6	CD	NUMBER	6	_	0	SENT_24	[p1l10t2323r61b2376],
2	.	.	O	.	_	0	SENT_24	[p1l10t2323r61b2376],

1	Morgenstern	NNP	PERSON	Morgenstern	nn	2	SENT_25	[p1l137t2322r553b2392],
2	LB	NNP	O	LB	_	0	SENT_25	[p1l571t2322r672b2388],
3	,	,	O	,	_	0	SENT_25	[p1l571t2322r672b2388],
4	Bartholomew	NNP	ORGANIZATION	Bartholomew	nn	5	SENT_25	[p1l695t2317r1132b2377],
5	LK	NNP	ORGANIZATION	LK	conj_and	2	SENT_25	[p1l1147t2322r1254b2388],
6	,	,	O	,	_	0	SENT_25	[p1l1147t2322r1254b2388],
7	Grotta	NNP	PERSON	Grotta	nn	8	SENT_25	[p1l1278t2321r1486b2376],
8	JC	NNP	O	JC	conj_and	2	SENT_25	[p1l1496t2321r1590b2388],
9	,	,	O	,	_	0	SENT_25	[p1l1496t2321r1590b2388],
10	Staub	NNP	O	Staub	nn	11	SENT_25	[p1l1615t2317r1792b2377],
11	L	NNP	O	L	conj_and	2	SENT_25	[p1l1813t2322r1868b2388],
12	,	,	O	,	_	0	SENT_25	[p1l1813t2322r1868b2388],
13	King	NNP	O	King	nn	14	SENT_25	[p1l1891t2317r2047b2392],
14	M	NNP	O	M	conj_and	2	SENT_25	[p1l2062t2322r2144b2388],
15	,	,	O	,	_	0	SENT_25	[p1l2062t2322r2144b2388],
16	Chan	NNP	PERSON	Chan	nn	19	SENT_25	[p1l10t2413r177b2472],
17	W.	NNP	PERSON	W.	nn	19	SENT_25	[p1l198t2418r277b2472],
18	Sustained	JJ	PERSON	sustained	amod	19	SENT_25	[p1l307t2413r618b2473],
19	benefit	NN	O	benefit	conj_and	2	SENT_25	[p1l642t2412r865b2472],
20	of	IN	O	of	_	0	SENT_25	[p1l886t2412r962b2472],
21	a	DT	O	a	det	22	SENT_25	[p1l971t2433r1004b2472],
22	community	NN	O	community	prep_of	19	SENT_25	[p1l1028t2414r1395b2489],
23	and	CC	O	and	_	0	SENT_25	[p1l1415t2413r1533b2472],
24	professional	JJ	O	professional	amod	25	SENT_25	[p1l1556t2412r1952b2489],
25	intervention	NN	O	intervention	conj_and	2	SENT_25	[p1l1975t2414r2148b2472, p1l6t2510r245b2569],
26	to	TO	O	to	aux	27	SENT_25	[p1l264t2522r324b2569],
27	increase	VB	O	increase	infmod	2	SENT_25	[p1l342t2510r603b2568],
28	acute	JJ	O	acute	amod	30	SENT_25	[p1l621t2523r787b2570],
29	stroke	NN	O	stroke	nn	30	SENT_25	[p1l807t2510r1002b2570],
30	therapy	NN	O	therapy	dobj	27	SENT_25	[p1l1021t2510r1268b2585],
31	.	.	O	.	_	0	SENT_25	[p1l1021t2510r1268b2585],

1	Arch	NNP	O	Arch	nn	3	SENT_26	[p1l1287t2510r1441b2568],
2	Intern	NNP	O	Intern	nn	3	SENT_26	[p1l1457t2515r1653b2568],
3	Med	NNP	O	Med	_	0	SENT_26	[p1l1669t2510r1810b2569],
4	2003	CD	DATE	2003	num	3	SENT_26	[p1l1828t2514r2145b2581],
5	;	:	O	;	_	0	SENT_26	[p1l1828t2514r2145b2581],
6	163	CD	NUMBER	163	num	8	SENT_26	[p1l1828t2514r2145b2581],
7	:	:	O	:	_	0	SENT_26	[p1l1828t2514r2145b2581],
8	2198-202	CD	NUMBER	2198-202	dep	3	SENT_26	[p1l10t2610r329b2665],
9	.	.	O	.	_	0	SENT_26	[p1l10t2610r329b2665],

1	7	CD	NUMBER	7	_	0	SENT_27	[p1l11t2711r61b2762],
2	.	.	O	.	_	0	SENT_27	[p1l11t2711r61b2762],

1	Mayer	NNP	ORGANIZATION	Mayer	nn	2	SENT_28	[p1l137t2708r334b2779],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_28	[p1l350t2707r450b2775],
3	,	,	O	,	_	0	SENT_28	[p1l350t2707r450b2775],
4	Brun	NNP	PERSON	Brun	nn	5	SENT_28	[p1l469t2708r625b2763],
5	NC	NNP	O	NC	appos	2	SENT_28	[p1l640t2707r762b2775],
6	,	,	O	,	_	0	SENT_28	[p1l640t2707r762b2775],
7	Broderick	NNP	PERSON	Broderick	nn	8	SENT_28	[p1l781t2703r1147b2775],
8	]	NNP	O	]	appos	2	SENT_28	[p1l781t2703r1147b2775],
9	,	,	O	,	_	0	SENT_28	[p1l781t2703r1147b2775],
10	et	FW	O	et	nn	11	SENT_28	[p1l1167t2715r1225b2762],
11	al.	FW	O	al.	appos	2	SENT_28	[p1l1237t2703r1308b2762],
12	.	.	O	.	_	0	SENT_28	[p1l1237t2703r1308b2762],

1	Safety	NN	O	safety	_	0	SENT_29	[p1l1330t2702r1518b2779],
2	and	CC	O	and	_	0	SENT_29	[p1l1530t2703r1648b2762],
3	feasibility	NN	O	feasibility	conj_and	1	SENT_29	[p1l1664t2702r1974b2779],
4	of	IN	O	of	_	0	SENT_29	[p1l1986t2702r2062b2762],
5	recombinant	JJ	O	recombinant	amod	7	SENT_29	[p1l2064t2723r2148b2762, p1l10t2800r359b2859],
6	factor	NN	O	factor	nn	7	SENT_29	[p1l385t2799r571b2859],
7	VIIa	NN	O	vium	prep_of	1	SENT_29	[p1l594t2805r725b2859],
8	for	IN	O	for	_	0	SENT_29	[p1l753t2799r846b2859],
9	acute	JJ	O	acute	amod	11	SENT_29	[p1l872t2812r1038b2860],
10	intracerebral	JJ	O	intracerebral	amod	11	SENT_29	[p1l1066t2800r1473b2859],
11	hemorrhage	NN	O	hemorrhage	prep_for	1	SENT_29	[p1l1502t2800r1912b2876],
12	.	.	O	.	_	0	SENT_29	[p1l1502t2800r1912b2876],

1	Stroke	NNP	O	Stroke	_	0	SENT_30	[p1l1947t2800r2149b2860],
2	2005	CD	DATE	2005	num	1	SENT_30	[p1l10t2901r454b2967],
3	;	:	O	;	_	0	SENT_30	[p1l10t2901r454b2967],
4	36:74	CD	NUMBER	36:74	number	5	SENT_30	[p1l10t2901r454b2967],
5	-9	CD	NUMBER	-9	dep	1	SENT_30	[p1l10t2901r454b2967],
6	.	.	O	.	_	0	SENT_30	[p1l10t2901r454b2967],

1	8	CD	NUMBER	8	_	0	SENT_31	[p1l9t2999r61b3053],
2	.	.	O	.	_	0	SENT_31	[p1l9t2999r61b3053],

1	Qureshi	NNP	PERSON	Qureshi	nn	2	SENT_32	[p1l139t2993r393b3067],
2	AI	NNP	O	AI	_	0	SENT_32	[p1l407t2999r497b3066],
3	,	,	O	,	_	0	SENT_32	[p1l407t2999r497b3066],
4	Bliwise	NNP	PERSON	Bliwise	nn	5	SENT_32	[p1l517t2993r746b3053],
5	DL	NNP	O	DL	appos	2	SENT_32	[p1l763t2998r872b3066],
6	,	,	O	,	_	0	SENT_32	[p1l763t2998r872b3066],
7	Bliwise	NNP	PERSON	Bliwise	nn	9	SENT_32	[p1l892t2993r1121b3053],
8	N	NNP	PERSON	N	nn	9	SENT_32	[p1l1137t2999r1193b3053],
9	G	NNP	PERSON	G	appos	2	SENT_32	[p1l1196t2998r1267b3065],
10	,	,	O	,	_	0	SENT_32	[p1l1196t2998r1267b3065],
11	Akbar	NNP	O	Akbar	nn	12	SENT_32	[p1l1286t2993r1481b3053],
12	MS	NN	O	m	appos	2	SENT_32	[p1l1493t2998r1615b3066],
13	,	,	O	,	_	0	SENT_32	[p1l1493t2998r1615b3066],
14	Uzen	NNP	O	Uzen	nn	15	SENT_32	[p1l1635t2999r1800b3053],
15	G	NNP	O	G	appos	2	SENT_32	[p1l1817t2998r1889b3066],
16	,	,	O	,	_	0	SENT_32	[p1l1817t2998r1889b3066],
17	Frankel	NNP	PERSON	Frankel	appos	2	SENT_32	[p1l1909t2993r2150b3053],

1	MR.	NNP	O	MR.	nn	2	SENT_33	[p2l7t23r140b82],
2	Rate	NNP	O	Rate	_	0	SENT_33	[p2l172t23r314b82],
3	of	IN	O	of	_	0	SENT_33	[p2l346t18r422b78],
4	24-hour	JJ	DURATION	24-hour	amod	7	SENT_33	[p2l439t19r703b78],
5	blood	NN	O	blood	nn	7	SENT_33	[p2l733t18r919b78],
6	pressure	NN	O	pressure	nn	7	SENT_33	[p2l949t38r1227b95],
7	decline	NN	O	decline	prep_of	2	SENT_33	[p2l1260t18r1491b78],
8	and	CC	O	and	_	0	SENT_33	[p2l1522t18r1642b78],
9	mortality	NN	O	mortality	prep_of	2	SENT_33	[p2l1673t18r1972b95],
10	after	IN	O	after	_	0	SENT_33	[p2l2000t18r2149b78],
11	spontaneous	JJ	O	spontaneous	amod	13	SENT_33	[p2l11t128r415b192],
12	intracerebral	JJ	O	intracerebral	amod	13	SENT_33	[p2l433t115r836b175],
13	hemorrhage	NN	O	hemorrhage	prep_after	7	SENT_33	[p2l852t115r1259b192],
14	:	:	O	:	_	0	SENT_33	[p2l852t115r1259b192],
15	a	DT	O	a	det	17	SENT_33	[p2l1278t136r1312b175],
16	retrospective	JJ	O	retrospective	amod	17	SENT_33	[p2l1327t116r1730b192],
17	analysis	NN	O	analysis	dep	2	SENT_33	[p2l1746t116r1993b192],
18	with	IN	O	with	_	0	SENT_33	[p2l2008t115r2149b175],
19	a	DT	O	a	det	23	SENT_33	[p2l9t233r43b272],
20	random	JJ	O	random	amod	23	SENT_33	[p2l62t212r318b272],
21	effects	NNS	O	effect	nn	23	SENT_33	[p2l339t212r548b272],
22	regression	NN	O	regression	nn	23	SENT_33	[p2l569t213r912b289],
23	model	NN	O	model	prep_with	17	SENT_33	[p2l932t212r1155b272],
24	.	.	O	.	_	0	SENT_33	[p2l932t212r1155b272],

1	Crit	NNP	O	Crit	nn	2	SENT_34	[p2l1179t213r1303b272],
2	Care	NNP	O	Care	nsubj	3	SENT_34	[p2l1320t217r1466b272],
3	Med	VBD	O	med	_	0	SENT_34	[p2l1484t212r1627b272],
4	1999	CD	DATE	1999	dobj	3	SENT_34	[p2l1650t217r2136b285],
5	;	:	O	;	_	0	SENT_34	[p2l1650t217r2136b285],
6	27:480	CD	NUMBER	27:480	number	7	SENT_34	[p2l1650t217r2136b285],
7	—	CD	NUMBER	—	dep	4	SENT_34	[p2l1650t217r2136b285],
8	5	CD	NUMBER	5	dep	7	SENT_34	[p2l1650t217r2136b285],
9	.	.	O	.	_	0	SENT_34	[p2l1650t217r2136b285],

1	9	CD	NUMBER	9	_	0	SENT_35	[p2l9t316r61b369],
2	.	.	O	.	_	0	SENT_35	[p2l9t316r61b369],

1	Fogelholm	NNP	O	Fogelholm	nn	2	SENT_36	[p2l138t309r485b386],
2	R	NNP	O	R	_	0	SENT_36	[p2l506t314r571b382],
3	,	,	O	,	_	0	SENT_36	[p2l506t314r571b382],
4	Avikainen	NNP	PERSON	Avikainen	nn	5	SENT_36	[p2l594t309r913b369],
5	S	NNP	O	S	conj_and	2	SENT_36	[p2l937t314r989b382],
6	,	,	O	,	_	0	SENT_36	[p2l937t314r989b382],
7	Murros	NNP	O	Murros	nn	10	SENT_36	[p2l1013t315r1247b369],
8	K.	NNP	O	K.	nn	10	SENT_36	[p2l1271t315r1337b371],
9	Prognostic	NNP	O	Prognostic	nn	10	SENT_36	[p2l1361t310r1707b386],
10	value	NN	O	value	conj_and	2	SENT_36	[p2l1724t309r1889b369],
11	and	CC	O	and	_	0	SENT_36	[p2l1910t309r2029b369],
12	determinants	NNS	O	determinant	conj_and	2	SENT_36	[p2l2051t309r2148b369, p2l10t407r356b466],
13	of	IN	O	of	_	0	SENT_36	[p2l386t406r463b466],
14	ﬁrst-day	JJ	O	ﬁrst-day	amod	15	SENT_36	[p2l477t406r742b483],
15	mean	NN	O	mean	prep_of	12	SENT_36	[p2l768t426r943b466],
16	arterial	JJ	O	arterial	amod	17	SENT_36	[p2l972t406r1196b466],
17	pressure	NN	O	pressure	dep	2	SENT_36	[p2l1223t426r1496b483],
18	in	IN	O	in	_	0	SENT_36	[p2l1524t407r1585b465],
19	spontaneous	JJ	O	spontaneous	amod	22	SENT_36	[p2l1614t419r2021b483],
20	supratentorial	JJ	O	supratentorial	amod	22	SENT_36	[p2l2053t427r2147b466, p2l8t503r384b580],
21	intracerebral	JJ	O	intracerebral	amod	22	SENT_36	[p2l402t503r809b563],
22	hemorrhage	NN	O	hemorrhage	prep_in	17	SENT_36	[p2l828t504r1238b580],
23	.	.	O	.	_	0	SENT_36	[p2l828t504r1238b580],

1	Stroke	NNP	O	Stroke	_	0	SENT_37	[p2l1262t504r1465b564],
2	1997	CD	DATE	1997	num	1	SENT_37	[p2l1486t508r2088b576],
3	;	:	O	;	_	0	SENT_37	[p2l1486t508r2088b576],
4	28:1396	CD	NUMBER	28:1396	num	5	SENT_37	[p2l1486t508r2088b576],
5	—	NN	O	—	dep	1	SENT_37	[p2l1486t508r2088b576],
6	400	CD	NUMBER	400	dep	5	SENT_37	[p2l1486t508r2088b576],
7	.	.	O	.	_	0	SENT_37	[p2l1486t508r2088b576],

1	10	CD	NUMBER	10	_	0	SENT_38	[p2l12t606r98b660],
2	.	.	O	.	_	0	SENT_38	[p2l12t606r98b660],

1	Powers	NNP	O	Powers	nn	3	SENT_39	[p2l138t605r367b660],
2	W	NNP	O	W	nn	3	SENT_39	[p2l381t606r492b673],
3	]	NN	O	]	_	0	SENT_39	[p2l381t606r492b673],
4	,	,	O	,	_	0	SENT_39	[p2l381t606r492b673],
5	Zazulia	NNP	ORGANIZATION	Zazulia	nn	6	SENT_39	[p2l511t600r744b660],
6	AR	NNS	ORGANIZATION	ar	appos	3	SENT_39	[p2l756t605r871b673],
7	,	,	O	,	_	0	SENT_39	[p2l756t605r871b673],
8	Videen	JJ	ORGANIZATION	videen	amod	10	SENT_39	[p2l888t600r1108b660],
9	T	NN	ORGANIZATION	t	nn	10	SENT_39	[p2l1121t605r1168b659],
10	O	NN	ORGANIZATION	o	appos	3	SENT_39	[p2l1169t605r1236b673],
11	,	,	O	,	_	0	SENT_39	[p2l1169t605r1236b673],
12	et	FW	O	et	nn	13	SENT_39	[p2l1257t613r1315b660],
13	al.	FW	O	al.	appos	3	SENT_39	[p2l1326t600r1398b660],
14	.	.	O	.	_	0	SENT_39	[p2l1326t600r1398b660],

1	Autoregulation	NN	O	autoregulation	nsubj	13	SENT_40	[p2l1415t600r1900b677],
2	of	IN	O	of	_	0	SENT_40	[p2l1917t600r1992b660],
3	cerebral	JJ	O	cerebral	amod	5	SENT_40	[p2l1995t620r2148b660, p2l10t697r132b757],
4	blood	NN	O	blood	nn	5	SENT_40	[p2l168t697r350b757],
5	ﬂow	NN	O	ﬂow	prep_of	1	SENT_40	[p2l385t697r527b757],
6	surrounding	VBG	O	surround	partmod	5	SENT_40	[p2l560t697r962b774],
7	acute	JJ	O	acute	amod	8	SENT_40	[p2l993t710r1159b757],
8	(	NN	O	(	dobj	6	SENT_40	[p2l1198t702r1256b766],
9	6	CD	DURATION	6	number	11	SENT_40	[p2l1198t702r1256b766],
10	to	TO	DURATION	to	dep	11	SENT_40	[p2l1292t710r1352b757],
11	22	CD	DURATION	22	num	12	SENT_40	[p2l1387t702r1463b756],
12	hours	NNS	NUMBER	hour	tmod	8	SENT_40	[p2l1499t698r1704b766],
13	)	VBP	O	)	_	0	SENT_40	[p2l1499t698r1704b766],
14	intracerebral	JJ	O	intracerebral	amod	15	SENT_40	[p2l1743t697r2149b757],
15	hemorrhage	NN	O	hemorrhage	dobj	13	SENT_40	[p2l10t794r419b871],
16	.	.	O	.	_	0	SENT_40	[p2l10t794r419b871],

1	Neurology	NNP	O	Neurology	_	0	SENT_41	[p2l441t795r781b871],
2	2001	CD	DATE	2001	num	1	SENT_41	[p2l796t799r1280b866],
3	;	:	O	;	_	0	SENT_41	[p2l796t799r1280b866],
4	57:18	CD	NUMBER	57:18	number	5	SENT_41	[p2l796t799r1280b866],
5	-24	CD	NUMBER	-24	dep	1	SENT_41	[p2l796t799r1280b866],
6	.	.	O	.	_	0	SENT_41	[p2l796t799r1280b866],

1	1	CD	NUMBER	1	num	2	SENT_42	[p2l12t898r40b948],
2	1	CD	NUMBER	1	_	0	SENT_42	[p2l50t898r98b949],
3	.	.	O	.	_	0	SENT_42	[p2l50t898r98b949],

1	Becker	NNP	PERSON	Becker	nn	3	SENT_43	[p2l138t890r356b950],
2	K	NNP	O	K	nn	3	SENT_43	[p2l369t896r458b962],
3	]	NNP	O	]	_	0	SENT_43	[p2l369t896r458b962],
4	,	,	O	,	_	0	SENT_43	[p2l369t896r458b962],
5	Baxter	NNP	ORGANIZATION	Baxter	nn	6	SENT_43	[p2l476t895r680b949],
6	AB	NNP	ORGANIZATION	AB	appos	3	SENT_43	[p2l691t895r802b962],
7	,	,	O	,	_	0	SENT_43	[p2l691t895r802b962],
8	Cohen	NNP	PERSON	Cohen	nn	9	SENT_43	[p2l822t890r1030b950],
9	WA	NNP	O	WA	appos	3	SENT_43	[p2l1044t896r1175b962],
10	,	,	O	,	_	0	SENT_43	[p2l1044t896r1175b962],
11	et	FW	O	et	nn	12	SENT_43	[p2l1195t903r1254b949],
12	al.	FW	O	al.	appos	3	SENT_43	[p2l1265t890r1336b950],
13	.	.	O	.	_	0	SENT_43	[p2l1265t890r1336b950],

1	Withdrawal	NN	O	withdrawal	nsubj	8	SENT_44	[p2l1353t890r1730b950],
2	of	IN	O	of	_	0	SENT_44	[p2l1746t890r1822b950],
3	support	NN	O	support	prep_of	1	SENT_44	[p2l1825t903r2075b965],
4	in	IN	O	in	_	0	SENT_44	[p2l2087t891r2149b948],
5	intracerebral	JJ	O	intracerebral	amod	6	SENT_44	[p2l9t988r416b1047],
6	hemorrhage	NN	O	hemorrhage	prep_in	3	SENT_44	[p2l454t987r846b1064],
7	may	MD	O	may	aux	8	SENT_44	[p2l885t1007r1019b1064],
8	lead	VB	O	lead	_	0	SENT_44	[p2l1053t987r1183b1047],
9	to	TO	O	to	_	0	SENT_44	[p2l1222t1000r1282b1047],
10	self	NN	O	self	nn	15	SENT_44	[p2l1322t987r1740b1064],
11	—	NN	O	—	nn	15	SENT_44	[p2l1322t987r1740b1064],
12	ﬁ	NN	O	ﬁ	nn	15	SENT_44	[p2l1322t987r1740b1064],
13	.1	CD	NUMBER	.1	num	15	SENT_44	[p2l1322t987r1740b1064],
14	lﬁlling	NN	O	lﬁlling	nn	15	SENT_44	[p2l1322t987r1740b1064],
15	prophecies	NNS	O	prophecy	prep_to	8	SENT_44	[p2l1775t988r2145b1064],
16	.	.	O	.	_	0	SENT_44	[p2l1775t988r2145b1064],

1	Neurology	NNP	O	Neurology	_	0	SENT_45	[p2l8t1084r347b1161],
2	2001	CD	DATE	2001	num	1	SENT_45	[p2l363t1089r887b1157],
3	;	:	O	;	_	0	SENT_45	[p2l363t1089r887b1157],
4	56:766	CD	NUMBER	56:766	number	5	SENT_45	[p2l363t1089r887b1157],
5	—	CD	NUMBER	—	dep	1	SENT_45	[p2l363t1089r887b1157],
6	72	CD	NUMBER	72	dep	5	SENT_45	[p2l363t1089r887b1157],
7	.	.	O	.	_	0	SENT_45	[p2l363t1089r887b1157],

1	12	CD	NUMBER	12	_	0	SENT_46	[p2l12t1188r98b1240],
2	.	.	O	.	_	0	SENT_46	[p2l12t1188r98b1240],

1	HemphillJC	NN	PERSON	hemphilljc	_	0	SENT_47	[p2l138t1180r533b1255],
2	III	CD	PERSON	iii	num	1	SENT_47	[p2l557t1186r647b1252],
3	,	,	O	,	_	0	SENT_47	[p2l557t1186r647b1252],
4	Newman	NNP	PERSON	Newman	nn	8	SENT_47	[p2l673t1186r963b1240],
5	I	PRP	O	I	dep	8	SENT_47	[p2l979t1186r1023b1252],
6	,	,	O	,	_	0	SENT_47	[p2l979t1186r1023b1252],
7	Zhao	NNP	PERSON	Zhao	dep	8	SENT_47	[p2l1049t1180r1208b1240],
8	S	NNP	O	S	appos	1	SENT_47	[p2l1234t1185r1286b1252],
9	,	,	O	,	_	0	SENT_47	[p2l1234t1185r1286b1252],
10	Johnston	NNP	PERSON	Johnston	nn	11	SENT_47	[p2l1307t1180r1602b1249],
11	SC	NNP	O	SC	appos	8	SENT_47	[p2l1627t1185r1728b1240],
12	.	.	O	.	_	0	SENT_47	[p2l1627t1185r1728b1240],

1	Hospital	NNP	O	Hospital	nn	2	SENT_48	[p2l1754t1180r2028b1255],
2	usage	NN	O	usage	_	0	SENT_48	[p2l2051t1200r2147b1240, p2l9t1298r117b1354],
3	of	IN	O	of	_	0	SENT_48	[p2l141t1277r217b1337],
4	early	JJ	O	early	amod	8	SENT_48	[p2l228t1278r379b1354],
5	do-not	JJ	O	do-not	amod	8	SENT_48	[p2l399t1277r982b1337],
6	—	NN	O	—	nn	8	SENT_48	[p2l399t1277r982b1337],
7	resuscitate	NN	O	resuscitate	nn	8	SENT_48	[p2l399t1277r982b1337],
8	orders	NNS	O	order	prep_of	2	SENT_48	[p2l1007t1277r1207b1337],
9	and	CC	O	and	_	0	SENT_48	[p2l1232t1277r1350b1337],
10	outcome	NN	O	outcome	conj_and	8	SENT_48	[p2l1374t1290r1652b1337],
11	after	IN	O	after	_	0	SENT_48	[p2l1675t1277r1821b1337],
12	intracerebral	JJ	O	intracerebral	amod	13	SENT_48	[p2l1843t1278r2148b1337, p2l10t1374r132b1434],
13	hemorrhage	NN	O	hemorrhage	prep_after	2	SENT_48	[p2l151t1374r561b1451],
14	.	.	O	.	_	0	SENT_48	[p2l151t1374r561b1451],

1	Stroke	NNP	O	Stroke	_	0	SENT_49	[p2l586t1375r788b1434],
2	2004	CD	DATE	2004	num	1	SENT_49	[p2l807t1379r1331b1447],
3	;	:	O	;	_	0	SENT_49	[p2l807t1379r1331b1447],
4	35:1130	CD	NUMBER	35:1130	number	5	SENT_49	[p2l807t1379r1331b1447],
5	—	CD	NUMBER	—	dep	1	SENT_49	[p2l807t1379r1331b1447],
6	4	CD	NUMBER	4	dep	5	SENT_49	[p2l807t1379r1331b1447],
7	.	.	O	.	_	0	SENT_49	[p2l807t1379r1331b1447],

1	13	CD	NUMBER	13	_	0	SENT_50	[p2l12t1479r98b1531],
2	.	.	O	.	_	0	SENT_50	[p2l12t1479r98b1531],

1	Mendelow	JJ	O	mendelow	amod	2	SENT_51	[p2l137t1471r476b1531],
2	AD	NN	O	ad	_	0	SENT_51	[p2l490t1476r607b1544],
3	,	,	O	,	_	0	SENT_51	[p2l490t1476r607b1544],
4	Gregson	NNP	PERSON	Gregson	nn	5	SENT_51	[p2l630t1476r906b1548],
5	BA	NN	O	ba	appos	2	SENT_51	[p2l924t1476r1034b1544],
6	,	,	O	,	_	0	SENT_51	[p2l924t1476r1034b1544],
7	Fernandes	NNP	PERSON	Fernandes	nn	8	SENT_51	[p2l1056t1471r1387b1531],
8	HM	NNS	O	hm	appos	2	SENT_51	[p2l1408t1476r1546b1544],
9	,	,	O	,	_	0	SENT_51	[p2l1408t1476r1546b1544],
10	et	FW	O	et	nn	11	SENT_51	[p2l1570t1484r1628b1531],
11	al.	FW	O	al.	appos	2	SENT_51	[p2l1643t1471r1714b1531],
12	.	.	O	.	_	0	SENT_51	[p2l1643t1471r1714b1531],

1	Early	RB	O	early	dep	24	SENT_52	[p2l1737t1471r1898b1547],
2	surgery	NN	O	surgery	pobj	1	SENT_52	[p2l1915t1491r2152b1548],
3	versus	CC	O	versus	prep	2	SENT_52	[p2l6t1589r206b1628],
4	initial	JJ	O	initial	amod	6	SENT_52	[p2l236t1568r419b1628],
5	conservative	JJ	O	conservative	amod	6	SENT_52	[p2l447t1569r837b1628],
6	treatment	NN	O	treatment	dep	3	SENT_52	[p2l865t1581r1177b1628],
7	in	IN	O	in	_	0	SENT_52	[p2l1201t1569r1263b1627],
8	patients	NNS	O	patient	prep_in	6	SENT_52	[p2l1289t1569r1542b1645],
9	with	IN	O	with	_	0	SENT_52	[p2l1568t1568r1711b1628],
10	spontaneous	JJ	O	spontaneous	amod	13	SENT_52	[p2l1740t1581r2146b1645],
11	supratentorial	JJ	O	supratentorial	amod	13	SENT_52	[p2l11t1666r459b1742],
12	intracerebral	JJ	O	intracerebral	amod	13	SENT_52	[p2l481t1665r889b1725],
13	hematomas	NNS	O	hematoma	prep_with	1	SENT_52	[p2l912t1666r1285b1725],
14	in	IN	O	in	_	0	SENT_52	[p2l1309t1666r1371b1724],
15	the	DT	O	the	det	18	SENT_52	[p2l1395t1665r1492b1725],
16	International	NNP	MISC	International	nn	18	SENT_52	[p2l1515t1665r1932b1725],
17	Surgical	NNP	MISC	Surgical	nn	18	SENT_52	[p2l1957t1666r2148b1742, p2l10t1762r97b1822],
18	Trial	NNP	MISC	Trial	prep_in	13	SENT_52	[p2l111t1763r258b1822],
19	in	IN	MISC	in	_	0	SENT_52	[p2l276t1763r337b1821],
20	Intracerebral	NNP	MISC	Intracerebral	nn	23	SENT_52	[p2l354t1762r765b1822],
21	Haemorrhage	NNP	MISC	Haemorrhage	nn	23	SENT_52	[p2l782t1763r1225b1839],
22	(	NNP	O	(	nn	23	SENT_52	[p2l1247t1767r1528b1831],
23	STICH	NNP	O	STICH	prep_in	1	SENT_52	[p2l1247t1767r1528b1831],
24	)	CD	NUMBER	)	dep	28	SENT_52	[p2l1247t1767r1528b1831],
25	:	:	O	:	_	0	SENT_52	[p2l1247t1767r1528b1831],
26	a	DT	O	a	det	28	SENT_52	[p2l1548t1783r1581b1822],
27	randomized	JJ	O	randomized	amod	28	SENT_52	[p2l1598t1762r1984b1822],
28	trial	NN	O	trial	_	0	SENT_52	[p2l2002t1762r2145b1822],
29	.	.	O	.	_	0	SENT_52	[p2l2002t1762r2145b1822],

1	Lancet	NNP	O	Lancet	_	0	SENT_53	[p2l8t1864r221b1917],
2	2005	CD	DATE	2005	num	1	SENT_53	[p2l236t1863r389b1917],
3	;	:	O	;	_	0	SENT_53	[p2l400t1863r800b1930],
4	365:387	CD	NUMBER	365:387	number	5	SENT_53	[p2l400t1863r800b1930],
5	—	CD	NUMBER	—	dep	1	SENT_53	[p2l400t1863r800b1930],
6	97	CD	NUMBER	97	dep	5	SENT_53	[p2l400t1863r800b1930],
7	.	.	O	.	_	0	SENT_53	[p2l400t1863r800b1930],

1	14	CD	NUMBER	14	_	0	SENT_54	[p2l12t1963r98b2015],
2	.	.	O	.	_	0	SENT_54	[p2l12t1963r98b2015],

1	Morgenstern	NNP	PERSON	Morgenstern	nn	2	SENT_55	[p2l137t1961r553b2032],
2	LB	NNP	O	LB	_	0	SENT_55	[p2l568t1960r670b2028],
3	,	,	O	,	_	0	SENT_55	[p2l568t1960r670b2028],
4	Demchuk	NNP	PERSON	Demchuk	nn	5	SENT_55	[p2l690t1955r1005b2015],
5	AM	NNP	O	AM	appos	2	SENT_55	[p2l1016t1961r1147b2028],
6	,	,	O	,	_	0	SENT_55	[p2l1016t1961r1147b2028],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_55	[p2l1168t1956r1303b2016],
8	DH	NNP	O	DH	appos	2	SENT_55	[p2l1318t1960r1447b2028],
9	,	,	O	,	_	0	SENT_55	[p2l1318t1960r1447b2028],
10	F	NN	O	f	nn	12	SENT_55	[p2l1467t1961r1503b2014],
11	rankowski	NN	O	rankowskus	nn	12	SENT_55	[p2l1508t1955r1843b2015],
12	RF	NN	O	rf	appos	2	SENT_55	[p2l1858t1960r1954b2028],
13	,	,	O	,	_	0	SENT_55	[p2l1858t1960r1954b2028],
14	Grotta	NNP	PERSON	Grotta	nn	15	SENT_55	[p2l1975t1960r2147b2015, p2l10t2065r68b2112],
15	JC	NNP	O	JC	appos	2	SENT_55	[p2l85t2057r179b2121],
16	.	.	O	.	_	0	SENT_55	[p2l85t2057r179b2121],

1	Rebleeding	VBG	O	rebleed	_	0	SENT_56	[p2l208t2052r572b2129],
2	leads	NNS	O	lead	dobj	1	SENT_56	[p2l594t2052r755b2112],
3	to	TO	O	to	_	0	SENT_56	[p2l784t2065r843b2112],
4	poor	JJ	O	poor	amod	5	SENT_56	[p2l869t2072r1022b2129],
5	outcome	NN	O	outcome	prep_to	1	SENT_56	[p2l1047t2065r1324b2112],
6	in	IN	O	in	_	0	SENT_56	[p2l1349t2053r1411b2111],
7	ultra	NN	O	ultra	prep_in	5	SENT_56	[p2l1437t2052r1764b2129],
8	—	CD	NUMBER	—	num	10	SENT_56	[p2l1437t2052r1764b2129],
9	early	JJ	O	early	amod	10	SENT_56	[p2l1437t2052r1764b2129],
10	craniotomy	NN	O	craniotomy	tmod	1	SENT_56	[p2l1787t2053r2153b2129],
11	for	IN	O	for	_	0	SENT_56	[p2l10t2149r102b2209],
12	intracerebral	JJ	O	intracerebral	amod	13	SENT_56	[p2l119t2149r525b2209],
13	hemorrhage	NN	O	hemorrhage	prep_for	10	SENT_56	[p2l543t2149r954b2226],
14	.	.	O	.	_	0	SENT_56	[p2l543t2149r954b2226],

1	Neurology	NNP	O	Neurology	_	0	SENT_57	[p2l975t2149r1315b2226],
2	2001	CD	DATE	2001	num	1	SENT_57	[p2l1330t2154r1855b2222],
3	;	:	O	;	_	0	SENT_57	[p2l1330t2154r1855b2222],
4	56:1294	CD	NUMBER	56:1294	number	5	SENT_57	[p2l1330t2154r1855b2222],
5	-9	CD	NUMBER	-9	dep	1	SENT_57	[p2l1330t2154r1855b2222],
6	.	.	O	.	_	0	SENT_57	[p2l1330t2154r1855b2222],

1	15	CD	NUMBER	15	_	0	SENT_58	[p2l12t2253r98b2304],
2	.	.	O	.	_	0	SENT_58	[p2l12t2253r98b2304],

1	NINDS	NN	ORGANIZATION	nind	nn	2	SENT_59	[p2l137t2250r367b2305],
2	ICH	NN	O	ich	_	0	SENT_59	[p2l401t2250r530b2305],
3	Workshop	NNP	O	Workshop	nn	4	SENT_59	[p2l560t2245r894b2320],
4	Participants	NNS	O	participant	dep	2	SENT_59	[p2l926t2246r1324b2320],
5	.	.	O	.	_	0	SENT_59	[p2l926t2246r1324b2320],

1	Priorities	NNS	O	priority	_	0	SENT_60	[p2l1359t2246r1647b2305],
2	for	IN	O	for	_	0	SENT_60	[p2l1681t2245r1774b2305],
3	clinical	JJ	O	clinical	amod	4	SENT_60	[p2l1805t2245r2031b2304],
4	research	NN	O	research	prep_for	1	SENT_60	[p2l2063t2265r2148b2304, p2l11t2342r212b2402],
5	in	IN	O	in	_	0	SENT_60	[p2l228t2343r289b2401],
6	intracerebral	JJ	O	intracerebral	amod	7	SENT_60	[p2l305t2343r707b2402],
7	hemorrhage	NN	O	hemorrhage	prep_in	4	SENT_60	[p2l723t2342r1130b2419],
8	:	:	O	:	_	0	SENT_60	[p2l723t2342r1130b2419],
9	report	NN	O	report	dep	1	SENT_60	[p2l1150t2355r1346b2419],
10	from	IN	O	from	_	0	SENT_60	[p2l1359t2342r1514b2402],
11	a	DT	O	a	det	13	SENT_60	[p2l1530t2363r1564b2402],
12	National	NNP	ORGANIZATION	National	nn	13	SENT_60	[p2l1577t2342r1851b2402],
13	Institiute	NNP	ORGANIZATION	Institiute	prep_from	9	SENT_60	[p2l1866t2343r2150b2402],
14	of	IN	ORGANIZATION	of	_	0	SENT_60	[p2l10t2439r86b2499],
15	N	NNP	ORGANIZATION	N	nn	17	SENT_60	[p2l89t2445r145b2499],
16	eurologic	JJ	O	eurologic	amod	17	SENT_60	[p2l148t2440r448b2516],
17	Disorders	NNS	O	disorder	prep_of	13	SENT_60	[p2l465t2439r776b2499],
18	and	CC	O	and	_	0	SENT_60	[p2l796t2439r914b2499],
19	Stroke	NNP	O	Stroke	nn	20	SENT_60	[p2l934t2440r1136b2500],
20	Workshop	NNP	O	Workshop	conj_and	17	SENT_60	[p2l1152t2440r1504b2516],
21	.	.	O	.	_	0	SENT_60	[p2l1152t2440r1504b2516],

1	Stroke	NN	O	stroke	nn	2	SENT_61	[p2l1529t2439r1731b2500],
2	(	NN	O	(	_	0	SENT_61	[p2l1753t2440r1837b2508],
3	in	IN	O	in	_	0	SENT_61	[p2l1753t2440r1837b2508],
4	press	NN	O	press	nn	5	SENT_61	[p2l1854t2444r2066b2516],
5	)	NN	O	)	prep_in	2	SENT_61	[p2l1854t2444r2066b2516],
6	.	.	O	.	_	0	SENT_61	[p2l1854t2444r2066b2516],

1	Copyright	NN	O	copyright	_	0	SENT_62	[p2l11t2564r252b2628],
2	©	CD	NUMBER	©	num	6	SENT_62	[p2l273t2569r327b2623],
3	2005	CD	DATE	2005	num	6	SENT_62	[p2l351t2567r477b2613],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_62	[p2l498t2564r862b2613],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_62	[p2l883t2563r1082b2613],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_62	[p2l1100t2566r1284b2628],
7	.	.	O	.	_	0	SENT_62	[p2l1100t2566r1284b2628],

1	Chasing	VBG	O	chase	_	0	SENT_63	[p2l401t2703r617b2766],
2	Mutations	NNS	O	mutation	dobj	1	SENT_63	[p2l638t2704r906b2751],
3	in	IN	O	in	_	0	SENT_63	[p2l927t2704r970b2751],
4	the	DT	O	the	det	7	SENT_63	[p2l989t2703r1074b2751],
5	Epidermal	NNP	O	Epidermal	nn	7	SENT_63	[p2l1095t2703r1358b2766],
6	Growth	NN	O	growth	nn	7	SENT_63	[p2l1378t2703r1574b2751],
7	Factor	NN	O	factor	prep_in	1	SENT_63	[p2l1595t2708r1758b2751],
8	in	IN	O	in	_	0	SENT_63	[p2l882t2775r926b2822],
9	Lung	NN	O	lung	nn	10	SENT_63	[p2l950t2779r1080b2837],
10	Cancer	NN	O	cancer	prep_in	7	SENT_63	[p2l1096t2778r1279b2822],

1	Jonathan	NNP	PERSON	Jonathan	nn	3	SENT_64	[p2l631t2854r786b2894],
2	E.	NNP	PERSON	E.	nn	3	SENT_64	[p2l804t2857r829b2885],
3	Dowell	NNP	PERSON	Dowell	_	0	SENT_64	[p2l846t2854r968b2890],
4	,	,	O	,	_	0	SENT_64	[p2l846t2854r968b2890],
5	M.D.	NNP	O	M.D.	appos	3	SENT_64	[p2l986t2857r1076b2890],
6	,	,	O	,	_	0	SENT_64	[p2l986t2857r1076b2890],
7	andjohn	NN	PERSON	andjohn	nn	9	SENT_64	[p2l1091t2854r1240b2894],
8	D.	NNP	PERSON	D.	nn	9	SENT_64	[p2l1257t2857r1290b2885],
9	Minna	NNP	PERSON	Minna	appos	3	SENT_64	[p2l1307t2857r1422b2890],
10	,	,	O	,	_	0	SENT_64	[p2l1307t2857r1422b2890],
11	M.D.	NNP	O	M.D.	appos	3	SENT_64	[p2l1439t2857r1519b2885],

1	N	NN	O	n	_	0	SENT_65	[p2l8t3096r83b3167],
2	on	IN	O	on	dep	1	SENT_65	[p2l86t3089r654b3167],
3	—	CD	NUMBER	—	num	8	SENT_65	[p2l86t3089r654b3167],
4	small	JJ	O	small	amod	8	SENT_65	[p2l86t3089r654b3167],
5	—	JJ	O	—	amod	8	SENT_65	[p2l86t3089r654b3167],
6	cell	NN	O	cell	nn	8	SENT_65	[p2l86t3089r654b3167],
7	lung	NN	O	lung	nn	8	SENT_65	[p2l682t3089r874b3189],
8	cancer	NN	O	cancer	pobj	2	SENT_65	[p2l902t3114r1174b3167],
9	is	VBZ	O	be	cop	12	SENT_65	[p2l1201t3089r1265b3167],
10	the	DT	O	the	det	12	SENT_65	[p2l1298t3089r1425b3167],
11	leading	VBG	O	lead	amod	12	SENT_65	[p2l1455t3088r1767b3189],
12	cause	NN	O	cause	rcmod	8	SENT_65	[p2l1794t3115r2023b3168],
13	of	IN	O	of	_	0	SENT_65	[p2l2054t3088r2154b3167],
14	death	NN	O	death	prep_of	12	SENT_65	[p2l11t3217r245b3295],
15	from	IN	O	from	_	0	SENT_65	[p2l272t3216r483b3295],
16	cancer	NN	O	cancer	prep_from	14	SENT_65	[p2l510t3242r791b3295],
17	in	IN	O	in	_	0	SENT_65	[p2l815t3217r896b3294],
18	men	NNS	O	man	prep_in	16	SENT_65	[p2l923t3242r1112b3295],
19	and	CC	O	and	_	0	SENT_65	[p2l1138t3217r1296b3295],
20	women	NNS	O	woman	conj_and	18	SENT_65	[p2l1319t3242r1639b3296],
21	in	IN	O	in	_	0	SENT_65	[p2l1662t3217r1743b3294],
22	the	DT	O	the	det	23	SENT_65	[p2l1767t3217r1895b3295],
23	United	NNP	LOCATION	United	prep_in	12	SENT_65	[p2l1919t3217r2134b3295, p2l11t3343r106b3421],

1	States	NNPS	O	States	nsubj	6	SENT_66	[p2l128t3349r395b3438],
2	,	,	O	,	_	0	SENT_66	[p2l128t3349r395b3438],
3	and	CC	O	and	_	0	SENT_66	[p2l420t3343r574b3422],
4	worldwide	RB	O	worldwide	advmod	1	SENT_66	[p2l589t3344r1034b3422],
5	it	PRP	O	it	nsubj	6	SENT_66	[p2l1054t3344r1113b3421],
6	kills	VBZ	O	kill	_	0	SENT_66	[p2l1127t3343r1299b3423],
7	more	JJR	O	more	mwe	8	SENT_66	[p2l1321t3369r1539b3421],
8	than	IN	O	than	quantmod	10	SENT_66	[p2l1560t3344r1745b3421],
9	1	CD	NUMBER	1	number	10	SENT_66	[p2l1769t3349r1813b3420],
10	million	CD	NUMBER	million	num	11	SENT_66	[p2l1834t3343r2136b3422],
11	people	NNS	O	people	dobj	6	SENT_66	[p2l9t3472r287b3572],
12	annually	RB	SET	annually	advmod	6	SENT_66	[p2l326t3472r694b3572],
13	.	.	O	.	_	0	SENT_66	[p2l326t3472r694b3572],

1	Approximately	RB	O	approximately	quantmod	2	SENT_67	[p2l735t3471r1353b3572],
2	two	CD	NUMBER	two	num	3	SENT_67	[p2l1389t3488r1539b3551],
3	thirds	NNS	O	third	_	0	SENT_67	[p2l1580t3471r1823b3550],
4	of	IN	O	of	_	0	SENT_67	[p2l1871t3471r1972b3550],
5	patients	NNS	O	patient	prep_of	3	SENT_67	[p2l1998t3498r2132b3572, p2l11t3600r236b3678],
6	with	IN	O	with	_	0	SENT_67	[p2l259t3600r445b3679],
7	non	JJ	O	non	amod	13	SENT_67	[p2l470t3599r1091b3678],
8	—	JJ	O	—	amod	13	SENT_67	[p2l470t3599r1091b3678],
9	small	JJ	O	small	amod	13	SENT_67	[p2l470t3599r1091b3678],
10	—	NN	O	—	nn	13	SENT_67	[p2l470t3599r1091b3678],
11	cell	NN	O	cell	nn	13	SENT_67	[p2l470t3599r1091b3678],
12	lung	NN	O	lung	nn	13	SENT_67	[p2l1114t3599r1306b3700],
13	cancer	NN	O	cancer	prep_with	5	SENT_67	[p2l1328t3625r1599b3678],
14	present	JJ	DATE	present	amod	3	SENT_67	[p2l1620t3616r1934b3700],
15	with	IN	O	with	_	0	SENT_67	[p2l1949t3600r2136b3679],
16	locally	RB	O	locally	advmod	20	SENT_67	[p3l9t20r281b121],
17	advanced	VBN	O	advance	amod	20	SENT_67	[p3l303t20r689b100],
18	or	CC	O	or	_	0	SENT_67	[p3l717t46r805b99],
19	metastatic	JJ	O	metastatic	conj_or	17	SENT_67	[p3l829t21r1259b99],
20	disease	NN	O	disease	prep_with	14	SENT_67	[p3l1287t21r1584b99],
21	that	WDT	O	that	nsubj	22	SENT_67	[p3l1612t21r1776b99],
22	requires	VBZ	O	require	rcmod	20	SENT_67	[p3l1798t21r2133b121],
23	systemic	JJ	O	systemic	amod	24	SENT_67	[p3l12t149r372b249],
24	therapy	NN	O	therapy	dobj	22	SENT_67	[p3l394t149r712b249],
25	in	IN	O	in	_	0	SENT_67	[p3l728t149r810b226],
26	addition	NN	O	addition	prep_in	24	SENT_67	[p3l832t148r1184b227],
27	to	TO	O	to	_	0	SENT_67	[p3l1207t165r1286b227],
28	surgery	NN	O	surgery	nn	31	SENT_67	[p3l1312t175r1626b249],
29	or	CC	O	or	_	0	SENT_67	[p3l1645t174r1734b227],
30	radiation	NN	O	radiation	conj_or	28	SENT_67	[p3l1754t149r2135b227],
31	therapy	NN	O	therapy	prep_to	22	SENT_67	[p3l11t277r339b377],
32	.	.	O	.	_	0	SENT_67	[p3l11t277r339b377],

1	The	DT	O	the	det	3	SENT_68	[p3l378t277r539b355],
2	good	JJ	O	good	amod	3	SENT_68	[p3l576t276r788b377],
3	news	NN	O	news	nsubj	4	SENT_68	[p3l825t302r1037b356],
4	is	VBZ	O	be	_	0	SENT_68	[p3l1076t277r1140b355],
5	that	IN	O	that	complm	12	SENT_68	[p3l1181t277r1345b355],
6	the	DT	O	the	det	7	SENT_68	[p3l1379t276r1507b355],
7	results	NNS	O	result	nsubj	12	SENT_68	[p3l1544t276r1818b356],
8	of	IN	O	of	_	0	SENT_68	[p3l1858t276r1958b355],
9	systemic	JJ	O	systemic	amod	10	SENT_68	[p3l1979t303r2134b377, p3l11t405r241b483],
10	therapy	NN	O	therapy	prep_of	7	SENT_68	[p3l272t405r596b505],
11	are	VBP	O	be	aux	12	SENT_68	[p3l625t431r753b483],
12	improving	VBG	O	improve	ccomp	4	SENT_68	[p3l789t405r1264b505],
13	:	:	O	:	_	0	SENT_68	[p3l789t405r1264b505],
14	chemotherapy	NN	O	chemotherapy	nsubj	18	SENT_68	[p3l1304t404r1922b505],
15	prolongs	VBZ	O	prolong	parataxis	4	SENT_68	[p3l1951t430r2132b505, p3l9t533r245b633],
16	survival	NN	O	survival	dobj	15	SENT_68	[p3l279t533r605b612],
17	and	CC	O	and	_	0	SENT_68	[p3l634t532r792b611],
18	improves	VBZ	O	improve	parataxis	4	SENT_68	[p3l822t533r1219b633],
19	the	DT	O	the	det	20	SENT_68	[p3l1252t533r1383b611],
20	quality	NN	O	quality	dobj	18	SENT_68	[p3l1415t532r1707b633],
21	of	IN	O	of	_	0	SENT_68	[p3l1734t532r1835b611],
22	life	NN	O	life	prep_of	20	SENT_68	[p3l1847t532r1980b611],
23	for	IN	O	for	_	0	SENT_68	[p3l2012t532r2136b611],
24	patients	NNS	O	patient	prep_for	18	SENT_68	[p3l9t661r342b761],
25	with	IN	O	with	_	0	SENT_68	[p3l364t660r551b740],
26	non	JJ	O	non	amod	32	SENT_68	[p3l576t661r1222b739],
27	—	JJ	O	—	amod	32	SENT_68	[p3l576t661r1222b739],
28	small	JJ	O	small	amod	32	SENT_68	[p3l576t661r1222b739],
29	—	NN	O	—	nn	32	SENT_68	[p3l576t661r1222b739],
30	cell	NN	O	cell	nn	32	SENT_68	[p3l576t661r1222b739],
31	lung	NN	O	lung	nn	32	SENT_68	[p3l1250t661r1447b761],
32	cancer	NN	O	cancer	prep_with	24	SENT_68	[p3l1474t686r1771b739],
33	.	.	O	.	_	0	SENT_68	[p3l1474t686r1771b739],

1	The	DT	O	the	det	3	SENT_69	[p3l1799t661r1958b739],
2	bad	JJ	O	bad	amod	3	SENT_69	[p3l1985t660r2136b739],
3	news	NN	O	news	nsubj	4	SENT_69	[p3l10t814r220b868],
4	is	VBZ	O	be	_	0	SENT_69	[p3l245t789r309b867],
5	that	IN	O	that	complm	11	SENT_69	[p3l334t788r498b867],
6	systemic	JJ	O	systemic	amod	7	SENT_69	[p3l517t789r874b889],
7	therapy	NN	O	therapy	nsubj	11	SENT_69	[p3l900t789r1224b889],
8	is	VBZ	O	be	cop	11	SENT_69	[p3l1245t789r1311b867],
9	still	RB	O	still	advmod	11	SENT_69	[p3l1341t789r1497b867],
10	woefully	RB	O	woefully	advmod	11	SENT_69	[p3l1519t788r1890b889],
11	inadequate	JJ	O	inadequate	ccomp	4	SENT_69	[p3l1911t789r2132b867, p3l11t933r317b1017],
12	:	:	O	:	_	0	SENT_69	[p3l1911t789r2132b867, p3l11t933r317b1017],
13	only	RB	O	only	quantmod	16	SENT_69	[p3l350t917r535b1017],
14	30	CD	NUMBER	30	number	16	SENT_69	[p3l561t922r661b995],
15	to	TO	O	to	dep	16	SENT_69	[p3l691t933r771b995],
16	40	CD	PERCENT	40	num	17	SENT_69	[p3l799t922r903b995],
17	percent	NN	PERCENT	percent	nsubj	29	SENT_69	[p3l931t933r1249b1017],
18	of	IN	O	of	_	0	SENT_69	[p3l1270t916r1370b995],
19	patients	NNS	O	patient	prep_of	17	SENT_69	[p3l1376t917r1707b1017],
20	with	IN	O	with	_	0	SENT_69	[p3l1730t917r1918b996],
21	metastatic	JJ	O	metastatic	amod	23	SENT_69	[p3l1943t933r2134b995, p3l10t1045r278b1123],
22	non	JJ	O	non	amod	23	SENT_69	[p3l300t1044r945b1123],
23	—	NN	O	—	prep_with	19	SENT_69	[p3l300t1044r945b1123],
24	small	JJ	O	small	amod	28	SENT_69	[p3l300t1044r945b1123],
25	—	NN	O	—	nn	28	SENT_69	[p3l300t1044r945b1123],
26	cell	NN	O	cell	nn	28	SENT_69	[p3l300t1044r945b1123],
27	lung	NN	O	lung	nn	28	SENT_69	[p3l969t1045r1166b1145],
28	cancer	NN	O	cancer	dep	23	SENT_69	[p3l1189t1070r1469b1123],
29	survive	VBP	O	survive	parataxis	4	SENT_69	[p3l1492t1045r1776b1124],
30	for	IN	O	for	_	0	SENT_69	[p3l1799t1044r1921b1123],
31	even	RB	O	even	advmod	33	SENT_69	[p3l1944t1070r2133b1124],
32	one	CD	DURATION	one	num	33	SENT_69	[p3l11t1171r165b1224],
33	year	NN	NUMBER	year	prep_for	29	SENT_69	[p3l188t1172r384b1246],
34	.	.	O	.	_	0	SENT_69	[p3l188t1172r384b1246],

1	For	IN	O	for	_	0	SENT_70	[p3l138t1281r282b1352],
2	this	DT	O	this	det	3	SENT_70	[p3l308t1274r460b1352],
3	reason	NN	O	reason	prep_for	38	SENT_70	[p3l491t1299r795b1369],
4	,	,	O	,	_	0	SENT_70	[p3l491t1299r795b1369],
5	the	DT	O	the	det	6	SENT_70	[p3l829t1274r958b1352],
6	ﬁnding	NN	O	ﬁnding	nsubj	38	SENT_70	[p3l987t1273r1299b1374],
7	that	WDT	O	that	det	8	SENT_70	[p3l1324t1274r1491b1352],
8	therapy	NN	O	therapy	nsubj	9	SENT_70	[p3l1515t1274r1832b1374],
9	targeted	VBN	O	target	rcmod	6	SENT_70	[p3l1856t1290r2133b1374, p3l11t1402r107b1480],
10	against	IN	O	against	_	0	SENT_70	[p3l145t1402r461b1502],
11	the	DT	O	the	det	15	SENT_70	[p3l496t1402r628b1480],
12	epidermal	JJ	O	epidermal	amod	15	SENT_70	[p3l668t1402r1102b1502],
13	growth	NN	O	growth	nn	15	SENT_70	[p3l1141t1402r1450b1502],
14	factor	NN	O	factor	nn	15	SENT_70	[p3l1489t1401r1741b1480],
15	receptor	NN	O	receptor	prep_against	9	SENT_70	[p3l1777t1418r2136b1502],
16	(	CD	NUMBER	(	num	18	SENT_70	[p3l15t1536r324b1622],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_70	[p3l15t1536r324b1622],
18	)	NN	O	)	nsubj	19	SENT_70	[p3l15t1536r324b1622],
19	had	VBD	O	have	rcmod	15	SENT_70	[p3l353t1531r508b1609],
20	substantial	JJ	O	substantial	amod	22	SENT_70	[p3l532t1531r996b1610],
21	clinical	JJ	O	clinical	amod	22	SENT_70	[p3l1020t1531r1320b1609],
22	beneﬁts	NNS	O	beneﬁts	dobj	19	SENT_70	[p3l1344t1530r1677b1609],
23	in	IN	O	in	_	0	SENT_70	[p3l1701t1531r1782b1608],
24	10	CD	NUMBER	10	number	26	SENT_70	[p3l1809t1536r1905b1609],
25	to	TO	O	to	dep	26	SENT_70	[p3l1930t1547r2009b1609],
26	20	CD	PERCENT	20	num	27	SENT_70	[p3l2033t1536r2134b1609],
27	percent	NN	PERCENT	percent	prep_in	22	SENT_70	[p3l9t1675r324b1759],
28	of	IN	O	of	_	0	SENT_70	[p3l344t1658r444b1737],
29	patients	NNS	O	patient	prep_of	27	SENT_70	[p3l448t1659r777b1759],
30	with	IN	O	with	_	0	SENT_70	[p3l799t1659r986b1738],
31	non	JJ	O	non	amod	37	SENT_70	[p3l1011t1658r1632b1737],
32	—	JJ	O	—	amod	37	SENT_70	[p3l1011t1658r1632b1737],
33	small	JJ	O	small	amod	37	SENT_70	[p3l1011t1658r1632b1737],
34	—	NN	O	—	nn	37	SENT_70	[p3l1011t1658r1632b1737],
35	cell	NN	O	cell	nn	37	SENT_70	[p3l1011t1658r1632b1737],
36	lung	NN	O	lung	nn	37	SENT_70	[p3l1655t1659r1846b1759],
37	cancer	NN	O	cancer	prep_with	19	SENT_70	[p3l1867t1684r2139b1737],
38	was	VBD	O	be	_	0	SENT_70	[p3l6t1813r166b1866],
39	of	IN	O	of	_	0	SENT_70	[p3l194t1786r294b1865],
40	great	JJ	O	great	amod	41	SENT_70	[p3l301t1803r517b1887],
41	interest	NN	O	interest	prep_of	38	SENT_70	[p3l536t1787r876b1865],
42	.	.	O	.	_	0	SENT_70	[p3l536t1787r876b1865],

1	An	DT	O	a	det	3	SENT_71	[p3l904t1794r1024b1864],
2	important	JJ	O	important	amod	3	SENT_71	[p3l1048t1787r1482b1887],
3	example	NN	O	example	nsubj	13	SENT_71	[p3l1502t1787r1854b1887],
4	of	IN	O	of	_	0	SENT_71	[p3l1880t1786r1980b1865],
5	targeted	VBN	O	target	amod	6	SENT_71	[p3l1987t1803r2133b1865, p3l10t1914r241b2015],
6	therapy	NN	O	therapy	prep_of	3	SENT_71	[p3l271t1915r594b2015],
7	that	WDT	O	that	nsubj	9	SENT_71	[p3l619t1915r789b1993],
8	is	VBZ	O	be	aux	9	SENT_71	[p3l812t1915r878b1993],
9	revolutionizing	VBG	O	revolutionize	rcmod	6	SENT_71	[p3l910t1914r1572b2015],
10	cancer	NN	O	cancer	nn	11	SENT_71	[p3l1599t1940r1879b1993],
11	treatment	NN	O	treatment	dobj	9	SENT_71	[p3l1906t1931r2132b1993, p3l8t2059r235b2121],
12	is	VBZ	O	be	cop	13	SENT_71	[p3l258t2043r323b2121],
13	imatinib	NN	O	imatinib	_	0	SENT_71	[p3l354t2042r738b2138],
14	,	,	O	,	_	0	SENT_71	[p3l354t2042r738b2138],
15	which	WDT	O	which	nsubj	16	SENT_71	[p3l768t2042r1030b2122],
16	inhibits	VBZ	O	inhibit	rcmod	13	SENT_71	[p3l1058t2042r1389b2121],
17	the	DT	O	the	det	20	SENT_71	[p3l1423t2042r1556b2121],
18	ABL	NNP	ORGANIZATION	ABL	nn	20	SENT_71	[p3l1585t2049r1768b2121],
19	tyrosine	NN	O	tyrosine	nn	20	SENT_71	[p3l1798t2043r2147b2143],
20	kinase	NN	O	kinase	dobj	16	SENT_71	[p3l8t2170r289b2250],
21	that	WDT	O	that	nsubjpass	23	SENT_71	[p3l321t2171r494b2249],
22	is	VBZ	O	be	auxpass	23	SENT_71	[p3l520t2171r587b2249],
23	activated	VBN	O	activate	rcmod	20	SENT_71	[p3l620t2171r1005b2250],
24	by	IN	O	by	_	0	SENT_71	[p3l1037t2171r1136b2271],
25	the	DT	O	the	det	26	SENT_71	[p3l1164t2171r1297b2249],
26	BCR	NN	O	bcr	agent	23	SENT_71	[p3l1326t2176r1687b2250],
27	.	.	O	.	_	0	SENT_71	[p3l1326t2176r1687b2250],

1	—	NN	O	—	_	0	SENT_72	[p3l1326t2176r1687b2250],
2	.	.	O	.	_	0	SENT_72	[p3l1326t2176r1687b2250],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_73	[p3l1326t2176r1687b2250],
2	transloca	NN	O	transloca	_	0	SENT_73	[p3l1715t2171r2146b2249],
3	—	CD	NUMBER	—	num	4	SENT_73	[p3l1715t2171r2146b2249],
4	tion	NN	O	tion	dep	2	SENT_73	[p3l9t2299r177b2377],
5	in	IN	O	in	_	0	SENT_73	[p3l202t2299r284b2376],
6	chronic	JJ	O	chronic	amod	8	SENT_73	[p3l311t2299r632b2377],
7	myeloid	JJ	O	myeloid	amod	8	SENT_73	[p3l658t2299r997b2399],
8	leukemia	NN	O	leukemia	prep_in	4	SENT_73	[p3l1021t2299r1434b2394],
9	,	,	O	,	_	0	SENT_73	[p3l1021t2299r1434b2394],
10	and	CC	O	and	_	0	SENT_73	[p3l1465t2298r1622b2377],
11	c	NN	O	c	conj_and	2	SENT_73	[p3l1649t2299r1859b2394],
12	—	CD	NUMBER	—	num	13	SENT_73	[p3l1649t2299r1859b2394],
13	l	NN	O	l	dep	14	SENT_73	[p3l1649t2299r1859b2394],
14	<	JJR	O	<	dep	11	SENT_73	[p3l1649t2299r1859b2394],
15	it	PRP	O	it	dep	2	SENT_73	[p3l1649t2299r1859b2394],
16	,	,	O	,	_	0	SENT_73	[p3l1649t2299r1859b2394],
17	which	WDT	O	which	nsubjpass	19	SENT_73	[p3l1886t2299r2149b2378],
18	is	VBZ	O	be	auxpass	19	SENT_73	[p3l8t2427r73b2505],
19	activated	VBN	O	activate	rcmod	15	SENT_73	[p3l99t2427r484b2506],
20	by	IN	O	by	_	0	SENT_73	[p3l510t2427r609b2527],
21	a	DT	O	a	det	23	SENT_73	[p3l628t2453r673b2505],
22	somatic	JJ	O	somatic	amod	23	SENT_73	[p3l697t2427r1039b2505],
23	mutation	NN	O	mutation	agent	19	SENT_73	[p3l1063t2427r1459b2506],
24	in	IN	O	in	_	0	SENT_73	[p3l1480t2427r1562b2504],
25	gastrointestinal	JJ	O	gastrointestinal	amod	27	SENT_73	[p3l1582t2427r2148b2527, p3l8t2556r137b2635],
26	stromal	JJ	O	stromal	amod	27	SENT_73	[p3l164t2555r489b2635],
27	tumors	NNS	O	tumor	prep_in	23	SENT_73	[p3l514t2572r843b2636],
28	.	.	O	.	_	0	SENT_73	[p3l514t2572r843b2636],

1	EGFR	NN	ORGANIZATION	egfr	nsubjpass	12	SENT_74	[p3l137t2690r414b2780],
2	,	,	O	,	_	0	SENT_74	[p3l137t2690r414b2780],
3	a	DT	O	a	det	6	SENT_74	[p3l447t2711r492b2763],
4	receptor	NN	O	receptor	nn	6	SENT_74	[p3l518t2701r879b2785],
5	tyrosine	NN	O	tyrosine	nn	6	SENT_74	[p3l904t2685r1249b2785],
6	kinase	NN	O	kinase	appos	1	SENT_74	[p3l1277t2685r1580b2780],
7	,	,	O	,	_	0	SENT_74	[p3l1277t2685r1580b2780],
8	is	VBZ	O	be	auxpass	10	SENT_74	[p3l1612t2685r1679b2763],
9	frequently	RB	O	frequently	advmod	10	SENT_74	[p3l1708t2684r2152b2785],
10	overexpressed	VBN	O	overexpress	_	0	SENT_74	[p3l9t2812r622b2913],
11	and	CC	O	and	_	0	SENT_74	[p3l658t2812r817b2891],
12	activated	VBN	O	activate	conj_and	10	SENT_74	[p3l853t2812r1233b2892],
13	to	TO	O	to	_	0	SENT_74	[p3l1270t2829r1350b2891],
14	a	DT	O	a	det	16	SENT_74	[p3l1387t2839r1432b2891],
15	phosphorylated	JJ	O	phosphorylated	amod	16	SENT_74	[p3l1465t2812r2148b2913],
16	state	NN	O	state	prep_to	10	SENT_74	[p3l11t2957r211b3019],
17	in	IN	O	in	_	0	SENT_74	[p3l243t2941r326b3018],
18	non	JJ	O	non	amod	24	SENT_74	[p3l359t2940r1009b3019],
19	—	JJ	O	—	amod	24	SENT_74	[p3l359t2940r1009b3019],
20	small	JJ	O	small	amod	24	SENT_74	[p3l359t2940r1009b3019],
21	—	NN	O	—	nn	24	SENT_74	[p3l359t2940r1009b3019],
22	cell	NN	O	cell	nn	24	SENT_74	[p3l359t2940r1009b3019],
23	lung	NN	O	lung	nn	24	SENT_74	[p3l1040t2941r1239b3041],
24	cancer	NN	O	cancer	prep_in	16	SENT_74	[p3l1269t2966r1570b3019],
25	.	.	O	.	_	0	SENT_74	[p3l1269t2966r1570b3019],

1	The	DT	O	the	det	4	SENT_75	[p3l1604t2941r1770b3019],
2	tyrosine	NN	O	tyrosine	nn	4	SENT_75	[p3l1803t2941r2148b3041],
3	kinase	NN	O	kinase	nn	4	SENT_75	[p3l8t3068r286b3148],
4	activity	NN	O	activity	nsubj	11	SENT_75	[p3l316t3069r622b3169],
5	of	IN	O	of	_	0	SENT_75	[p3l648t3068r750b3147],
6	phosphorylated	JJ	O	phosphorylated	amod	7	SENT_75	[p3l760t3069r1443b3169],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_75	[p3l1472t3074r1736b3152],
8	in	IN	O	in	_	0	SENT_75	[p3l1754t3069r1837b3146],
9	cancer	NN	O	cancer	nn	10	SENT_75	[p3l1868t3094r2151b3147],
10	cells	NNS	O	cell	prep_in	7	SENT_75	[p3l9t3197r189b3275],
11	results	VBZ	O	result	_	0	SENT_75	[p3l220t3196r495b3276],
12	in	IN	O	in	_	0	SENT_75	[p3l525t3197r605b3274],
13	the	DT	O	the	det	14	SENT_75	[p3l635t3197r763b3275],
14	phosphorylation	NN	O	phosphorylation	prep_in	11	SENT_75	[p3l791t3197r1486b3297],
15	of	IN	O	of	_	0	SENT_75	[p3l1516t3196r1616b3275],
16	downstream	JJ	O	downstream	amod	17	SENT_75	[p3l1627t3197r2150b3276],
17	proteins	NNS	O	protein	prep_of	14	SENT_75	[p3l7t3325r356b3425],
18	that	WDT	O	that	nsubj	19	SENT_75	[p3l385t3325r551b3403],
19	incite	VBP	O	incite	rcmod	14	SENT_75	[p3l571t3325r801b3403],
20	cell	NN	O	cell	dobj	19	SENT_75	[p3l828t3324r969b3403],
21	proliferation	NN	O	proliferation	dobj	11	SENT_75	[p3l993t3324r1548b3425],
22	,	,	O	,	_	0	SENT_75	[p3l993t3324r1548b3425],
23	invasion	NN	O	invasion	dobj	11	SENT_75	[p3l1579t3325r1956b3420],
24	,	,	O	,	_	0	SENT_75	[p3l1579t3325r1956b3420],
25	metastasis	NN	O	metastasis	dobj	11	SENT_75	[p3l1987t3351r2148b3403, p3l9t3453r355b3548],
26	,	,	O	,	_	0	SENT_75	[p3l1987t3351r2148b3403, p3l9t3453r355b3548],
27	and	CC	O	and	_	0	SENT_75	[p3l385t3453r544b3531],
28	inhibition	NN	O	inhibition	dobj	11	SENT_75	[p3l568t3453r1002b3531],
29	of	IN	O	of	_	0	SENT_75	[p3l1027t3452r1129b3531],
30	apoptosis	NN	O	apoptosis	prep_of	21	SENT_75	[p3l1135t3453r1581b3553],
31	.	.	O	.	_	0	SENT_75	[p3l1135t3453r1581b3553],

1	Because	IN	O	because	mark	4	SENT_76	[p3l1610t3459r1958b3532],
2	several	JJ	O	several	amod	3	SENT_76	[p3l1985t3479r2148b3532, p3l9t3581r162b3659],
3	cancers	NNS	O	cancer	nsubj	4	SENT_76	[p3l186t3606r499b3659],
4	overexpress	VBP	O	overexpress	advcl	14	SENT_76	[p3l525t3606r1016b3681],
5	EGFR	NN	ORGANIZATION	egfr	dobj	4	SENT_76	[p3l1040t3586r1312b3676],
6	,	,	O	,	_	0	SENT_76	[p3l1040t3586r1312b3676],
7	this	DT	O	this	det	9	SENT_76	[p3l1342t3581r1494b3659],
8	tyrosine	NN	O	tyrosine	nn	9	SENT_76	[p3l1521t3581r1854b3681],
9	kinase	NN	O	kinase	nsubj	14	SENT_76	[p3l1878t3581r2148b3660],
10	has	VBZ	O	have	aux	14	SENT_76	[p3l8t3708r153b3787],
11	been	VBN	O	be	cop	14	SENT_76	[p3l187t3709r391b3787],
12	a	DT	O	a	det	14	SENT_76	[p3l421t3735r466b3787],
13	favorite	JJ	O	favorite	amod	14	SENT_76	[p3l496t3708r820b3788],
14	target	NN	O	target	_	0	SENT_76	[p3l852t3725r1108b3809],
15	for	IN	O	for	_	0	SENT_76	[p3l1134t3708r1260b3787],
16	treatment	NN	O	treatment	prep_for	14	SENT_76	[p3l1289t3725r1735b3787],
17	.	.	O	.	_	0	SENT_76	[p3l1289t3725r1735b3787],

1	Two	CD	NUMBER	two	num	7	SENT_77	[p3l1768t3714r1949b3788],
2	oral	JJ	O	oral	amod	7	SENT_77	[p3l1983t3709r2148b3787],
3	anilinoquinazoline	JJ	O	anilinoquinazoline	amod	7	SENT_77	[p4l8t22r832b122],
4	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_77	[p4l868t27r1133b105],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_77	[p4l1159t22r1504b122],
6	kinase	NN	O	kinase	nn	7	SENT_77	[p4l1541t21r1819b101],
7	inhibitors	NNS	O	inhibitor	nsubjpass	21	SENT_77	[p4l1855t22r2147b100, p4l9t166r194b245],
8	,	,	O	,	_	0	SENT_77	[p4l1855t22r2147b100, p4l9t166r194b245],
9	geﬁtinib	NN	O	geﬁtinib	nn	11	SENT_77	[p4l228t149r581b250],
10	(	CD	NUMBER	(	num	11	SENT_77	[p4l615t156r918b241],
11	Iressa	NNP	O	Iressa	appos	7	SENT_77	[p4l615t156r918b241],
12	)	NN	O	)	dep	11	SENT_77	[p4l615t156r918b241],
13	and	CC	O	and	_	0	SENT_77	[p4l952t149r1107b228],
14	erlotinib	NN	O	erlotinib	dep	11	SENT_77	[p4l1136t149r1493b228],
15	(	CD	NUMBER	(	num	17	SENT_77	[p4l1527t155r1926b245],
16	Tarceva	NNP	MISC	Tarceva	nn	17	SENT_77	[p4l1527t155r1926b245],
17	)	NN	O	)	dep	11	SENT_77	[p4l1527t155r1926b245],
18	,	,	O	,	_	0	SENT_77	[p4l1527t155r1926b245],
19	have	VBP	O	have	aux	21	SENT_77	[p4l1959t149r2148b229],
20	been	VBN	O	be	auxpass	21	SENT_77	[p4l9t278r207b356],
21	approved	VBN	O	approve	_	0	SENT_77	[p4l242t278r629b378],
22	in	IN	O	in	_	0	SENT_77	[p4l663t278r744b355],
23	the	DT	O	the	det	25	SENT_77	[p4l779t278r907b356],
24	United	NNP	LOCATION	United	nn	25	SENT_77	[p4l941t277r1225b356],
25	States	NNPS	LOCATION	States	prep_in	21	SENT_77	[p4l1261t283r1503b356],
26	for	IN	O	for	_	0	SENT_77	[p4l1540t277r1663b356],
27	use	NN	O	use	prep_for	21	SENT_77	[p4l1694t304r1832b357],
28	as	IN	O	as	_	0	SENT_77	[p4l1867t304r1950b356],
29	second	JJ	ORDINAL	second	amod	31	SENT_77	[p4l1989t304r2148b356, p4l9t405r371b484],
30	—	NN	O	—	nn	31	SENT_77	[p4l1989t304r2148b356, p4l9t405r371b484],
31	line	NN	O	line	prep_as	27	SENT_77	[p4l1989t304r2148b356, p4l9t405r371b484],
32	or	CC	O	or	_	0	SENT_77	[p4l414t431r505b484],
33	third	JJ	ORDINAL	third	amod	36	SENT_77	[p4l544t405r953b484],
34	—	NN	O	—	nn	36	SENT_77	[p4l544t405r953b484],
35	line	NN	O	line	nn	36	SENT_77	[p4l544t405r953b484],
36	therapy	NN	O	therapy	conj_or	27	SENT_77	[p4l996t405r1322b506],
37	in	IN	O	in	_	0	SENT_77	[p4l1359t406r1441b483],
38	advanced	JJ	O	advanced	amod	39	SENT_77	[p4l1482t405r1884b485],
39	nonsmall	JJ	O	nonsmall	amod	43	SENT_77	[p4l1926t431r2151b484, p4l11t533r416b612],
40	—	NN	O	—	nn	43	SENT_77	[p4l1926t431r2151b484, p4l11t533r416b612],
41	cell	NN	O	cell	nn	43	SENT_77	[p4l1926t431r2151b484, p4l11t533r416b612],
42	lung	NN	O	lung	nn	43	SENT_77	[p4l436t534r629b634],
43	cancer	NN	O	cancer	prep_in	36	SENT_77	[p4l648t559r935b612],
44	.	.	O	.	_	0	SENT_77	[p4l648t559r935b612],

1	In	IN	O	in	_	0	SENT_78	[p4l961t541r1048b611],
2	comparison	NN	O	comparison	prep_in	9	SENT_78	[p4l1070t534r1571b634],
3	with	IN	O	with	_	0	SENT_78	[p4l1588t534r1776b613],
4	placebo	NN	O	placebo	prep_with	2	SENT_78	[p4l1796t534r2144b634],
5	,	,	O	,	_	0	SENT_78	[p4l1796t534r2144b634],
6	treatment	NN	O	treatment	nsubj	9	SENT_78	[p4l9t678r419b740],
7	with	IN	O	with	_	0	SENT_78	[p4l434t661r622b741],
8	erlotinib	NN	O	erlotinib	prep_with	6	SENT_78	[p4l647t661r1001b740],
9	improved	VBD	O	improve	_	0	SENT_78	[p4l1026t662r1425b762],
10	one	CD	NUMBER	one	num	14	SENT_78	[p4l1450t687r1810b762],
11	—	CD	NUMBER	—	num	14	SENT_78	[p4l1450t687r1810b762],
12	year	NN	NUMBER	year	nn	14	SENT_78	[p4l1450t687r1810b762],
13	survival	NN	O	survival	nn	14	SENT_78	[p4l1832t662r2148b741],
14	rates	NNS	O	rate	tmod	9	SENT_78	[p4l9t806r240b885],
15	,	,	O	,	_	0	SENT_78	[p4l9t806r240b885],
16	from	IN	O	from	_	0	SENT_78	[p4l268t789r480b868],
17	22	CD	NUMBER	22	number	19	SENT_78	[p4l503t795r605b867],
18	to	TO	O	to	dep	19	SENT_78	[p4l631t806r711b868],
19	31	CD	PERCENT	31	num	20	SENT_78	[p4l737t795r838b868],
20	percent	NN	PERCENT	percent	prep_from	9	SENT_78	[p4l861t806r1210b890],
21	,	,	O	,	_	0	SENT_78	[p4l861t806r1210b890],
22	in	IN	O	in	_	0	SENT_78	[p4l1238t790r1321b867],
23	patients	NNS	O	patient	prep_in	9	SENT_78	[p4l1343t790r1688b890],
24	with	IN	O	with	_	0	SENT_78	[p4l1709t790r1903b869],
25	non830	JJ	O	non830	prep_with	23	SENT_78	[p4l1926t815r2151b868, p4l149t969r206b992],

1	N	NN	O	n	nn	3	SENT_79	[p4l880t971r894b987],
2	ENGL	NN	ORGANIZATION	engl	nn	3	SENT_79	[p4l909t971r976b987],
3	MED	NN	O	med	_	0	SENT_79	[p4l1008t971r1061b986],
4	352	CD	NUMBER	352	dep	3	SENT_79	[p4l1073t965r1139b993],
5	;	:	O	;	_	0	SENT_79	[p4l1073t965r1139b993],
6	8	CD	NUMBER	8	num	7	SENT_79	[p4l1073t965r1139b993],
7	WWW	NN	O	www	dep	3	SENT_79	[p4l1174t971r1294b993],
8	.	.	O	.	_	0	SENT_79	[p4l1174t971r1294b993],

1	NEj	NN	O	nej	nn	3	SENT_80	[p4l1174t971r1294b993],
2	M.ORG	NN	O	m.org	nn	3	SENT_80	[p4l1302t971r1385b987],
3	FEBRUARY	NN	DATE	february	_	0	SENT_80	[p4l1425t971r1552b987],
4	24	CD	DATE	24	dep	3	SENT_80	[p4l1564t971r1602b993],
5	,	,	DATE	,	_	0	SENT_80	[p4l1564t971r1602b993],
6	2005	CD	DATE	2005	appos	4	SENT_80	[p4l1615t971r1678b993],

1	T	NN	O	t	_	0	SENT_81	[p4l936t1005r956b1028],
2	e	SYM	O	e	dep	3	SENT_81	[p4l973t1012r987b1028],
3	ew	FW	O	ew	rcmod	1	SENT_81	[p4l1021t1012r1058b1028],
4	England	NNP	O	England	nn	5	SENT_81	[p4l1067t1004r1178b1035],
5	Journal	NNP	O	Journal	dep	1	SENT_81	[p4l1187t1004r1284b1028],
6	of	IN	O	of	_	0	SENT_81	[p4l1294t1004r1323b1028],
7	Medicine	NNP	O	Medicine	prep_of	5	SENT_81	[p4l1330t1004r1455b1028],

1	Downloaded	VBN	O	download	_	0	SENT_82	[p4l378t1045r548b1068],
2	from	IN	O	from	_	0	SENT_82	[p4l557t1045r621b1068],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_82	[p4l630t1045r748b1075],
4	at	IN	O	at	_	0	SENT_82	[p4l759t1049r782b1068],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_82	[p4l790t1045r973b1068],
6	on	IN	O	on	_	0	SENT_82	[p4l982t1052r1015b1068],
7	January	NNP	DATE	January	prep_on	1	SENT_82	[p4l1023t1045r1126b1075],
8	5	CD	DATE	5	num	7	SENT_82	[p4l1136t1045r1159b1072],
9	,	,	DATE	,	_	0	SENT_82	[p4l1136t1045r1159b1072],
10	2014	CD	DATE	2014	num	7	SENT_82	[p4l1170t1045r1242b1068],
11	.	.	O	.	_	0	SENT_82	[p4l1170t1045r1242b1068],

1	For	IN	O	for	_	0	SENT_83	[p4l1252t1045r1299b1068],
2	personal	JJ	O	personal	amod	3	SENT_83	[p4l1307t1045r1419b1075],
3	use	NN	O	use	pobj	1	SENT_83	[p4l1428t1052r1472b1068],
4	only	RB	O	only	advmod	3	SENT_83	[p4l1482t1045r1546b1075],
5	.	.	O	.	_	0	SENT_83	[p4l1482t1045r1546b1075],

1	No	DT	O	no	det	3	SENT_84	[p4l1557t1045r1597b1068],
2	other	JJ	O	other	amod	3	SENT_84	[p4l1607t1045r1675b1068],
3	uses	NNS	O	use	_	0	SENT_84	[p4l1683t1052r1739b1068],
4	without	IN	O	without	_	0	SENT_84	[p4l1749t1045r1850b1068],
5	permission	NN	O	permission	prep_without	3	SENT_84	[p4l1859t1045r2011b1075],
6	.	.	O	.	_	0	SENT_84	[p4l1859t1045r2011b1075],

1	Copyright	NN	O	copyright	_	0	SENT_85	[p4l728t1086r863b1117],
2	©	CD	NUMBER	©	num	6	SENT_85	[p4l872t1086r896b1110],
3	2005	CD	DATE	2005	num	6	SENT_85	[p4l906t1086r970b1110],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_85	[p4l980t1086r1171b1110],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_85	[p4l1181t1086r1289b1110],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_85	[p4l1300t1086r1405b1117],
7	.	.	O	.	_	0	SENT_85	[p4l1300t1086r1405b1117],

1	All	DT	O	all	det	2	SENT_86	[p4l1416t1086r1457b1110],
2	rights	NNS	O	rights	nsubj	3	SENT_86	[p4l1466t1086r1541b1117],
3	reserved	VBN	O	reserve	_	0	SENT_86	[p4l1551t1086r1670b1110],
4	.	.	O	.	_	0	SENT_86	[p4l1551t1086r1670b1110],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_87	[p4l979t1192r1181b1211],

1	small	JJ	O	small	amod	2	SENT_88	[p4l12t1405r431b1484],
2	—	JJ	O	—	amod	3	SENT_88	[p4l12t1405r431b1484],
3	cell	NN	O	cell	_	0	SENT_88	[p4l12t1405r431b1484],
4	lung	NN	O	lung	nn	5	SENT_88	[p4l454t1406r651b1506],
5	cancer	NN	O	cancer	dep	3	SENT_88	[p4l674t1431r954b1484],
6	Who	WP	O	who	nsubj	7	SENT_88	[p4l972t1406r1157b1485],
7	had	VBD	O	have	rcmod	5	SENT_88	[p4l1184t1406r1341b1484],
8	progressive	JJ	O	progressive	amod	10	SENT_88	[p4l1365t1406r1860b1506],
9	metastatic	JJ	O	metastatic	amod	10	SENT_88	[p4l1886t1422r2132b1484, p4l12t1534r240b1612],
10	disease	NN	O	disease	dobj	7	SENT_88	[p4l282t1534r579b1612],
11	after	IN	O	after	_	0	SENT_88	[p4l620t1533r810b1612],
12	receiving	VBG	O	receive	prepc_after	7	SENT_88	[p4l848t1534r1224b1634],
13	other	JJ	O	other	amod	14	SENT_88	[p4l1263t1534r1483b1612],
14	chemotherapy	NN	O	chemotherapy	dobj	12	SENT_88	[p4l1522t1534r2130b1634],
15	.	.	O	.	_	0	SENT_88	[p4l1522t1534r2130b1634],

1	Particularly	RB	O	particularly	advmod	2	SENT_89	[p4l9t1662r486b1762],
2	tantalizing	JJ	O	tantalizing	dep	3	SENT_89	[p4l519t1662r979b1762],
3	were	VBD	O	be	_	0	SENT_89	[p4l1008t1688r1210b1741],
4	the	DT	O	the	det	8	SENT_89	[p4l1248t1662r1377b1740],
5	occasionally	RB	O	occasionally	advmod	6	SENT_89	[p4l1415t1661r1934b1762],
6	dramatic	JJ	O	dramatic	amod	8	SENT_89	[p4l1967t1662r2135b1740, p4l11t1790r241b1868],
7	clinical	JJ	O	clinical	amod	8	SENT_89	[p4l264t1789r558b1868],
8	responses	NNS	O	response	nsubj	3	SENT_89	[p4l580t1815r993b1890],
9	that	WDT	O	that	nsubj	12	SENT_89	[p4l1018t1790r1182b1868],
10	Were	VBD	O	be	cop	12	SENT_89	[p4l1195t1816r1394b1869],
11	durable	JJ	O	durable	amod	12	SENT_89	[p4l1417t1789r1730b1869],
12	(	NN	O	(	rcmod	8	SENT_89	[p4l1757t1790r1932b1885],
13	i.e.	FW	O	i.e.	dep	12	SENT_89	[p4l1757t1790r1932b1885],
14	,	,	O	,	_	0	SENT_89	[p4l1757t1790r1932b1885],
15	lasted	VBD	O	last	dep	13	SENT_89	[p4l1959t1789r2135b1868, p4l11t1917r107b1996],
16	several	JJ	DURATION	several	amod	17	SENT_89	[p4l134t1918r425b1997],
17	years	NNS	DURATION	year	tmod	15	SENT_89	[p4l447t1925r727b2018],
18	)	RB	O	)	advmod	15	SENT_89	[p4l447t1925r727b2018],
19	.	.	O	.	_	0	SENT_89	[p4l447t1925r727b2018],

1	This	DT	DATE	this	det	3	SENT_90	[p4l755t1918r944b1996],
2	past	JJ	DATE	past	amod	3	SENT_90	[p4l971t1934r1154b2018],
3	year	NN	DATE	year	tmod	12	SENT_90	[p4l1171t1944r1367b2018],
4	,	,	O	,	_	0	SENT_90	[p4l1171t1944r1367b2018],
5	two	CD	NUMBER	two	num	6	SENT_90	[p4l1399t1934r1553b1997],
6	groups	NNS	O	group	nsubj	12	SENT_90	[p4l1581t1943r1880b2018],
7	of	IN	O	of	prep	6	SENT_90	[p4l1909t1917r2011b1996],
8	in	IN	O	in	pcomp	7	SENT_90	[p4l2018t1918r2135b1995],
9	—	NN	O	—	nn	10	SENT_90	[p4l2018t1918r2135b1995],
10	vestigators	NNS	O	vestigator	pobj	8	SENT_90	[p4l6t2046r454b2146],
11	simultaneously	RB	O	simultaneously	advmod	12	SENT_90	[p4l493t2046r1130b2146],
12	reported	VBD	O	report	_	0	SENT_90	[p4l1161t2045r1513b2146],
13	the	DT	O	the	det	15	SENT_90	[p4l1550t2046r1677b2124],
14	important	JJ	O	important	amod	15	SENT_90	[p4l1713t2046r2139b2146],
15	discovery	NN	O	discovery	dobj	12	SENT_90	[p4l11t2174r414b2274],
16	that	IN	O	that	complm	25	SENT_90	[p4l443t2173r613b2252],
17	most	JJS	O	most	amod	18	SENT_90	[p4l641t2190r860b2252],
18	patients	NNS	O	patient	nsubj	25	SENT_90	[p4l888t2174r1229b2274],
19	who	WP	O	who	nsubj	20	SENT_90	[p4l1261t2173r1446b2253],
20	had	VBD	O	have	rcmod	18	SENT_90	[p4l1481t2173r1638b2252],
21	a	DT	O	a	det	22	SENT_90	[p4l1671t2200r1715b2252],
22	response	NN	O	response	dobj	20	SENT_90	[p4l1747t2199r2134b2274],
23	to	TO	O	to	_	0	SENT_90	[p4l11t2318r90b2380],
24	geﬁtinib	NN	O	geﬁtinib	prep_to	22	SENT_90	[p4l125t2301r474b2402],
25	had	VBD	O	have	ccomp	12	SENT_90	[p4l508t2301r660b2380],
26	tumors	NNS	O	tumor	dobj	25	SENT_90	[p4l693t2318r989b2381],
27	with	IN	O	with	_	0	SENT_90	[p4l1020t2302r1206b2381],
28	somatic	JJ	O	somatic	amod	29	SENT_90	[p4l1240t2302r1565b2380],
29	mutations	NNS	O	mutation	prep_with	25	SENT_90	[p4l1596t2302r2020b2381],
30	of	IN	O	of	dep	31	SENT_90	[p4l2055t2301r2154b2380],
31	EGFR	NN	ORGANIZATION	egfr	dep	34	SENT_90	[p4l9t2436r224b2509],
32	—	CD	NUMBER	—	num	31	SENT_90	[p4l242t2475r349b2482],
33	small	JJ	O	small	amod	34	SENT_90	[p4l375t2430r606b2508],
34	deletions	NNS	O	deletion	dep	42	SENT_90	[p4l634t2429r1051b2525],
35	,	,	O	,	_	0	SENT_90	[p4l634t2429r1051b2525],
36	insertions	NNS	O	insertion	dep	42	SENT_90	[p4l1084t2430r1540b2525],
37	,	,	O	,	_	0	SENT_90	[p4l1084t2430r1540b2525],
38	or	CC	O	or	_	0	SENT_90	[p4l1574t2455r1664b2508],
39	point	NN	O	point	dep	42	SENT_90	[p4l1688t2430r1921b2530],
40	mis	FW	O	mis	nn	42	SENT_90	[p4l1943t2430r2132b2508],
41	—	FW	O	—	nn	42	SENT_90	[p4l1943t2430r2132b2508],
42	sense	NN	O	sense	dep	25	SENT_90	[p4l12t2583r246b2636],
43	mutations	NNS	O	mutation	nsubj	44	SENT_90	[p4l270t2558r709b2637],
44	—	VBP	O	—	rcmod	42	SENT_90	[p4l731t2602r839b2610],
45	that	IN	O	that	complm	46	SENT_90	[p4l859t2558r1029b2636],
46	affect	VBP	O	affect	ccomp	44	SENT_90	[p4l1047t2557r1288b2636],
47	critical	JJ	O	critical	amod	49	SENT_90	[p4l1308t2558r1599b2636],
48	amino	NN	O	amino	nn	49	SENT_90	[p4l1621t2558r1895b2636],
49	acids	NNS	O	acid	dobj	46	SENT_90	[p4l1919t2557r2132b2636],
50	in	IN	O	in	_	0	SENT_90	[p4l10t2686r92b2763],
51	the	DT	O	the	det	55	SENT_90	[p4l119t2686r250b2764],
52	ATP	NN	O	atp	nn	55	SENT_90	[p4l273t2685r829b2786],
53	—	NN	O	—	nn	55	SENT_90	[p4l273t2685r829b2786],
54	binding	NN	O	binding	nn	55	SENT_90	[p4l273t2685r829b2786],
55	cleft	NN	O	cleft	prep_in	46	SENT_90	[p4l853t2685r1040b2764],
56	of	IN	O	of	_	0	SENT_90	[p4l1062t2685r1163b2764],
57	the	DT	O	the	det	60	SENT_90	[p4l1172t2686r1303b2764],
58	tyrosine	NN	O	tyrosine	nn	60	SENT_90	[p4l1330t2686r1672b2786],
59	kinase	NN	O	kinase	nn	60	SENT_90	[p4l1698t2685r1971b2765],
60	domain	NN	O	domain	prep_of	55	SENT_90	[p4l1996t2685r2134b2764, p4l11t2814r226b2892],
61	of	IN	O	of	_	0	SENT_90	[p4l256t2813r357b2892],
62	the	DT	O	the	det	65	SENT_90	[p4l368t2813r497b2892],
63	receptor	NN	O	receptor	nn	65	SENT_90	[p4l527t2819r1004b2914],
64	.1	NN	NUMBER	.1	nn	65	SENT_90	[p4l527t2819r1004b2914],
65	»	NN	O	»	prep_of	42	SENT_90	[p4l527t2819r1004b2914],
66	2	CD	NUMBER	2	dobj	73	SENT_90	[p4l527t2819r1004b2914],
67	This	DT	O	this	dep	66	SENT_90	[p4l1030t2814r1215b2892],
68	very	RB	O	very	advmod	69	SENT_90	[p4l1243t2840r1416b2914],
69	cleft	NN	O	cleft	nsubj	73	SENT_90	[p4l1442t2813r1624b2892],
70	is	VBZ	O	be	cop	73	SENT_90	[p4l1648t2814r1713b2892],
71	the	DT	O	the	det	73	SENT_90	[p4l1746t2814r1875b2892],
72	binding	NN	O	binding	nn	73	SENT_90	[p4l1906t2813r2132b2892, p4l10t2942r149b3042],
73	site	NN	O	site	rcmod	65	SENT_90	[p4l169t2942r309b3020],
74	for	IN	O	for	_	0	SENT_90	[p4l331t2941r452b3020],
75	the	DT	O	the	det	77	SENT_90	[p4l472t2942r599b3020],
76	inhibitor	NN	O	inhibitor	nn	77	SENT_90	[p4l620t2942r992b3020],
77	drugs	NNS	O	drug	prep_for	73	SENT_90	[p4l1011t2941r1270b3042],
78	.	.	O	.	_	0	SENT_90	[p4l1011t2941r1270b3042],

1	These	DT	O	these	det	3	SENT_91	[p4l1294t2942r1543b3020],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_91	[p4l1562t2948r1773b3021],
3	mutants	NNS	O	mutant	nsubj	26	SENT_91	[p4l1788t2958r2133b3021],
4	have	VBP	O	have	aux	5	SENT_91	[p4l11t3070r204b3149],
5	increased	VBN	O	increase	_	0	SENT_91	[p4l229t3070r643b3148],
6	and	CC	O	and	_	0	SENT_91	[p4l669t3070r828b3148],
7	prolonged	VBN	O	prolong	conj_and	5	SENT_91	[p4l852t3070r1305b3170],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_91	[p4l1332t3070r1678b3170],
9	kinase	NN	O	kinase	nn	10	SENT_91	[p4l1704t3069r1983b3149],
10	ac	NN	O	ac	iobj	5	SENT_91	[p4l2008t3096r2132b3148],
11	—	CD	NUMBER	—	num	12	SENT_91	[p4l2008t3096r2132b3148],
12	tivity	NN	O	tivity	dobj	5	SENT_91	[p4l11t3198r221b3298],
13	in	IN	O	in	_	0	SENT_91	[p4l243t3198r325b3275],
14	response	NN	O	response	prep_in	5	SENT_91	[p4l353t3223r739b3298],
15	to	TO	O	to	_	0	SENT_91	[p4l766t3214r846b3276],
16	the	DT	O	the	det	18	SENT_91	[p4l874t3198r1006b3276],
17	ligand	NN	O	ligand	nn	18	SENT_91	[p4l1031t3197r1303b3298],
18	(	NN	O	(	prep_to	14	SENT_91	[p4l1334t3197r1799b3298],
19	epidermal	JJ	O	epidermal	amod	22	SENT_91	[p4l1334t3197r1799b3298],
20	growth	NN	O	growth	nn	22	SENT_91	[p4l1825t3198r2134b3298],
21	factor	NN	O	factor	nn	22	SENT_91	[p4l11t3325r278b3417],
22	)	NN	O	)	dep	18	SENT_91	[p4l11t3325r278b3417],
23	and	CC	O	and	_	0	SENT_91	[p4l306t3325r460b3404],
24	are	VBP	O	be	cop	26	SENT_91	[p4l483t3352r607b3404],
25	exquisitely	RB	O	exquisitely	advmod	26	SENT_91	[p4l633t3326r1073b3426],
26	sensitive	JJ	O	sensitive	conj_and	5	SENT_91	[p4l1094t3326r1446b3405],
27	to	TO	O	to	_	0	SENT_91	[p4l1470t3342r1549b3404],
28	anilinoquina	NN	O	anilinoquina	nn	31	SENT_91	[p4l1573t3325r2135b3426],
29	—	NN	O	—	nn	31	SENT_91	[p4l1573t3325r2135b3426],
30	zoline	NN	O	zoline	nn	31	SENT_91	[p4l10t3454r264b3532],
31	EGFRinhibitors	NNS	O	egfrinhibitor	prep_to	26	SENT_91	[p4l283t3453r984b3537],
32	.	.	O	.	_	0	SENT_91	[p4l283t3453r984b3537],

1	This	DT	O	this	det	2	SENT_92	[p4l1007t3454r1190b3532],
2	phenomenon	NN	O	phenomenon	nsubj	5	SENT_92	[p4l1212t3454r1777b3554],
3	is	VBZ	O	be	cop	5	SENT_92	[p4l1797t3454r1861b3532],
4	an	DT	O	a	det	5	SENT_92	[p4l1884t3479r1986b3532],
5	example	NN	O	example	_	0	SENT_92	[p4l2010t3480r2132b3532, p4l10t3582r269b3682],
6	of	IN	O	of	_	0	SENT_92	[p4l290t3581r390b3660],
7	what	WP	O	what	dobj	10	SENT_92	[p4l387t3582r599b3661],
8	Bernard	NNP	PERSON	Bernard	nn	9	SENT_92	[p4l613t3582r948b3660],
9	Weinstein	NNP	PERSON	Weinstein	nsubj	10	SENT_92	[p4l964t3582r1385b3660],
10	called	VBD	O	call	prepc_of	5	SENT_92	[p4l1406t3581r1647b3660],
11	“	CD	NUMBER	“	num	13	SENT_92	[p4l1687t3586r2135b3682],
12	oncogene	NN	O	oncogene	nn	13	SENT_92	[p4l1687t3586r2135b3682],
13	addiction	NN	O	addiction	dobj	10	SENT_92	[p4l10t3709r420b3788],
14	.	.	O	.	_	0	SENT_92	[p4l10t3709r420b3788],

1	”	NN	O	”	nsubj	19	SENT_93	[p4l433t3715r509b3762],
2	3	CD	NUMBER	3	num	1	SENT_93	[p4l433t3715r509b3762],
3	The	DT	O	the	det	4	SENT_93	[p4l528t3710r686b3788],
4	abnormality	NN	O	abnormality	nsubj	8	SENT_93	[p4l706t3709r1210b3810],
5	of	IN	O	of	_	0	SENT_93	[p4l1225t3709r1325b3788],
6	the	DT	O	the	det	7	SENT_93	[p4l1327t3709r1453b3788],
7	oncogene	NN	O	oncogene	prep_of	4	SENT_93	[p4l1474t3735r1874b3810],
8	drives	VBZ	O	drive	rcmod	1	SENT_93	[p4l1896t3710r2134b3789],
9	the	DT	O	the	det	10	SENT_93	[p5l11t23r139b101],
10	cell	NN	O	cell	dobj	8	SENT_93	[p5l168t22r308b101],
11	toward	IN	O	toward	_	0	SENT_93	[p5l336t23r627b102],
12	malignancy	NN	O	malignancy	prep_toward	10	SENT_93	[p5l655t22r1143b123],
13	and	CC	O	and	_	0	SENT_93	[p5l1166t23r1343b118],
14	,	,	O	,	_	0	SENT_93	[p5l1166t23r1343b118],
15	in	IN	O	in	rcmod	1	SENT_93	[p5l1376t23r1457b100],
16	so	RB	O	so	pcomp	15	SENT_93	[p5l1487t48r1576b101],
17	doing	VBG	O	do	partmod	1	SENT_93	[p5l1607t23r1873b123],
18	,	,	O	,	_	0	SENT_93	[p5l1607t23r1873b123],
19	alters	VBZ	O	alter	_	0	SENT_93	[p5l1907t23r2132b101],
20	cell	NN	O	cell	nn	23	SENT_93	[p5l11t150r576b251],
21	—	NN	O	—	nn	23	SENT_93	[p5l11t150r576b251],
22	signaling	NN	O	signaling	nn	23	SENT_93	[p5l11t150r576b251],
23	pathways	NNS	O	pathway	dobj	19	SENT_93	[p5l597t151r983b251],
24	in	IN	O	in	_	0	SENT_93	[p5l1010t151r1090b228],
25	a	DT	O	a	det	26	SENT_93	[p5l1115t177r1159b229],
26	way	NN	O	way	prep_in	23	SENT_93	[p5l1179t177r1344b251],
27	that	WDT	O	that	nsubj	28	SENT_93	[p5l1365t151r1529b229],
28	makes	VBZ	O	make	rcmod	26	SENT_93	[p5l1549t151r1816b230],
29	the	DT	O	the	det	30	SENT_93	[p5l1844t151r1971b229],
30	cell	NN	O	cell	nsubj	32	SENT_93	[p5l1998t151r2136b229],
31	absolutely	RB	O	absolutely	advmod	32	SENT_93	[p5l10t278r449b379],
32	dependent	JJ	O	dependent	xcomp	28	SENT_93	[p5l472t278r931b379],
33	on	IN	O	on	_	0	SENT_93	[p5l953t304r1060b357],
34	the	DT	O	the	det	35	SENT_93	[p5l1087t279r1219b357],
35	oncogene	NN	O	oncogene	prep_on	32	SENT_93	[p5l1247t304r1663b379],
36	for	IN	O	for	_	0	SENT_93	[p5l1690t278r1816b357],
37	its	PRP$	O	its	poss	38	SENT_93	[p5l1838t279r1936b357],
38	survival	NN	O	survival	prep_for	35	SENT_93	[p5l1967t305r2132b358, p5l6t407r223b486],
39	.	.	O	.	_	0	SENT_93	[p5l1967t305r2132b358, p5l6t407r223b486],

1	Weinstein	NNP	PERSON	Weinstein	nsubj	3	SENT_94	[p5l252t407r686b485],
2	playfully	RB	O	playfully	advmod	3	SENT_94	[p5l712t406r1082b507],
3	pointed	VBD	O	point	ccomp	17	SENT_94	[p5l1104t407r1435b507],
4	out	RP	O	out	prt	3	SENT_94	[p5l1463t423r1605b486],
5	that	IN	O	that	complm	12	SENT_94	[p5l1629t407r1798b485],
6	this	DT	O	this	det	7	SENT_94	[p5l1821t407r1976b485],
7	dependence	NN	O	dependence	nsubj	12	SENT_94	[p5l2007t407r2135b485, p5l9t535r403b635],
8	was	VBD	O	be	cop	12	SENT_94	[p5l421t561r579b614],
9	the	DT	O	the	det	10	SENT_94	[p5l603t534r729b613],
10	cancer	NN	O	cancer	poss	12	SENT_94	[p5l752t540r1082b613],
11	’s	POS	O	’s	_	0	SENT_94	[p5l752t540r1082b613],
12	Achilles	NNPS	O	Achilles	ccomp	3	SENT_94	[p5l1102t535r1451b613],
13	’	CD	NUMBER	’	num	14	SENT_94	[p5l1102t535r1451b613],
14	“	CD	NUMBER	“	nsubj	15	SENT_94	[p5l1481t534r1759b630],
15	heal	VBP	O	heal	rcmod	12	SENT_94	[p5l1481t534r1759b630],
16	,	,	O	,	_	0	SENT_94	[p5l1481t534r1759b630],
17	”	VBP	O	”	_	0	SENT_94	[p5l1481t534r1759b630],
18	and	CC	O	and	_	0	SENT_94	[p5l1785t535r1938b613],
19	thus	RB	O	thus	advmod	23	SENT_94	[p5l1959t535r2135b614],
20	the	DT	O	the	det	22	SENT_94	[p5l11t663r138b741],
21	general	JJ	O	general	amod	22	SENT_94	[p5l169t663r485b763],
22	strategy	NN	O	strategy	nsubj	23	SENT_94	[p5l521t679r859b763],
23	is	VBZ	O	be	conj_and	17	SENT_94	[p5l888t663r954b741],
24	to	TO	O	to	aux	25	SENT_94	[p5l992t679r1072b741],
25	discover	VB	O	discover	xcomp	23	SENT_94	[p5l1109t663r1465b742],
26	mutated	VBN	O	mutate	dep	25	SENT_94	[p5l1497t662r1855b742],
27	oncogenes	NNS	O	oncogene	dobj	26	SENT_94	[p5l1889t688r2132b741, p5l10t816r255b891],
28	and	CC	O	and	_	0	SENT_94	[p5l288t790r446b869],
29	develop	VB	O	develop	conj_and	25	SENT_94	[p5l477t791r805b891],
30	drugs	NNS	O	drug	dobj	29	SENT_94	[p5l838t791r1080b891],
31	targeted	VBN	O	target	partmod	30	SENT_94	[p5l1114t790r1467b891],
32	to	TO	O	to	_	0	SENT_94	[p5l1498t807r1579b869],
33	their	PRP$	O	they	poss	35	SENT_94	[p5l1612t791r1808b869],
34	protein	NN	O	protein	nn	35	SENT_94	[p5l1832t791r2136b891],
35	products	NNS	O	product	prep_to	31	SENT_94	[p5l9t919r402b1019],
36	.	.	O	.	_	0	SENT_94	[p5l9t919r402b1019],

1	This	DT	O	this	det	2	SENT_95	[p5l428t919r611b997],
2	concept	NN	O	concept	nsubj	3	SENT_95	[p5l638t935r969b1019],
3	underlies	VBZ	O	underlie	_	0	SENT_95	[p5l988t919r1372b998],
4	the	DT	O	the	det	5	SENT_95	[p5l1399t919r1527b997],
5	present	JJ	DATE	present	dobj	3	SENT_95	[p5l1550t935r1865b1019],
6	thinking	VBG	O	think	amod	5	SENT_95	[p5l1885t919r2135b998, p5l10t1047r147b1147],
7	about	IN	O	about	_	0	SENT_95	[p5l174t1047r414b1126],
8	BCR	NN	O	bcr	prep_about	5	SENT_95	[p5l438t1052r802b1142],
9	.	.	O	.	_	0	SENT_95	[p5l438t1052r802b1142],

1	—	NN	O	—	_	0	SENT_96	[p5l438t1052r802b1142],
2	.	.	O	.	_	0	SENT_96	[p5l438t1052r802b1142],

1	ABL	NNP	ORGANIZATION	ABL	nsubj	11	SENT_97	[p5l438t1052r802b1142],
2	,	,	O	,	_	0	SENT_97	[p5l438t1052r802b1142],
3	mutated	VBN	O	mutate	partmod	11	SENT_97	[p5l839t1046r1184b1126],
4	c	NN	O	c	nsubj	8	SENT_97	[p5l1217t1046r1392b1142],
5	—	CD	NUMBER	—	num	4	SENT_97	[p5l1217t1046r1392b1142],
6	l	NN	O	l	amod	4	SENT_97	[p5l1217t1046r1392b1142],
7	<	JJR	O	<	dep	6	SENT_97	[p5l1217t1046r1392b1142],
8	it	PRP	O	it	xcomp	3	SENT_97	[p5l1217t1046r1392b1142],
9	,	,	O	,	_	0	SENT_97	[p5l1217t1046r1392b1142],
10	phosphatidylinosi	NNS	O	phosphatidylinosus	nsubj	11	SENT_97	[p5l1424t1046r2132b1147],
11	—	VBP	O	—	_	0	SENT_97	[p5l1424t1046r2132b1147],
12	tol	NN	O	tol	dobj	11	SENT_97	[p5l11t1173r192b1251],
13	—	CD	NUMBER	—	number	14	SENT_97	[p5l11t1173r192b1251],
14	3	CD	NUMBER	3	num	16	SENT_97	[p5l11t1173r192b1251],
15	kinase	NN	O	kinase	nn	16	SENT_97	[p5l226t1173r463b1251],
16	mutations	NNS	O	mutation	nsubj	25	SENT_97	[p5l486t1174r930b1253],
17	in	IN	O	in	_	0	SENT_97	[p5l959t1174r1042b1250],
18	colon	NN	O	colon	nn	19	SENT_97	[p5l1070t1174r1310b1252],
19	cancer	NN	O	cancer	prep_in	16	SENT_97	[p5l1340t1199r1641b1268],
20	,	,	O	,	_	0	SENT_97	[p5l1340t1199r1641b1268],
21	occasional	JJ	O	occasional	amod	23	SENT_97	[p5l1675t1174r2134b1252],
22	HER2/neu	NN	O	her2/neu	nn	23	SENT_97	[p5l9t1308r402b1399],
23	(	NN	O	(	appos	19	SENT_97	[p5l450t1301r650b1393],
24	also	RB	O	also	advmod	25	SENT_97	[p5l450t1301r650b1393],
25	called	VBD	O	call	rcmod	12	SENT_97	[p5l695t1301r944b1380],
26	ERBB2	NN	O	erbb2	nn	28	SENT_97	[p5l984t1308r1285b1393],
27	)	NN	O	)	nn	28	SENT_97	[p5l984t1308r1285b1393],
28	mutations	NNS	O	mutation	dobj	25	SENT_97	[p5l1332t1302r1771b1381],
29	in	IN	O	in	_	0	SENT_97	[p5l1816t1302r1898b1379],
30	lung	NN	O	lung	nn	31	SENT_97	[p5l1940t1302r2137b1402],
31	cancer	NN	O	cancer	prep_in	28	SENT_97	[p5l11t1455r309b1525],
32	,	,	O	,	_	0	SENT_97	[p5l11t1455r309b1525],
33	and	CC	O	and	_	0	SENT_97	[p5l358t1430r514b1508],
34	genome	NN	O	genome	conj_and	28	SENT_97	[p5l552t1429r1121b1530],
35	—	CD	NUMBER	—	num	37	SENT_97	[p5l552t1429r1121b1530],
36	wide	JJ	O	wide	amod	37	SENT_97	[p5l552t1429r1121b1530],
37	searches	NNS	O	search	dep	34	SENT_97	[p5l1161t1429r1512b1508],
38	for	IN	O	for	_	0	SENT_97	[p5l1553t1429r1674b1508],
39	mutations	NNS	O	mutation	prep_for	25	SENT_97	[p5l1710t1430r2134b1509],
40	through	IN	O	through	_	0	SENT_97	[p5l11t1558r348b1658],
41	the	DT	O	the	det	42	SENT_97	[p5l381t1558r512b1636],
42	sequencing	NN	O	sequencing	prep_through	25	SENT_97	[p5l549t1558r1042b1658],
43	of	IN	O	of	_	0	SENT_97	[p5l1074t1557r1176b1636],
44	all	DT	O	all	det	46	SENT_97	[p5l1192t1557r1292b1636],
45	tyrosine	NN	O	tyrosine	nn	46	SENT_97	[p5l1327t1558r1669b1658],
46	kinases	NNS	O	kinase	prep_of	42	SENT_97	[p5l1704t1557r2016b1637],
47	or	CC	O	or	_	0	SENT_97	[p5l2050t1583r2139b1636],
48	all	DT	O	all	det	49	SENT_97	[p5l10t1685r108b1764],
49	kinases	NNS	O	kinase	conj_or	42	SENT_97	[p5l135t1686r444b1765],
50	in	IN	O	in	_	0	SENT_97	[p5l473t1686r554b1763],
51	various	JJ	O	various	amod	52	SENT_97	[p5l577t1686r880b1765],
52	cancers	NNS	O	cancer	prep_in	49	SENT_97	[p5l910t1711r1246b1764],
53	.	.	O	.	_	0	SENT_97	[p5l910t1711r1246b1764],

1	Any	DT	O	any	nsubj	13	SENT_98	[p5l1275t1693r1442b1786],
2	of	IN	O	of	_	0	SENT_98	[p5l1466t1685r1566b1764],
3	these	DT	O	these	det	4	SENT_98	[p5l1576t1686r1794b1764],
4	kinases	NNS	O	kinase	prep_of	1	SENT_98	[p5l1822t1686r2132b1765],
5	that	WDT	O	that	nsubj	10	SENT_98	[p5l11t1814r179b1892],
6	in	IN	O	in	_	0	SENT_98	[p5l211t1814r294b1891],
7	the	DT	O	the	det	9	SENT_98	[p5l333t1814r464b1892],
8	mutated	VBN	O	mutate	amod	9	SENT_98	[p5l504t1814r861b1893],
9	form	NN	O	form	prep_in	10	SENT_98	[p5l900t1813r1110b1892],
10	have	VBP	O	have	rcmod	4	SENT_98	[p5l1149t1814r1340b1893],
11	oncogenic	JJ	O	oncogenic	amod	12	SENT_98	[p5l1380t1814r1826b1914],
12	effects	NNS	O	effect	dobj	10	SENT_98	[p5l1865t1813r2133b1892],
13	become	VBP	O	become	_	0	SENT_98	[p5l11t1941r337b2020],
14	important	JJ	O	important	amod	16	SENT_98	[p5l361t1942r789b2042],
15	new	JJ	O	new	amod	16	SENT_98	[p5l808t1967r983b2021],
16	“	NN	O	“	nsubj	19	SENT_98	[p5l1007t1941r1514b2042],
17	druggable	JJ	O	druggable	amod	19	SENT_98	[p5l1007t1941r1514b2042],
18	”	NN	O	”	nn	19	SENT_98	[p5l1007t1941r1514b2042],
19	targets	NNS	O	target	xcomp	13	SENT_98	[p5l1543t1958r1851b2042],
20	.	.	O	.	_	0	SENT_98	[p5l1543t1958r1851b2042],

1	Despite	IN	O	despite	_	0	SENT_99	[p5l138t2070r454b2170],
2	the	DT	O	the	det	3	SENT_99	[p5l487t2070r614b2148],
3	successes	NNS	O	success	prep_despite	9	SENT_99	[p5l648t2096r1043b2149],
4	of	IN	O	of	_	0	SENT_99	[p5l1078t2069r1178b2148],
5	targeted	VBN	O	target	amod	6	SENT_99	[p5l1193t2070r1532b2170],
6	therapy	NN	O	therapy	prep_of	3	SENT_99	[p5l1564t2070r1887b2170],
7	,	,	O	,	_	0	SENT_99	[p5l1564t2070r1887b2170],
8	clinicians	NNS	O	clinician	nsubj	9	SENT_99	[p5l1925t2070r2135b2148, p5l11t2198r221b2276],
9	know	VBP	O	know	_	0	SENT_99	[p5l248t2197r487b2277],
10	that	IN	O	that	complm	15	SENT_99	[p5l514t2198r684b2276],
11	the	DT	O	the	det	12	SENT_99	[p5l709t2198r840b2276],
12	tumors	NNS	O	tumor	nsubj	15	SENT_99	[p5l870t2214r1176b2277],
13	eventually	RB	O	eventually	advmod	15	SENT_99	[p5l1209t2198r1641b2298],
14	became	VBD	O	become	cop	15	SENT_99	[p5l1667t2198r1993b2276],
15	resistant	JJ	O	resistant	ccomp	9	SENT_99	[p5l2023t2224r2135b2276, p5l12t2326r290b2404],
16	to	TO	O	to	_	0	SENT_99	[p5l312t2342r390b2404],
17	the	DT	O	the	det	18	SENT_99	[p5l418t2326r545b2404],
18	treatment	NN	O	treatment	prep_to	15	SENT_99	[p5l573t2342r998b2404],
19	.	.	O	.	_	0	SENT_99	[p5l573t2342r998b2404],

1	Detailed	JJ	O	detailed	amod	3	SENT_100	[p5l1029t2325r1375b2404],
2	molecular	JJ	O	molecular	amod	3	SENT_100	[p5l1402t2326r1820b2405],
3	studies	NNS	O	study	nsubj	8	SENT_100	[p5l1845t2326r2134b2405],
4	in	IN	O	in	_	0	SENT_100	[p5l10t2454r90b2531],
5	chronic	JJ	O	chronic	amod	7	SENT_100	[p5l133t2454r459b2532],
6	myeloid	JJ	O	myeloid	amod	7	SENT_100	[p5l501t2454r844b2554],
7	leukemia	NN	O	leukemia	prep_in	3	SENT_100	[p5l884t2453r1281b2533],
8	showed	VBD	O	show	_	0	SENT_100	[p5l1323t2453r1651b2533],
9	that	IN	O	that	complm	15	SENT_100	[p5l1694t2454r1864b2532],
10	resistance	NN	O	resistance	nsubjpass	15	SENT_100	[p5l1901t2454r2132b2532, p5l11t2598r239b2660],
11	to	TO	O	to	_	0	SENT_100	[p5l268t2598r348b2660],
12	imatinib	NN	O	imatinib	prep_to	10	SENT_100	[p5l376t2581r739b2660],
13	was	VBD	O	be	auxpass	15	SENT_100	[p5l763t2608r927b2661],
14	often	RB	O	often	advmod	15	SENT_100	[p5l958t2581r1179b2660],
15	associated	VBN	O	associate	ccomp	8	SENT_100	[p5l1206t2581r1651b2660],
16	with	IN	O	with	_	0	SENT_100	[p5l1674t2582r1867b2661],
17	a	DT	O	a	det	18	SENT_100	[p5l1893t2608r1938b2660],
18	mutation	NN	O	mutation	prep_with	15	SENT_100	[p5l1964t2608r2135b2661, p5l11t2710r254b2788],

1	in	IN	O	in	_	0	SENT_101	[p5l292t2710r372b2787],
2	the	DT	O	the	det	5	SENT_101	[p5l412t2710r539b2788],
3	BCR-ABL	NN	MISC	bcr-abl	nn	5	SENT_101	[p5l577t2715r922b2789],
4	fusion	NN	O	fusion	nn	5	SENT_101	[p5l958t2709r1220b2789],
5	gene	NN	O	gene	prep_in	30	SENT_101	[p5l1260t2735r1479b2810],
6	,	,	O	,	_	0	SENT_101	[p5l1260t2735r1479b2810],
7	and	CC	O	and	dep	10	SENT_101	[p5l1523t2709r1677b2788],
8	saturation	NN	O	saturation	nn	9	SENT_101	[p5l1718t2710r2136b2789],
9	analysis	NN	O	analysis	nsubj	10	SENT_101	[p5l10t2837r343b2938],
10	allowed	VBD	O	allow	parataxis	30	SENT_101	[p5l376t2837r703b2917],
11	the	DT	O	the	det	12	SENT_101	[p5l735t2838r864b2916],
12	identiﬁcation	NN	O	identiﬁcation	dobj	10	SENT_101	[p5l895t2837r1461b2916],
13	of	IN	O	of	_	0	SENT_101	[p5l1493t2837r1593b2916],
14	all	DT	O	all	det	16	SENT_101	[p5l1606t2837r1705b2916],
15	such	JJ	O	such	amod	16	SENT_101	[p5l1737t2838r1932b2917],
16	mutants	NNS	O	mutant	prep_of	12	SENT_101	[p5l1963t2864r2134b2917, p5l11t2971r285b3044],
17	.4	CD	NUMBER	.4	dep	16	SENT_101	[p5l1963t2864r2134b2917, p5l11t2971r285b3044],
18	However	RB	O	however	advmod	10	SENT_101	[p5l312t2973r698b3061],
19	,	,	O	,	_	0	SENT_101	[p5l312t2973r698b3061],
20	the	DT	O	the	det	22	SENT_101	[p5l731t2966r859b3044],
21	real	JJ	O	real	amod	22	SENT_101	[p5l886t2965r1037b3044],
22	importance	NN	O	importance	nsubj	30	SENT_101	[p5l1062t2966r1543b3066],
23	of	IN	O	of	_	0	SENT_101	[p5l1571t2965r1670b3044],
24	the	DT	O	the	det	25	SENT_101	[p5l1679t2966r1807b3044],
25	discovery	NN	O	discovery	prep_of	22	SENT_101	[p5l1838t2966r2134b3045, p5l11t3120r139b3194],
26	of	IN	O	of	_	0	SENT_101	[p5l176t3093r278b3172],
27	these	DT	O	these	det	29	SENT_101	[p5l301t3093r524b3172],
28	new	JJ	O	new	amod	29	SENT_101	[p5l566t3119r744b3173],
29	mutations	NNS	O	mutation	prep_of	25	SENT_101	[p5l781t3094r1220b3173],
30	was	VBD	O	be	_	0	SENT_101	[p5l1260t3120r1423b3173],
31	that	IN	O	that	complm	36	SENT_101	[p5l1467t3093r1637b3172],
32	new	JJ	O	new	amod	33	SENT_101	[p5l1674t3119r1851b3173],
33	drugs	NNS	O	drug	nsubjpass	38	SENT_101	[p5l1891t3094r2132b3194],
34	could	MD	O	could	aux	36	SENT_101	[p5l11t3222r247b3301],
35	be	VB	O	be	auxpass	36	SENT_101	[p5l281t3222r376b3300],
36	designed	VBN	O	design	ccomp	30	SENT_101	[p5l409t3222r789b3322],
37	and	CC	O	and	_	0	SENT_101	[p5l821t3222r976b3300],
38	identiﬁed	VBN	O	identiﬁed	ccomp	30	SENT_101	[p5l1008t3221r1411b3300],
39	to	TO	O	to	aux	40	SENT_101	[p5l1444t3238r1523b3300],
40	inhibit	VB	O	inhibit	xcomp	38	SENT_101	[p5l1556t3222r1842b3300],
41	the	DT	O	the	det	43	SENT_101	[p5l1870t3221r1996b3300],
42	resistant	JJ	O	resistant	amod	43	SENT_101	[p5l2026t3248r2135b3300, p5l12t3350r288b3428],
43	receptor	NN	O	receptor	dobj	40	SENT_101	[p5l316t3366r673b3450],
44	,	,	O	,	_	0	SENT_101	[p5l316t3366r673b3450],
45	thereby	RB	O	thereby	advmod	46	SENT_101	[p5l713t3350r1020b3450],
46	allowing	VBG	O	allow	conj_and	36	SENT_101	[p5l1049t3350r1410b3450],
47	effective	JJ	O	effective	amod	49	SENT_101	[p5l1440t3349r1775b3429],
48	secondline	NN	O	secondline	nn	49	SENT_101	[p5l1811t3349r2134b3428, p5l10t3478r165b3556],
49	therapy	NN	O	therapy	dobj	46	SENT_101	[p5l190t3478r508b3578],
50	to	TO	O	to	aux	52	SENT_101	[p5l528t3494r607b3556],
51	be	VB	O	be	auxpass	52	SENT_101	[p5l634t3477r730b3556],
52	directed	VBN	O	direct	xcomp	46	SENT_101	[p5l756t3477r1094b3556],
53	at	IN	O	at	_	0	SENT_101	[p5l1118t3494r1198b3556],
54	the	DT	O	the	det	56	SENT_101	[p5l1218t3478r1347b3556],
55	same	JJ	O	same	amod	56	SENT_101	[p5l1374t3504r1591b3556],
56	target	NN	O	target	prep_at	52	SENT_101	[p5l1617t3494r1884b3578],
57	.	.	O	.	_	0	SENT_101	[p5l1617t3494r1884b3578],

1	In	IN	O	in	dep	11	SENT_102	[p5l138t3613r224b3683],
2	this	DT	O	this	det	3	SENT_102	[p5l268t3606r424b3684],
3	issue	NN	O	issue	pobj	1	SENT_102	[p5l469t3606r685b3685],
4	of	IN	O	of	_	0	SENT_102	[p5l730t3605r832b3684],
5	the	DT	O	the	det	6	SENT_102	[p5l857t3605r988b3684],
6	journal	NN	O	journal	prep_of	3	SENT_102	[p5l1016t3605r1334b3706],
7	,	,	O	,	_	0	SENT_102	[p5l1016t3605r1334b3706],
8	Kobayashi	NNP	PERSON	Kobayashi	appos	6	SENT_102	[p5l1382t3605r1830b3706],
9	et	FW	O	et	nn	10	SENT_102	[p5l1874t3622r1952b3684],
10	al.	FW	O	al.	dep	8	SENT_102	[p5l1990t3606r2130b3684],
11	5	CD	NUMBER	5	_	0	SENT_102	[p5l1990t3606r2130b3684],

1	show	NN	O	show	_	0	SENT_103	[p6l12t21r241b100],
2	that	IN	O	that	complm	6	SENT_103	[p6l261t20r431b99],
3	the	DT	O	the	det	5	SENT_103	[p6l450t21r581b99],
4	same	JJ	O	same	amod	5	SENT_103	[p6l606t47r823b99],
5	principle	NN	O	principle	nsubj	6	SENT_103	[p6l843t20r1221b121],
6	holds	VBZ	O	hold	ccomp	1	SENT_103	[p6l1243t20r1474b99],
7	for	IN	O	for	_	0	SENT_103	[p6l1498t20r1621b99],
8	non	JJ	O	non	amod	14	SENT_103	[p6l1639t20r2132b99],
9	—	JJ	O	—	amod	14	SENT_103	[p6l1639t20r2132b99],
10	small	JJ	O	small	amod	14	SENT_103	[p6l1639t20r2132b99],
11	—	NN	O	—	nn	14	SENT_103	[p6l1639t20r2132b99],
12	cell	NN	O	cell	nn	14	SENT_103	[p6l11t149r156b227],
13	lung	NN	O	lung	nn	14	SENT_103	[p6l179t149r376b249],
14	cancer	NN	O	cancer	prep_for	6	SENT_103	[p6l397t174r678b227],
15	that	WDT	O	that	nsubj	18	SENT_103	[p6l699t148r865b227],
16	has	VBZ	O	have	aux	18	SENT_103	[p6l882t149r1023b227],
17	become	VBN	O	become	cop	18	SENT_103	[p6l1048t149r1376b227],
18	resistant	JJ	O	resistant	rcmod	14	SENT_103	[p6l1399t149r1767b227],
19	to	TO	O	to	_	0	SENT_103	[p6l1784t165r1863b227],
20	therapy	NN	O	therapy	prep_to	18	SENT_103	[p6l1887t149r2134b227, p6l9t303r109b377],
21	targeted	VBN	O	target	partmod	20	SENT_103	[p6l134t277r487b377],
22	to	TO	O	to	_	0	SENT_103	[p6l516t293r596b355],
23	a	DT	O	a	det	25	SENT_103	[p6l625t303r670b355],
24	mutated	VBN	O	mutate	amod	25	SENT_103	[p6l697t276r1055b356],
25	EGFR	NN	ORGANIZATION	egfr	prep_to	21	SENT_103	[p6l1082t282r1358b360],
26	.	.	O	.	_	0	SENT_103	[p6l1082t282r1358b360],

1	The	DT	O	the	det	2	SENT_104	[p6l1389t277r1553b355],
2	investigators	NNS	O	investigator	nsubj	3	SENT_104	[p6l1581t277r2132b377],
3	performed	VBD	O	perform	_	0	SENT_104	[p6l9t404r454b505],
4	a	DT	DURATION	a	det	6	SENT_104	[p6l487t431r531b483],
5	second	JJ	DURATION	second	amod	6	SENT_104	[p6l564t404r857b483],
6	biopsy	NN	O	biopsy	dobj	3	SENT_104	[p6l890t404r1166b505],
7	in	IN	O	in	_	0	SENT_104	[p6l1194t405r1275b482],
8	a	DT	O	a	det	9	SENT_104	[p6l1307t431r1351b483],
9	patient	NN	O	patient	prep_in	3	SENT_104	[p6l1381t405r1677b505],
10	with	IN	O	with	_	0	SENT_104	[p6l1700t404r1887b484],
11	nonsmall	JJ	O	nonsmall	amod	15	SENT_104	[p6l1921t430r2139b483, p6l12t532r419b611],
12	—	NN	O	—	nn	15	SENT_104	[p6l1921t430r2139b483, p6l12t532r419b611],
13	cell	NN	O	cell	nn	15	SENT_104	[p6l1921t430r2139b483, p6l12t532r419b611],
14	lung	NN	O	lung	nn	15	SENT_104	[p6l443t532r641b633],
15	cancer	NN	O	cancer	prep_with	3	SENT_104	[p6l664t558r944b611],
16	whose	WP$	O	whose	poss	17	SENT_104	[p6l962t532r1233b612],
17	tumor	NN	O	tumor	nsubj	18	SENT_104	[p6l1257t549r1518b612],
18	had	VBD	O	have	rcmod	15	SENT_104	[p6l1537t532r1691b611],
19	one	CD	NUMBER	one	dobj	18	SENT_104	[p6l1715t558r1867b611],
20	of	IN	O	of	_	0	SENT_104	[p6l1893t532r1995b611],
21	the	DT	O	the	det	22	SENT_104	[p6l2003t533r2134b611],
22	mutations	NNS	O	mutation	prep_of	19	SENT_104	[p6l11t661r450b740],
23	that	WDT	O	that	nsubj	24	SENT_104	[p6l483t661r653b739],
24	increase	VBP	O	increase	rcmod	22	SENT_104	[p6l678t661r1032b739],
25	the	DT	O	the	det	26	SENT_104	[p6l1064t661r1195b739],
26	susceptibility	NN	O	susceptibility	dobj	24	SENT_104	[p6l1228t661r1800b761],
27	to	TO	O	to	_	0	SENT_104	[p6l1827t677r1907b739],
28	geﬁ	NN	O	geﬁ	nn	29	SENT_104	[p6l1939t660r2133b761],
29	tinib	NN	O	tinib	prep_to	24	SENT_104	[p6l11t789r234b867],
30	.	.	O	.	_	0	SENT_104	[p6l11t789r234b867],

1	This	DT	O	this	det	2	SENT_105	[p6l266t789r454b867],
2	tumor	NN	O	tumor	nsubj	4	SENT_105	[p6l486t805r753b868],
3	had	VBD	O	have	aux	4	SENT_105	[p6l780t789r937b867],
4	progressed	VBN	O	progress	_	0	SENT_105	[p6l966t788r1445b889],
5	after	IN	O	after	_	0	SENT_105	[p6l1474t788r1672b867],
6	a	DT	O	a	det	10	SENT_105	[p6l1697t815r1742b867],
7	tvvo	NN	O	tvvo	nn	10	SENT_105	[p6l1771t805r2139b889],
8	—	CD	NUMBER	—	num	10	SENT_105	[p6l1771t805r2139b889],
9	year	NN	NUMBER	year	nn	10	SENT_105	[p6l1771t805r2139b889],
10	response	NN	O	response	prep_after	4	SENT_105	[p6l11t942r387b1017],
11	to	TO	O	to	_	0	SENT_105	[p6l408t933r486b995],
12	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_105	[p6l509t916r885b1017],
13	,	,	O	,	_	0	SENT_105	[p6l509t916r885b1017],
14	and	CC	O	and	_	0	SENT_105	[p6l910t917r1065b995],
15	the	DT	O	the	det	17	SENT_105	[p6l1086t916r1214b995],
16	biopsy	NN	O	biopsy	nn	17	SENT_105	[p6l1237t917r1513b1017],
17	specimen	NN	O	specimen	nsubj	18	SENT_105	[p6l1531t917r1930b1017],
18	contained	VBD	O	contain	conj_and	4	SENT_105	[p6l1952t942r2135b995, p6l11t1045r278b1123],
19	a	DT	DURATION	a	det	21	SENT_105	[p6l318t1071r362b1123],
20	second	JJ	DURATION	second	amod	21	SENT_105	[p6l402t1044r703b1123],
21	mutation	NN	O	mutation	dobj	18	SENT_105	[p6l743t1045r1140b1124],
22	in	IN	O	in	_	0	SENT_105	[p6l1180t1045r1262b1122],
23	the	DT	O	the	det	26	SENT_105	[p6l1303t1045r1434b1123],
24	tyrosine	NN	O	tyrosine	nn	26	SENT_105	[p6l1475t1045r1818b1145],
25	kinase	NN	O	kinase	nn	26	SENT_105	[p6l1858t1045r2134b1124],
26	domain	NN	O	domain	prep_in	18	SENT_105	[p6l11t1173r340b1251],
27	of	IN	O	of	_	0	SENT_105	[p6l367t1172r469b1251],
28	EGFR	NN	ORGANIZATION	egfr	prep_of	26	SENT_105	[p6l474t1179r708b1252],
29	.	.	O	.	_	0	SENT_105	[p6l474t1179r708b1252],

1	Elegant	JJ	O	elegant	amod	10	SENT_106	[p6l738t1173r1068b1273],
2	molecular	JJ	O	molecular	amod	4	SENT_106	[p6l1088t1173r1540b1268],
3	,	,	O	,	_	0	SENT_106	[p6l1088t1173r1540b1268],
4	biologic	JJ	O	biologic	amod	10	SENT_106	[p6l1572t1173r1945b1273],
5	,	,	O	,	_	0	SENT_106	[p6l1572t1173r1945b1273],
6	and	CC	O	and	_	0	SENT_106	[p6l1976t1172r2134b1251],
7	computer	NN	O	computer	amod	10	SENT_106	[p6l11t1301r884b1401],
8	—	CD	NUMBER	—	num	7	SENT_106	[p6l11t1301r884b1401],
9	modeling	NN	O	modeling	nn	10	SENT_106	[p6l11t1301r884b1401],
10	studies	NNS	O	study	nsubj	11	SENT_106	[p6l908t1300r1207b1380],
11	showed	VBD	O	show	_	0	SENT_106	[p6l1237t1300r1566b1380],
12	that	IN	O	that	complm	16	SENT_106	[p6l1592t1301r1762b1379],
13	this	DT	DATE	this	det	15	SENT_106	[p6l1784t1301r1939b1379],
14	second	JJ	DATE	second	amod	15	SENT_106	[p6l1968t1327r2133b1379, p6l11t1428r174b1507],
15	mutation	NN	O	mutation	nsubj	16	SENT_106	[p6l199t1429r589b1508],
16	replaced	VBD	O	replace	ccomp	11	SENT_106	[p6l616t1428r971b1529],
17	threonine	NN	O	threonine	dobj	16	SENT_106	[p6l998t1429r1409b1507],
18	with	IN	O	with	_	0	SENT_106	[p6l1431t1428r1620b1508],
19	methionine	NN	O	methionine	prep_with	16	SENT_106	[p6l1647t1429r2135b1507],
20	at	IN	O	at	_	0	SENT_106	[p6l10t1573r89b1635],
21	position	NN	O	position	prep_at	16	SENT_106	[p6l109t1557r458b1657],
22	790	CD	NUMBER	790	number	23	SENT_106	[p6l486t1562r637b1635],
23	(	CD	NUMBER	(	num	25	SENT_106	[p6l669t1562r1029b1648],
24	T79OM	NN	O	t79om	nn	25	SENT_106	[p6l669t1562r1029b1648],
25	)	NN	O	)	dep	11	SENT_106	[p6l669t1562r1029b1648],
26	in	IN	O	in	_	0	SENT_106	[p6l1060t1557r1142b1634],
27	the	DT	O	the	det	29	SENT_106	[p6l1168t1556r1297b1635],
28	catalytic	JJ	O	catalytic	amod	29	SENT_106	[p6l1324t1557r1667b1657],
29	cleft	NN	O	cleft	prep_in	25	SENT_106	[p6l1693t1556r1876b1635],
30	of	IN	O	of	_	0	SENT_106	[p6l1897t1556r1998b1635],
31	the	DT	O	the	det	35	SENT_106	[p6l2006t1557r2135b1635],
32	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_106	[p6l9t1690r268b1768],
33	tyrosine	NN	O	tyrosine	nn	35	SENT_106	[p6l290t1685r624b1785],
34	kinase	NN	O	kinase	nn	35	SENT_106	[p6l655t1685r926b1764],
35	domain	NN	O	domain	prep_of	29	SENT_106	[p6l958t1685r1305b1780],
36	,	,	O	,	_	0	SENT_106	[p6l958t1685r1305b1780],
37	thereby	RB	O	thereby	advmod	38	SENT_106	[p6l1342t1684r1657b1785],
38	preventing	VBG	O	prevent	ccomp	11	SENT_106	[p6l1682t1685r2139b1785],
39	the	DT	O	the	det	40	SENT_106	[p6l11t1813r140b1891],
40	access	NN	O	access	dobj	38	SENT_106	[p6l170t1839r433b1891],
41	of	IN	O	of	_	0	SENT_106	[p6l466t1812r567b1891],
42	geﬁtinib	NN	O	geﬁtinib	prep_of	40	SENT_106	[p6l579t1812r934b1913],
43	to	TO	O	to	_	0	SENT_106	[p6l966t1829r1045b1891],
44	the	DT	O	the	det	48	SENT_106	[p6l1077t1812r1205b1891],
45	geﬁtinib	NN	O	geﬁtinib	nn	48	SENT_106	[p6l1235t1812r1965b1913],
46	—	NN	O	—	nn	48	SENT_106	[p6l1235t1812r1965b1913],
47	binding	VBG	O	bind	amod	48	SENT_106	[p6l1235t1812r1965b1913],
48	site	NN	O	site	prep_to	38	SENT_106	[p6l1993t1813r2135b1891],
49	while	IN	O	while	mark	50	SENT_106	[p6l6t1940r237b2020],
50	preserving	VBG	O	preserve	advcl	38	SENT_106	[p6l259t1941r707b2041],
51	the	DT	O	the	det	53	SENT_106	[p6l726t1941r855b2019],
52	kinase	NN	O	kinase	nn	53	SENT_106	[p6l877t1940r1148b2020],
53	activity	NN	O	activity	dobj	50	SENT_106	[p6l1169t1941r1465b2041],
54	of	IN	O	of	_	0	SENT_106	[p6l1483t1940r1584b2019],
55	the	DT	O	the	det	60	SENT_106	[p6l1588t1940r1717b2019],
56	ligand	NN	O	ligand	nn	60	SENT_106	[p6l1737t1940r2004b2041],
57	aﬁ	NN	O	aﬁ	nn	60	SENT_106	[p6l2025t1940r2134b2019],
58	ter	NN	O	ter	nn	60	SENT_106	[p6l11t2085r124b2147],
59	ligand	NN	O	ligand	nn	60	SENT_106	[p6l154t2068r420b2169],
60	stimulation	NN	O	stimulation	prep_of	53	SENT_106	[p6l456t2069r964b2148],
61	.	.	O	.	_	0	SENT_106	[p6l456t2069r964b2148],

1	Thus	RB	O	thus	advmod	11	SENT_107	[p6l1001t2069r1238b2164],
2	,	,	O	,	_	0	SENT_107	[p6l1001t2069r1238b2164],
3	the	DT	O	the	det	5	SENT_107	[p6l1279t2068r1408b2147],
4	oncogenic	JJ	O	oncogenic	amod	5	SENT_107	[p6l1444t2069r1881b2169],
5	function	NN	O	function	nsubjpass	11	SENT_107	[p6l1915t2068r2134b2148, p6l11t2196r177b2274],
6	of	IN	O	of	_	0	SENT_107	[p6l221t2195r321b2274],
7	the	DT	O	the	det	9	SENT_107	[p6l347t2196r476b2273],
8	mutated	VBN	O	mutate	amod	9	SENT_107	[p6l519t2196r871b2274],
9	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_107	[p6l913t2201r1172b2279],
10	was	VBD	O	be	auxpass	11	SENT_107	[p6l1200t2222r1361b2275],
11	retained	VBN	O	retain	_	0	SENT_107	[p6l1407t2196r1776b2290],
12	,	,	O	,	_	0	SENT_107	[p6l1407t2196r1776b2290],
13	but	CC	O	but	_	0	SENT_107	[p6l1826t2196r1967b2275],
14	the	DT	O	the	det	15	SENT_107	[p6l2006t2196r2135b2273],
15	ability	NN	O	ability	nsubjpass	30	SENT_107	[p6l10t2323r270b2424],
16	of	IN	O	of	_	0	SENT_107	[p6l293t2323r393b2402],
17	geﬁtinib	NN	O	geﬁtinib	prep_of	15	SENT_107	[p6l402t2323r757b2424],
18	or	CC	O	or	_	0	SENT_107	[p6l785t2349r875b2402],
19	erlotinib	NN	O	erlotinib	prep_of	15	SENT_107	[p6l899t2324r1258b2402],
20	to	TO	O	to	aux	21	SENT_107	[p6l1286t2340r1365b2402],
21	bind	VB	O	bind	infmod	15	SENT_107	[p6l1394t2323r1584b2402],
22	to	TO	O	to	_	0	SENT_107	[p6l1612t2340r1691b2402],
23	the	DT	O	the	det	24	SENT_107	[p6l1719t2324r1849b2402],
24	receptor	NN	O	receptor	prep_to	21	SENT_107	[p6l1875t2350r2134b2424, p6l11t2468r130b2530],
25	by	IN	O	by	_	0	SENT_107	[p6l149t2451r246b2552],
26	a	DT	DURATION	a	det	28	SENT_107	[p6l261t2478r306b2530],
27	second	JJ	DURATION	second	amod	28	SENT_107	[p6l326t2451r619b2530],
28	mutation	NN	O	mutation	prep_by	21	SENT_107	[p6l640t2452r1026b2531],
29	was	VBD	O	be	auxpass	30	SENT_107	[p6l1042t2478r1202b2531],
30	lost	VBN	O	lose	conj_but	11	SENT_107	[p6l1224t2452r1398b2530],
31	.	.	O	.	_	0	SENT_107	[p6l1224t2452r1398b2530],

1	The	DT	O	the	det	2	SENT_108	[p6l1421t2451r1582b2530],
2	investigators	NNS	O	investigator	nsubj	3	SENT_108	[p6l1602t2452r2134b2552],
3	screened	VBD	O	screen	_	0	SENT_108	[p6l12t2579r377b2658],
4	other	JJ	O	other	amod	6	SENT_108	[p6l406t2580r627b2658],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_108	[p6l652t2585r908b2663],
6	inhibitors	NNS	O	inhibitor	dobj	3	SENT_108	[p6l926t2579r1333b2658],
7	with	IN	O	with	_	0	SENT_108	[p6l1360t2580r1547b2659],
8	different	JJ	O	different	amod	9	SENT_108	[p6l1576t2579r1938b2658],
9	molecular	JJ	O	molecular	prep_with	3	SENT_108	[p6l1964t2605r2134b2658, p6l10t2708r295b2787],

1	structures	NNS	O	structure	_	0	SENT_109	[p6l315t2724r731b2787],
2	and	CC	O	and	_	0	SENT_109	[p6l754t2708r910b2786],
3	found	VBN	O	find	conj_and	1	SENT_109	[p6l931t2707r1182b2787],
4	at	IN	O	at	quantmod	6	SENT_109	[p6l1203t2724r1282b2786],
5	least	JJS	O	least	mwe	4	SENT_109	[p6l1297t2707r1494b2786],
6	one	CD	NUMBER	one	dobj	3	SENT_109	[p6l1512t2733r1664b2786],
7	that	WDT	O	that	nsubj	8	SENT_109	[p6l1686t2708r1855b2786],
8	inhibited	VBD	O	inhibit	rcmod	6	SENT_109	[p6l1873t2708r2133b2786, p6l10t2835r170b2914],

1	the	DT	O	the	det	2	SENT_110	[p6l205t2836r336b2914],
2	newly	RB	O	newly	nsubj	3	SENT_110	[p6l371t2835r623b2936],
3	mutated	VBN	O	mutate	_	0	SENT_110	[p6l653t2835r1010b2915],
4	receptor	NN	O	receptor	dobj	3	SENT_110	[p6l1045t2852r1421b2936],
5	.	.	O	.	_	0	SENT_110	[p6l1045t2852r1421b2936],

1	Their	PRP$	O	they	poss	3	SENT_111	[p6l1458t2836r1692b2914],
2	modeling	NN	O	modeling	nn	3	SENT_111	[p6l1724t2836r2139b2936],
3	studies	NNS	O	study	nsubj	4	SENT_111	[p6l12t2964r306b3043],
4	provide	VBP	O	provide	_	0	SENT_111	[p6l334t2963r649b3064],
5	a	DT	O	a	det	7	SENT_111	[p6l676t2990r721b3042],
6	molecular	JJ	O	molecular	amod	7	SENT_111	[p6l745t2963r1171b3043],
7	rationale	NN	O	rationale	dobj	4	SENT_111	[p6l1195t2964r1566b3042],
8	for	IN	O	for	_	0	SENT_111	[p6l1594t2963r1717b3042],
9	the	DT	O	the	det	10	SENT_111	[p6l1741t2964r1871b3042],
10	selection	NN	O	selection	prep_for	7	SENT_111	[p6l1899t2964r2134b3042, p6l11t3092r177b3170],
11	of	IN	O	of	_	0	SENT_111	[p6l202t3091r303b3170],
12	such	PDT	O	such	predet	15	SENT_111	[p6l311t3091r506b3171],
13	a	DT	O	a	det	15	SENT_111	[p6l530t3118r574b3170],
14	new	JJ	O	new	amod	15	SENT_111	[p6l598t3117r774b3171],
15	drug	NN	O	drug	prep_of	10	SENT_111	[p6l795t3091r1015b3192],
16	.	.	O	.	_	0	SENT_111	[p6l795t3091r1015b3192],

1	The	DT	O	the	det	2	SENT_112	[p6l136t3219r296b3298],
2	story	NN	O	story	nsubj	6	SENT_112	[p6l331t3236r536b3320],
3	is	VBZ	O	be	cop	6	SENT_112	[p6l564t3220r628b3298],
4	even	RB	O	even	advmod	6	SENT_112	[p6l664t3245r849b3299],
5	more	RBR	O	more	advmod	6	SENT_112	[p6l882t3245r1100b3298],
6	interesting	JJ	O	interesting	_	0	SENT_112	[p6l1132t3220r1606b3320],
7	,	,	O	,	_	0	SENT_112	[p6l1132t3220r1606b3320],
8	because	IN	O	because	mark	13	SENT_112	[p6l1646t3220r1974b3299],
9	the	DT	O	the	det	12	SENT_112	[p6l2007t3220r2135b3298],
10	T79OM	NN	O	t79om	nn	12	SENT_112	[p6l7t3353r313b3426],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_112	[p6l350t3353r613b3431],
12	mutation	NN	O	mutation	nsubj	13	SENT_112	[p6l639t3348r1036b3427],
13	corresponds	VBZ	O	correspond	advcl	6	SENT_112	[p6l1074t3347r1607b3448],
14	structurally	RB	O	structurally	advmod	13	SENT_112	[p6l1648t3347r2139b3448],
15	to	TO	O	to	_	0	SENT_112	[p6l11t3492r91b3554],
16	the	DT	O	the	det	18	SENT_112	[p6l114t3476r243b3554],
17	threonine	NN	O	threonine	nn	18	SENT_112	[p6l265t3475r1260b3555],
18	—	NN	O	—	prep_to	13	SENT_112	[p6l265t3475r1260b3555],
19	to	TO	O	to	_	0	SENT_112	[p6l265t3475r1260b3555],
20	—	CD	NUMBER	—	num	22	SENT_112	[p6l265t3475r1260b3555],
21	isoleucine	NN	O	isoleucine	nn	22	SENT_112	[p6l265t3475r1260b3555],
22	mutation	NN	O	mutation	prep_to	13	SENT_112	[p6l1282t3476r1672b3555],
23	at	IN	O	at	_	0	SENT_112	[p6l1692t3492r1771b3554],
24	position	NN	O	position	prep_at	22	SENT_112	[p6l1786t3476r2135b3576],
25	315	CD	NUMBER	315	num	24	SENT_112	[p6l11t3609r161b3682],
26	of	IN	O	of	_	0	SENT_112	[p6l212t3603r312b3682],
27	BCR	NN	O	bcr	prep_of	24	SENT_112	[p6l339t3609r707b3699],
28	.	.	O	.	_	0	SENT_112	[p6l339t3609r707b3699],

1	—	NN	O	—	_	0	SENT_113	[p6l339t3609r707b3699],
2	.	.	O	.	_	0	SENT_113	[p6l339t3609r707b3699],

1	ABL	NNP	ORGANIZATION	ABL	_	0	SENT_114	[p6l339t3609r707b3699],
2	,	,	O	,	_	0	SENT_114	[p6l339t3609r707b3699],
3	which	WDT	O	which	nsubj	5	SENT_114	[p6l754t3603r1013b3683],
4	commonly	RB	O	commonly	advmod	5	SENT_114	[p6l1061t3604r1512b3704],
5	confers	VBZ	O	confer	rcmod	1	SENT_114	[p6l1555t3603r1861b3682],
6	resistance	NN	O	resistance	dobj	5	SENT_114	[p6l1911t3604r2134b3682, p7l11t37r232b99],

1	to	TO	O	to	aux	2	SENT_115	[p7l255t37r334b99],
2	imatinib	VB	O	imatinib	_	0	SENT_115	[p7l357t21r707b99],
3	in	IN	O	in	_	0	SENT_115	[p7l731t21r811b98],
4	chronic	JJ	O	chronic	amod	6	SENT_115	[p7l834t21r1149b99],
5	myeloid	JJ	O	myeloid	amod	6	SENT_115	[p7l1171t20r1503b121],
6	leukemia	NN	O	leukemia	prep_in	2	SENT_115	[p7l1523t21r1927b100],
7	.	.	O	.	_	0	SENT_115	[p7l1523t21r1927b100],

1	This	DT	O	this	det	2	SENT_116	[p7l1952t20r2134b99],
2	type	NN	O	type	nsubjpass	8	SENT_116	[p7l11t165r183b249],
3	of	IN	O	of	_	0	SENT_116	[p7l220t148r322b227],
4	change	NN	O	change	prep_of	2	SENT_116	[p7l340t148r647b249],
5	had	VBD	O	have	aux	8	SENT_116	[p7l684t148r841b227],
6	already	RB	O	already	advmod	8	SENT_116	[p7l877t148r1187b249],
7	been	VBN	O	be	auxpass	8	SENT_116	[p7l1220t149r1422b227],
8	introduced	VBN	O	introduce	_	0	SENT_116	[p7l1458t149r1929b228],
9	into	IN	O	into	_	0	SENT_116	[p7l1964t149r2133b227],
10	EGFR	NN	ORGANIZATION	egfr	prep_into	8	SENT_116	[p7l9t282r273b360],
11	two	CD	DURATION	two	num	12	SENT_116	[p7l314t293r470b356],
12	years	NNS	NUMBER	year	tmod	8	SENT_116	[p7l518t303r739b377],
13	previously	RB	DATE	previously	advmod	12	SENT_116	[p7l791t276r1240b377],
14	by	IN	O	by	_	0	SENT_116	[p7l1287t277r1386b377],
15	other	JJ	O	other	amod	16	SENT_116	[p7l1433t277r1664b355],
16	investigators	NNS	O	investigator	agent	8	SENT_116	[p7l1712t277r2133b377, p7l11t420r202b498],
17	,	,	O	,	_	0	SENT_116	[p7l1712t277r2133b377, p7l11t420r202b498],
18	Who	WP	O	who	nsubj	19	SENT_116	[p7l233t404r419b483],
19	found	VBD	O	find	rcmod	16	SENT_116	[p7l450t403r698b482],
20	that	IN	O	that	complm	22	SENT_116	[p7l722t403r884b481],
21	it	PRP	O	it	nsubj	22	SENT_116	[p7l902t404r961b481],
22	caused	VBD	O	cause	ccomp	19	SENT_116	[p7l980t403r1259b483],
23	resistance	NN	O	resistance	dobj	22	SENT_116	[p7l1282t404r1691b481],
24	to	TO	O	to	_	0	SENT_116	[p7l1715t420r1793b482],
25	anilinoquinazolines	NNS	O	anilinoquinazoline	prep_to	22	SENT_116	[p7l1817t404r2135b482, p7l11t532r609b632],
26	.6	CD	NUMBER	.6	num	25	SENT_116	[p7l1817t404r2135b482, p7l11t532r609b632],
27	This	DT	O	this	det	28	SENT_116	[p7l635t531r819b610],
28	ﬁnding	NN	O	ﬁnding	nsubj	29	SENT_116	[p7l850t531r1160b632],
29	suggests	VBZ	O	suggest	rcmod	25	SENT_116	[p7l1187t548r1546b632],
30	that	IN	O	that	complm	32	SENT_116	[p7l1578t531r1743b610],
31	there	EX	O	there	expl	32	SENT_116	[p7l1767t532r1978b610],
32	are	VBP	O	be	ccomp	29	SENT_116	[p7l2008t558r2134b610],
33	mechanisms	NNS	O	mechanism	nsubj	32	SENT_116	[p7l11t660r535b738],
34	of	IN	O	of	_	0	SENT_116	[p7l559t659r658b738],
35	drug	NN	O	drug	nn	36	SENT_116	[p7l661t659r858b760],
36	resistance	NN	O	resistance	prep_of	33	SENT_116	[p7l875t660r1286b738],
37	common	JJ	O	common	amod	36	SENT_116	[p7l1309t685r1682b738],
38	to	TO	O	to	_	0	SENT_116	[p7l1705t676r1783b738],
39	tyrosine	NN	O	tyrosine	nn	41	SENT_116	[p7l1806t660r2134b760],
40	kinase	NN	O	kinase	nn	41	SENT_116	[p7l10t788r289b867],
41	inhibitors	NNS	O	inhibitor	prep_to	37	SENT_116	[p7l337t788r765b866],
42	that	WDT	O	that	nsubjpass	45	SENT_116	[p7l816t788r988b866],
43	could	MD	O	could	aux	45	SENT_116	[p7l1032t787r1271b867],
44	be	VB	O	be	auxpass	45	SENT_116	[p7l1320t788r1417b866],
45	predicted	VBN	O	predict	rcmod	41	SENT_116	[p7l1464t787r1873b888],
46	from	IN	O	from	_	0	SENT_116	[p7l1922t787r2134b866],
47	the	DT	O	the	det	48	SENT_116	[p7l11t916r143b994],
48	start	NN	O	start	prep_from	45	SENT_116	[p7l171t932r388b994],
49	.	.	O	.	_	0	SENT_116	[p7l171t932r388b994],

1	We	PRP	O	we	nsubj	4	SENT_117	[p7l416t923r551b994],
2	should	MD	O	should	aux	4	SENT_117	[p7l580t916r873b995],
3	also	RB	O	also	advmod	4	SENT_117	[p7l900t916r1071b994],
4	recognize	VB	O	recognize	_	0	SENT_117	[p7l1099t916r1520b1016],
5	that	IN	O	that	complm	10	SENT_117	[p7l1548t916r1718b994],
6	the	DT	O	the	det	8	SENT_117	[p7l1740t916r1872b994],
7	drugresistance	NN	O	drugresistance	nn	8	SENT_117	[p7l1900t916r2134b1016, p7l11t1044r442b1121],
8	mutation	NN	O	mutation	nsubj	10	SENT_117	[p7l474t1044r871b1122],
9	can	MD	O	can	aux	10	SENT_117	[p7l902t1069r1048b1121],
10	occur	VB	O	occur	ccomp	4	SENT_117	[p7l1079t1068r1318b1122],
11	in	IN	O	in	_	0	SENT_117	[p7l1345t1044r1427b1120],
12	either	CC	O	either	prep_in	10	SENT_117	[p7l1459t1044r1707b1121],
13	the	DT	O	the	det	16	SENT_117	[p7l1735t1044r1867b1121],
14	originally	RB	O	originally	advmod	15	SENT_117	[p7l1899t1044r2133b1143, p7l11t1171r218b1272],
15	mutated	VBN	O	mutate	amod	16	SENT_117	[p7l251t1172r608b1251],
16	EGFR	NN	ORGANIZATION	egfr	conj	10	SENT_117	[p7l643t1178r859b1251],
17	or	CC	O	or	_	0	SENT_117	[p7l891t1197r982b1250],
18	the	DT	O	the	det	22	SENT_117	[p7l1017t1172r1148b1250],
19	Wild	NNP	O	Wild	nn	22	SENT_117	[p7l1181t1171r1584b1272],
20	—	CD	NUMBER	—	num	22	SENT_117	[p7l1181t1171r1584b1272],
21	type	NN	O	type	nn	22	SENT_117	[p7l1181t1171r1584b1272],
22	allele	NN	O	allele	dep	10	SENT_117	[p7l1621t1171r1845b1250],
23	in	IN	O	in	_	0	SENT_117	[p7l1882t1172r1965b1249],
24	the	DT	O	the	det	25	SENT_117	[p7l2003t1172r2134b1250],
25	tumor	NN	O	tumor	prep_in	10	SENT_117	[p7l11t1316r289b1379],
26	.	.	O	.	_	0	SENT_117	[p7l11t1316r289b1379],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_118	[p7l317t1305r575b1383],
2	receptors	NNS	O	receptor	nsubj	3	SENT_118	[p7l589t1316r974b1400],
3	form	VBP	O	form	_	0	SENT_118	[p7l1000t1299r1206b1378],
4	homodimers	NNS	O	homodimer	dobj	3	SENT_118	[p7l1230t1299r1769b1378],
5	and	CC	O	and	_	0	SENT_118	[p7l1794t1300r1949b1378],
6	het	NN	O	het	nn	8	SENT_118	[p7l1973t1299r2135b1378],
7	—	CD	NUMBER	—	num	8	SENT_118	[p7l1973t1299r2135b1378],
8	erodimers	NNS	O	erodimer	conj_and	4	SENT_118	[p7l11t1428r475b1523],
9	;	:	O	;	_	0	SENT_118	[p7l11t1428r475b1523],
10	dimerization	NN	O	dimerization	nsubj	31	SENT_118	[p7l526t1428r1079b1506],
11	of	IN	O	of	_	0	SENT_118	[p7l1125t1427r1227b1506],
12	an	DT	O	a	det	13	SENT_118	[p7l1252t1453r1354b1506],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	10	SENT_118	[p7l1398t1433r1660b1511],
14	carrying	VBG	O	carry	partmod	13	SENT_118	[p7l1696t1428r2050b1528],
15	a	DT	O	a	det	19	SENT_118	[p7l2091t1454r2136b1506],
16	drug	NN	O	drug	nn	19	SENT_118	[p7l11t1556r684b1656],
17	—	NN	O	—	nn	19	SENT_118	[p7l11t1556r684b1656],
18	resistance	NN	O	resistance	nn	19	SENT_118	[p7l11t1556r684b1656],
19	mutation	NN	O	mutation	dobj	14	SENT_118	[p7l708t1556r1097b1635],
20	in	IN	O	in	_	0	SENT_118	[p7l1121t1556r1202b1633],
21	a	DT	O	a	det	25	SENT_118	[p7l1226t1582r1271b1634],
22	Wild	NNP	O	Wild	nn	25	SENT_118	[p7l1290t1556r1683b1656],
23	—	CD	NUMBER	—	num	25	SENT_118	[p7l1290t1556r1683b1656],
24	type	NN	O	type	nn	25	SENT_118	[p7l1290t1556r1683b1656],
25	allele	NN	O	allele	prep_in	19	SENT_118	[p7l1708t1555r1925b1634],
26	with	IN	O	with	_	0	SENT_118	[p7l1946t1556r2135b1635],
27	the	DT	O	the	det	29	SENT_118	[p7l11t1684r139b1762],
28	oncogenic	JJ	O	oncogenic	amod	29	SENT_118	[p7l161t1684r593b1784],
29	EGFR	NN	ORGANIZATION	egfr	prep_with	14	SENT_118	[p7l612t1689r870b1767],
30	could	MD	O	could	aux	31	SENT_118	[p7l881t1683r1111b1763],
31	affect	VB	O	affect	parataxis	3	SENT_118	[p7l1131t1683r1365b1762],
32	the	DT	O	the	det	33	SENT_118	[p7l1381t1684r1509b1762],
33	function	NN	O	function	dobj	31	SENT_118	[p7l1530t1683r1883b1763],
34	of	IN	O	of	_	0	SENT_118	[p7l1905t1683r2005b1762],
35	the	DT	O	the	det	37	SENT_118	[p7l2007t1684r2135b1762],
36	oncogenic	JJ	O	oncogenic	amod	37	SENT_118	[p7l11t1812r448b1911],
37	receptor	NN	O	receptor	prep_of	33	SENT_118	[p7l472t1828r840b1911],
38	.	.	O	.	_	0	SENT_118	[p7l472t1828r840b1911],

1	It	PRP	O	it	nsubj	4	SENT_119	[p7l138t1947r204b2018],
2	will	MD	O	will	aux	4	SENT_119	[p7l229t1940r389b2019],
3	be	VB	O	be	cop	4	SENT_119	[p7l423t1939r520b2018],
4	important	JJ	O	important	_	0	SENT_119	[p7l553t1940r996b2040],
5	to	TO	O	to	aux	6	SENT_119	[p7l1025t1956r1105b2018],
6	discover	VB	O	discover	xcomp	4	SENT_119	[p7l1141t1939r1499b2019],
7	at	IN	O	at	_	0	SENT_119	[p7l1530t1956r1610b2018],
8	What	WDT	O	what	dobj	20	SENT_119	[p7l1634t1940r1851b2019],
9	stage	NN	O	stage	nsubj	20	SENT_119	[p7l1882t1956r2129b2040],
10	,	,	O	,	_	0	SENT_119	[p7l1882t1956r2129b2040],
11	in	IN	O	in	_	0	SENT_119	[p7l10t2068r92b2145],
12	the	DT	O	the	det	13	SENT_119	[p7l117t2068r244b2146],
13	pathogenesis	NN	O	pathogenesis	prep_in	20	SENT_119	[p7l267t2068r820b2168],
14	of	IN	O	of	_	0	SENT_119	[p7l846t2067r947b2146],
15	lung	NN	O	lung	nn	16	SENT_119	[p7l950t2067r1143b2168],
16	cancer	NN	O	cancer	prep_of	13	SENT_119	[p7l1164t2093r1452b2163],
17	,	,	O	,	_	0	SENT_119	[p7l1164t2093r1452b2163],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_119	[p7l1479t2074r1690b2147],
19	mutations	NNS	O	mutation	nsubj	20	SENT_119	[p7l1707t2068r2134b2147],
20	occur	VBP	O	occur	prepc_at	6	SENT_119	[p7l11t2221r265b2275],
21	.	.	O	.	_	0	SENT_119	[p7l11t2221r265b2275],

1	If	IN	O	if	mark	4	SENT_120	[p7l293t2195r375b2273],
2	they	PRP	O	they	nsubjpass	4	SENT_120	[p7l381t2195r561b2296],
3	are	VBP	O	be	auxpass	4	SENT_120	[p7l580t2222r708b2274],
4	found	VBN	O	find	advcl	12	SENT_120	[p7l732t2195r987b2275],
5	in	IN	O	in	_	0	SENT_120	[p7l1010t2196r1092b2273],
6	preneoplastic	JJ	O	preneoplastic	amod	7	SENT_120	[p7l1114t2195r1700b2296],
7	lesions	NNS	O	lesion	prep_in	4	SENT_120	[p7l1722t2196r2050b2291],
8	,	,	O	,	_	0	SENT_120	[p7l1722t2196r2050b2291],
9	it	PRP	O	it	nsubj	12	SENT_120	[p7l2078t2196r2139b2274],
10	may	MD	O	may	aux	12	SENT_120	[p7l11t2350r189b2424],
11	be	VB	O	be	cop	12	SENT_120	[p7l211t2324r307b2402],
12	possible	JJ	O	possible	_	0	SENT_120	[p7l332t2324r690b2424],
13	to	TO	O	to	aux	14	SENT_120	[p7l717t2340r796b2402],
14	screen	VB	O	screen	xcomp	12	SENT_120	[p7l824t2349r1099b2402],
15	for	IN	O	for	_	0	SENT_120	[p7l1124t2323r1249b2402],
16	them	PRP	O	they	prep_for	14	SENT_120	[p7l1272t2324r1492b2402],
17	and	CC	O	and	cc	14	SENT_120	[p7l1517t2323r1699b2419],
18	,	,	O	,	_	0	SENT_120	[p7l1517t2323r1699b2419],
19	if	IN	O	if	mark	22	SENT_120	[p7l1730t2323r1806b2401],
20	they	PRP	O	they	nsubj	22	SENT_120	[p7l1813t2323r1990b2424],
21	are	VBP	O	be	cop	22	SENT_120	[p7l2008t2350r2135b2402],
22	present	JJ	DATE	present	advcl	14	SENT_120	[p7l9t2468r354b2552],
23	,	,	O	,	_	0	SENT_120	[p7l9t2468r354b2552],
24	to	TO	O	to	aux	25	SENT_120	[p7l389t2468r469b2530],
25	use	VB	O	use	xcomp	22	SENT_120	[p7l499t2478r641b2531],
26	relatively	RB	O	relatively	advmod	30	SENT_120	[p7l670t2451r1055b2552],
27	nontoxic	JJ	O	nontoxic	amod	30	SENT_120	[p7l1080t2452r1459b2530],
28	tyrosine	NN	O	tyrosine	nn	30	SENT_120	[p7l1487t2452r1829b2552],
29	kinase	NN	O	kinase	nn	30	SENT_120	[p7l1858t2452r2134b2531],
30	inhibitors	NNS	O	inhibitor	dobj	25	SENT_120	[p7l10t2579r433b2658],
31	as	IN	O	as	_	0	SENT_120	[p7l462t2606r547b2658],
32	chemopreventive	JJ	O	chemopreventive	amod	33	SENT_120	[p7l576t2580r1309b2680],
33	agents	NNS	O	agent	prep_as	30	SENT_120	[p7l1335t2596r1641b2680],
34	.	.	O	.	_	0	SENT_120	[p7l1335t2596r1641b2680],

1	Most	JJS	O	most	amod	6	SENT_121	[p7l1670t2587r1892b2658],
2	nonsmall	JJ	O	nonsmall	amod	6	SENT_121	[p7l1914t2605r2138b2658, p7l12t2708r418b2786],
3	—	NN	O	—	nn	6	SENT_121	[p7l1914t2605r2138b2658, p7l12t2708r418b2786],
4	cell	NN	O	cell	nn	6	SENT_121	[p7l1914t2605r2138b2658, p7l12t2708r418b2786],
5	lung	NN	O	lung	nn	6	SENT_121	[p7l437t2708r629b2808],
6	cancers	NNS	O	cancer	nsubj	16	SENT_121	[p7l647t2733r957b2786],
7	do	VBP	O	do	aux	9	SENT_121	[p7l980t2708r1082b2786],
8	not	RB	O	not	neg	9	SENT_121	[p7l1105t2724r1247b2786],
9	have	VB	O	have	_	0	SENT_121	[p7l1263t2708r1449b2787],
10	these	DT	O	these	det	11	SENT_121	[p7l1470t2708r1686b2786],
11	mutations	NNS	O	mutation	dobj	9	SENT_121	[p7l1708t2708r2134b2787],
12	but	CC	O	but	_	0	SENT_121	[p7l11t2835r170b2931],
13	,	,	O	,	_	0	SENT_121	[p7l11t2835r170b2931],
14	rather	RB	O	rather	dep	9	SENT_121	[p7l206t2836r471b2931],
15	,	,	O	,	_	0	SENT_121	[p7l206t2836r471b2931],
16	overexpressed	VBN	O	overexpress	conj_but	9	SENT_121	[p7l507t2836r1093b2936],
17	and	CC	O	and	_	0	SENT_121	[p7l1122t2836r1276b2914],
18	activated	VBN	O	activate	conj_but	9	SENT_121	[p7l1305t2835r1667b2915],
19	phosphorylated	JJ	O	phosphorylated	amod	20	SENT_121	[p7l1695t2835r2135b2936, p7l6t2964r252b3064],
20	EGFR	NN	ORGANIZATION	egfr	dobj	16	SENT_121	[p7l283t2969r556b3047],
21	.	.	O	.	_	0	SENT_121	[p7l283t2969r556b3047],

1	Clinical	JJ	O	clinical	amod	2	SENT_122	[p7l597t2963r921b3042],
2	trials	NNS	O	trial	nsubj	3	SENT_122	[p7l959t2963r1171b3042],
3	suggest	VBP	O	suggest	_	0	SENT_122	[p7l1213t2980r1546b3064],
4	that	IN	O	that	complm	11	SENT_122	[p7l1580t2964r1749b3042],
5	some	DT	O	some	nsubj	11	SENT_122	[p7l1784t2989r2012b3042],
6	of	IN	O	of	_	0	SENT_122	[p7l2051t2963r2153b3042],
7	these	DT	O	these	det	8	SENT_122	[p7l11t3091r234b3170],
8	tumors	NNS	O	tumor	prep_of	5	SENT_122	[p7l259t3108r565b3171],
9	are	VBP	O	be	cop	11	SENT_122	[p7l590t3118r718b3170],
10	also	RB	O	also	advmod	11	SENT_122	[p7l742t3091r909b3170],
11	responsive	JJ	O	responsive	ccomp	3	SENT_122	[p7l932t3092r1382b3192],
12	to	TO	O	to	_	0	SENT_122	[p7l1405t3108r1484b3170],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_122	[p7l1508t3092r1842b3192],
14	kinase	NN	O	kinase	prep_to	11	SENT_122	[p7l1865t3092r2135b3171],

1	N	NN	O	n	nn	3	SENT_123	[p7l488t3273r501b3288],
2	ENGLJ	NN	O	englj	nn	3	SENT_123	[p7l517t3273r600b3294],
3	MED	NN	O	med	_	0	SENT_123	[p7l616t3273r668b3288],
4	352	CD	NUMBER	352	dep	3	SENT_123	[p7l680t3267r747b3294],
5	;	:	O	;	_	0	SENT_123	[p7l680t3267r747b3294],
6	8	CD	NUMBER	8	num	7	SENT_123	[p7l680t3267r747b3294],
7	WWW	NN	O	www	dep	3	SENT_123	[p7l781t3273r901b3294],
8	.	.	O	.	_	0	SENT_123	[p7l781t3273r901b3294],

1	NEJ	NN	O	nej	_	0	SENT_124	[p7l781t3273r901b3294],
2	M.ORG	NN	O	m.org	nn	3	SENT_124	[p7l909t3273r992b3288],
3	FEBRUARY	NN	DATE	february	dep	1	SENT_124	[p7l1032t3273r1159b3288],
4	24,2005	CD	NUMBER	24,2005	number	5	SENT_124	[p7l1171t3273r1285b3294],
5	831	CD	NUMBER	831	dep	3	SENT_124	[p7l1959t3271r2016b3293],

1	The	DT	O	the	det	4	SENT_125	[p7l702t3305r753b3328],
2	New	NNP	O	New	nn	4	SENT_125	[p7l762t3306r824b3328],
3	England	NNP	O	England	nn	4	SENT_125	[p7l833t3305r944b3335],
4	Journal	NNP	O	Journal	_	0	SENT_125	[p7l952t3305r1050b3328],
5	of	IN	O	of	_	0	SENT_125	[p7l1060t3305r1088b3328],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_125	[p7l1095t3305r1220b3328],

1	Downloaded	VBN	O	download	_	0	SENT_126	[p7l144t3345r314b3368],
2	from	IN	O	from	_	0	SENT_126	[p7l323t3345r387b3368],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_126	[p7l396t3345r514b3375],
4	at	IN	O	at	_	0	SENT_126	[p7l524t3349r547b3368],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_126	[p7l556t3345r739b3368],
6	on	IN	O	on	_	0	SENT_126	[p7l748t3352r780b3368],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_126	[p7l789t3345r849b3368],
8	5	CD	DATE	5	num	7	SENT_126	[p7l902t3345r924b3372],
9	,	,	DATE	,	_	0	SENT_126	[p7l902t3345r924b3372],
10	2014	CD	DATE	2014	num	7	SENT_126	[p7l935t3345r1007b3368],
11	.	.	O	.	_	0	SENT_126	[p7l935t3345r1007b3368],

1	For	IN	O	for	_	0	SENT_127	[p7l1018t3345r1064b3368],
2	personal	JJ	O	personal	amod	3	SENT_127	[p7l1072t3345r1184b3375],
3	use	NN	O	use	pobj	1	SENT_127	[p7l1194t3352r1237b3368],
4	only	RB	O	only	advmod	3	SENT_127	[p7l1247t3345r1311b3375],
5	.	.	O	.	_	0	SENT_127	[p7l1247t3345r1311b3375],

1	No	DT	O	no	det	3	SENT_128	[p7l1322t3345r1362b3368],
2	other	JJ	O	other	amod	3	SENT_128	[p7l1372t3345r1440b3368],
3	uses	NNS	O	use	_	0	SENT_128	[p7l1448t3352r1504b3368],
4	without	IN	O	without	_	0	SENT_128	[p7l1514t3345r1615b3368],
5	permission	NN	O	permission	prep_without	3	SENT_128	[p7l1624t3345r1776b3375],
6	.	.	O	.	_	0	SENT_128	[p7l1624t3345r1776b3375],

1	Copyright	NN	O	copyright	nn	5	SENT_129	[p7l494t3386r629b3416],
2	©	CD	NUMBER	©	num	5	SENT_129	[p7l638t3386r661b3409],
3	2005	CD	DATE	2005	num	5	SENT_129	[p7l672t3386r735b3409],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_129	[p7l746t3387r844b3409],
5	usetts	NNP	O	usetts	_	0	SENT_129	[p7l863t3390r937b3409],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_129	[p7l947t3386r1055b3409],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_129	[p7l1065t3386r1170b3416],
8	.	.	O	.	_	0	SENT_129	[p7l1065t3386r1170b3416],

1	All	DT	O	all	det	2	SENT_130	[p7l1181t3386r1223b3409],
2	rights	NNS	O	rights	nsubj	3	SENT_130	[p7l1232t3386r1306b3416],
3	reserved	VBN	O	reserve	_	0	SENT_130	[p7l1316t3386r1435b3409],
4	.	.	O	.	_	0	SENT_130	[p7l1316t3386r1435b3409],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_131	[p7l979t3491r1181b3510],

1	inhibitors	NNS	O	inhibitor	_	0	SENT_132	[p7l16t3705r457b3783],
2	.	.	O	.	_	0	SENT_132	[p7l16t3705r457b3783],

1	More	RBR	O	more	advmod	2	SENT_133	[p7l493t3712r717b3783],
2	intriguing	JJ	O	intriguing	_	0	SENT_133	[p7l749t3705r1174b3805],
3	is	VBZ	O	be	cop	5	SENT_133	[p7l1202t3705r1266b3783],
4	the	DT	O	the	det	5	SENT_133	[p7l1300t3704r1428b3783],
5	possibility	NN	O	possibility	dep	2	SENT_133	[p7l1458t3704r1890b3805],
6	that	IN	O	that	advmod	5	SENT_133	[p7l1917t3705r2082b3783],
7	a	DT	O	a	dep	6	SENT_133	[p7l2107t3731r2152b3783],

1	“	NN	O	“	nsubjpass	8	SENT_134	[p8l20t21r436b121],
2	synthetic	JJ	O	synthetic	amod	5	SENT_134	[p8l20t21r436b121],
3	lethal	JJ	O	lethal	amod	5	SENT_134	[p8l463t20r735b99],
4	”	NN	O	”	nn	5	SENT_134	[p8l463t20r735b99],
5	approach	NN	O	approach	dep	1	SENT_134	[p8l768t21r1172b121],
6	can	MD	O	can	aux	8	SENT_134	[p8l1205t46r1352b99],
7	be	VB	O	be	auxpass	8	SENT_134	[p8l1386t21r1483b99],
8	developed	VBN	O	develop	_	0	SENT_134	[p8l1517t20r1952b121],
9	as	IN	O	as	_	0	SENT_134	[p8l1984t47r2070b99],
10	a	DT	O	a	det	11	SENT_134	[p8l2105t47r2149b99],
11	variation	NN	O	variation	prep_as	8	SENT_134	[p8l12t149r395b228],
12	on	IN	O	on	_	0	SENT_134	[p8l427t174r535b227],
13	the	DT	O	the	det	14	SENT_134	[p8l566t149r698b227],
14	theme	NN	O	theme	prep_on	11	SENT_134	[p8l730t149r997b227],
15	of	IN	O	of	_	0	SENT_134	[p8l1029t148r1130b227],
16	oncogene	NN	O	oncogene	nn	17	SENT_134	[p8l1144t174r1562b249],
17	addiction	NN	O	addiction	prep_of	14	SENT_134	[p8l1592t149r2025b227],
18	.	.	O	.	_	0	SENT_134	[p8l1592t149r2025b227],

1	In	IN	O	in	_	0	SENT_135	[p8l2060t156r2148b226],
2	this	DT	O	this	det	3	SENT_135	[p8l17t277r173b355],
3	scheme	NN	O	scheme	prep_in	8	SENT_135	[p8l202t277r552b372],
4	,	,	O	,	_	0	SENT_135	[p8l202t277r552b372],
5	the	DT	O	the	det	7	SENT_135	[p8l582t277r714b355],
6	cancer	NN	O	cancer	nn	7	SENT_135	[p8l740t302r1022b355],
7	cell	NN	O	cell	nsubj	8	SENT_135	[p8l1044t277r1190b355],
8	requires	VBZ	O	require	_	0	SENT_135	[p8l1214t277r1564b377],
9	not	RB	O	not	neg	14	SENT_135	[p8l1591t293r1736b355],
10	only	RB	O	only	advmod	14	SENT_135	[p8l1757t277r1942b377],
11	activated	VBN	O	activate	amod	14	SENT_135	[p8l1962t277r2147b355, p8l12t405r230b484],
12	wild	JJ	O	wild	amod	14	SENT_135	[p8l245t404r630b505],
13	—	NN	O	—	nn	14	SENT_135	[p8l245t404r630b505],
14	type	NN	O	type	dobj	8	SENT_135	[p8l245t404r630b505],
15	phosphorylated	VBN	O	phosphorylate	partmod	14	SENT_135	[p8l649t404r1300b505],
16	EGFR	NN	ORGANIZATION	egfr	dobj	15	SENT_135	[p8l1318t405r1979b488],
17	—	CD	NUMBER	—	num	20	SENT_135	[p8l1318t405r1979b488],
18	mediated	JJ	O	mediated	amod	20	SENT_135	[p8l1318t405r1979b488],
19	signaling	NN	O	signaling	nn	20	SENT_135	[p8l2000t405r2149b505, p8l17t533r289b633],
20	(	NN	O	(	nsubj	29	SENT_135	[p8l321t532r613b624],
21	which	WDT	O	which	nsubjpass	24	SENT_135	[p8l321t532r613b624],
22	can	MD	O	can	aux	24	SENT_135	[p8l644t558r791b611],
23	be	VB	O	be	auxpass	24	SENT_135	[p8l822t532r919b611],
24	treated	VBN	O	treat	rcmod	20	SENT_135	[p8l950t532r1247b611],
25	with	IN	O	with	_	0	SENT_135	[p8l1272t532r1466b612],
26	tyrosine	NN	O	tyrosine	nn	28	SENT_135	[p8l1496t533r1840b633],
27	kinase	NN	O	kinase	nn	28	SENT_135	[p8l1871t532r2148b612],
28	inhibitors	NNS	O	inhibitor	prep_with	24	SENT_135	[p8l16t661r474b752],
29	)	VBP	O	)	rcmod	16	SENT_135	[p8l16t661r474b752],
30	but	CC	O	but	cc	14	SENT_135	[p8l503t661r647b740],
31	also	RB	O	also	advmod	14	SENT_135	[p8l665t660r836b739],
32	a	DT	O	a	det	33	SENT_135	[p8l860t687r905b739],
33	minimum	NN	O	minimum	dep	14	SENT_135	[p8l927t661r1360b740],
34	of	IN	O	of	_	0	SENT_135	[p8l1385t660r1486b739],
35	one	CD	NUMBER	one	num	37	SENT_135	[p8l1492t686r1647b739],
36	other	JJ	O	other	amod	37	SENT_135	[p8l1672t661r1901b739],
37	pathway	NN	O	pathway	prep_of	33	SENT_135	[p8l1920t661r2147b761, p8l12t815r194b889],
38	.	.	O	.	_	0	SENT_135	[p8l1920t661r2147b761, p8l12t815r194b889],

1	If	IN	O	if	mark	7	SENT_136	[p8l230t788r312b866],
2	these	DT	O	these	det	4	SENT_136	[p8l324t788r548b867],
3	second	JJ	ORDINAL	second	amod	4	SENT_136	[p8l581t788r879b867],
4	pathways	NNS	O	pathway	nsubjpass	7	SENT_136	[p8l907t789r1304b889],
5	could	MD	O	could	aux	7	SENT_136	[p8l1337t789r1575b868],
6	be	VB	O	be	auxpass	7	SENT_136	[p8l1606t789r1703b867],
7	identiﬁed	VBN	O	identiﬁed	advcl	25	SENT_136	[p8l1733t788r2148b867],
8	and	CC	O	and	_	0	SENT_136	[p8l16t916r173b995],
9	proteins	NNS	O	protein	nsubj	13	SENT_136	[p8l193t917r537b1017],
10	within	IN	O	within	_	0	SENT_136	[p8l556t917r827b996],
11	them	PRP	O	they	prep_within	9	SENT_136	[p8l850t917r1064b995],
12	“	RB	O	“	advmod	13	SENT_136	[p8l1091t916r1552b1017],
13	drugged	VBD	O	drug	advcl	25	SENT_136	[p8l1091t916r1552b1017],
14	,	,	O	,	_	0	SENT_136	[p8l1091t916r1552b1017],
15	”	NN	O	”	nsubj	25	SENT_136	[p8l1091t916r1552b1017],
16	perhaps	RB	O	perhaps	advmod	15	SENT_136	[p8l1577t917r1911b1017],
17	nonsmall	JJ	O	nonsmall	amod	21	SENT_136	[p8l1934t942r2153b995, p8l19t1044r434b1123],
18	—	NN	O	—	nn	21	SENT_136	[p8l1934t942r2153b995, p8l19t1044r434b1123],
19	cell	NN	O	cell	nn	21	SENT_136	[p8l1934t942r2153b995, p8l19t1044r434b1123],
20	lung	NN	O	lung	nn	21	SENT_136	[p8l455t1044r653b1145],
21	cancers	NNS	O	cancer	dep	15	SENT_136	[p8l674t1070r994b1123],
22	could	MD	O	could	aux	25	SENT_136	[p8l1020t1044r1253b1124],
23	have	VB	O	have	aux	25	SENT_136	[p8l1274t1045r1463b1124],
24	molecularly	RB	O	molecularly	advmod	25	SENT_136	[p8l1484t1044r1984b1145],
25	targeted	VBN	O	target	_	0	SENT_136	[p8l2001t1061r2148b1123, p8l16t1173r246b1273],
26	therapy	NN	O	therapy	dobj	25	SENT_136	[p8l271t1172r601b1273],
27	.	.	O	.	_	0	SENT_136	[p8l271t1172r601b1273],

1	From	IN	O	from	dep	23	SENT_137	[p8l22t1436r182b1492],
2	the	DT	O	the	det	4	SENT_137	[p8l227t1430r330b1492],
3	Hamon	NNP	ORGANIZATION	Hamon	nn	4	SENT_137	[p8l379t1435r621b1491],
4	Center	NNP	ORGANIZATION	Center	pobj	1	SENT_137	[p8l669t1435r884b1492],
5	for	IN	ORGANIZATION	for	_	0	SENT_137	[p8l923t1429r1015b1491],
6	Therapeutic	JJ	ORGANIZATION	therapeutic	amod	10	SENT_137	[p8l1052t1430r1449b1510],
7	Oncology	NNP	ORGANIZATION	Oncology	nn	10	SENT_137	[p8l1491t1430r1808b1511],
8	Research	NNP	ORGANIZATION	Research	nn	10	SENT_137	[p8l1855t1430r2145b1492],
9	(	CD	NUMBER	(	num	10	SENT_137	[p8l24t1532r505b1607],
10	J.E.D.	NNP	O	J.E.D.	prep_for	4	SENT_137	[p8l24t1532r505b1607],
11	,	,	O	,	_	0	SENT_137	[p8l24t1532r505b1607],
12	J.D.M.	NNP	O	J.D.M.	conj_and	10	SENT_137	[p8l24t1532r505b1607],
13	)	CD	NUMBER	)	num	12	SENT_137	[p8l24t1532r505b1607],
14	and	CC	O	and	_	0	SENT_137	[p8l539t1527r652b1588],
15	the	DT	O	the	det	18	SENT_137	[p8l679t1527r779b1588],
16	Departments	NNP	O	Departments	nn	18	SENT_137	[p8l811t1533r1226b1606],
17	oflnternal	JJ	O	oflnternal	amod	18	SENT_137	[p8l1253t1527r1579b1588],
18	Medicine	NN	O	medicine	conj_and	10	SENT_137	[p8l1614t1527r1903b1588],
19	(	CD	NUMBER	(	num	20	SENT_137	[p8l1937t1532r2147b1607],
20	J.E.D.	NNP	O	J.E.D.	dep	18	SENT_137	[p8l1937t1532r2147b1607],
21	,	,	O	,	_	0	SENT_137	[p8l1937t1532r2147b1607],
22	_	CD	NUMBER	_	num	23	SENT_137	[p8l6t1628r238b1703],
23	]	NN	O	]	_	0	SENT_137	[p8l6t1628r238b1703],
24	.	.	O	.	_	0	SENT_137	[p8l6t1628r238b1703],

1	D.M.	NNP	PERSON	D.M.	nn	2	SENT_138	[p8l6t1628r238b1703],
2	)	NNP	O	)	dep	6	SENT_138	[p8l6t1628r238b1703],
3	and	CC	O	and	_	0	SENT_138	[p8l271t1623r385b1684],
4	Pharmacology	NNP	O	Pharmacology	dep	6	SENT_138	[p8l419t1623r870b1703],
5	(	CD	NUMBER	(	num	4	SENT_138	[p8l901t1628r1493b1703],
6	J.D.M.	NNP	O	J.D.M.	_	0	SENT_138	[p8l901t1628r1493b1703],
7	)	CD	NUMBER	)	num	6	SENT_138	[p8l901t1628r1493b1703],
8	,	,	O	,	_	0	SENT_138	[p8l901t1628r1493b1703],
9	University	NNP	O	University	nn	13	SENT_138	[p8l901t1628r1493b1703],
10	ofTexas	NNP	O	ofTexas	nn	13	SENT_138	[p8l1517t1623r1767b1684],
11	Southwestern	NNP	ORGANIZATION	Southwestern	nn	13	SENT_138	[p8l1795t1623r2149b1684, p8l16t1741r115b1780],
12	Medical	NNP	ORGANIZATION	Medical	nn	13	SENT_138	[p8l148t1719r400b1780],
13	Center	NNP	ORGANIZATION	Center	appos	6	SENT_138	[p8l429t1724r652b1789],
14	,	,	O	,	_	0	SENT_138	[p8l429t1724r652b1789],
15	Dallas	NNP	LOCATION	Dallas	appos	6	SENT_138	[p8l686t1719r902b1780],
16	.	.	O	.	_	0	SENT_138	[p8l686t1719r902b1780],

1	1	LS	NUMBER	1	_	0	SENT_139	[p8l11t1824r59b1875],
2	.	.	O	.	_	0	SENT_139	[p8l11t1824r59b1875],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_140	[p8l136t1816r326b1891],
2	T	NN	O	t	nn	3	SENT_140	[p8l343t1821r428b1888],
3	]	NN	O	]	_	0	SENT_140	[p8l343t1821r428b1888],
4	,	,	O	,	_	0	SENT_140	[p8l343t1821r428b1888],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_140	[p8l451t1816r571b1875],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_140	[p8l589t1821r719b1888],
7	,	,	O	,	_	0	SENT_140	[p8l589t1821r719b1888],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_140	[p8l745t1816r1002b1875],
9	R	NNP	PERSON	R	appos	3	SENT_140	[p8l1020t1821r1085b1888],
10	,	,	O	,	_	0	SENT_140	[p8l1020t1821r1085b1888],
11	et	FW	O	et	nn	12	SENT_140	[p8l1109t1829r1168b1875],
12	al.	FW	O	al.	appos	3	SENT_140	[p8l1183t1816r1253b1875],
13	.	.	O	.	_	0	SENT_140	[p8l1183t1816r1253b1875],

1	Activating	VBG	O	activate	amod	2	SENT_141	[p8l1275t1817r1599b1892],
2	mutations	NNS	O	mutation	_	0	SENT_141	[p8l1616t1817r1939b1875],
3	in	IN	O	in	_	0	SENT_141	[p8l1960t1817r2021b1874],
4	the	DT	O	the	det	7	SENT_141	[p8l2042t1816r2139b1875],
5	epidermal	JJ	O	epidermal	amod	7	SENT_141	[p8l9t1912r331b1988],
6	growth	NN	O	growth	nn	7	SENT_141	[p8l365t1913r598b1988],
7	factor	NN	O	factor	prep_in	2	SENT_141	[p8l634t1912r824b1971],
8	receptor	NN	O	receptor	nn	10	SENT_141	[p8l857t1925r1127b1988],
9	underlying	VBG	O	underlie	amod	10	SENT_141	[p8l1161t1912r1514b1988],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_141	[p8l1548t1913r2038b1988],
11	of	IN	O	of	_	0	SENT_141	[p8l2077t1912r2153b1971],
12	non	JJ	O	non	amod	18	SENT_141	[p8l8t2008r494b2067],
13	—	JJ	O	—	amod	18	SENT_141	[p8l8t2008r494b2067],
14	small	JJ	O	small	amod	18	SENT_141	[p8l8t2008r494b2067],
15	—	NN	O	—	nn	18	SENT_141	[p8l8t2008r494b2067],
16	cell	NN	O	cell	nn	18	SENT_141	[p8l8t2008r494b2067],
17	lung	NN	O	lung	nn	18	SENT_141	[p8l520t2009r669b2084],
18	cancer	NN	O	cancer	prep_of	10	SENT_141	[p8l694t2027r905b2067],
19	to	TO	O	to	_	0	SENT_141	[p8l931t2021r992b2067],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_141	[p8l1020t2008r1313b2084],
21	.	.	O	.	_	0	SENT_141	[p8l1020t2008r1313b2084],

1	N	NN	O	n	nn	3	SENT_142	[p8l1343t2014r1399b2068],
2	Engl	NNP	O	Engl	nn	3	SENT_142	[p8l1424t2008r1573b2084],
3	J	NNP	O	J	nsubj	4	SENT_142	[p8l1593t2014r1621b2077],
4	Med	VBD	O	med	_	0	SENT_142	[p8l1644t2009r1787b2067],
5	2004	CD	DATE	2004	dobj	4	SENT_142	[p8l1814t2013r2136b2080],
6	;	:	O	;	_	0	SENT_142	[p8l1814t2013r2136b2080],
7	350	CD	NUMBER	350	num	9	SENT_142	[p8l1814t2013r2136b2080],
8	:	:	O	:	_	0	SENT_142	[p8l1814t2013r2136b2080],
9	2129-39	CD	NUMBER	2129-39	dep	5	SENT_142	[p8l8t2109r293b2163],
10	.	.	O	.	_	0	SENT_142	[p8l8t2109r293b2163],

1	2	LS	NUMBER	2	_	0	SENT_143	[p8l7t2207r59b2258],
2	.	.	O	.	_	0	SENT_143	[p8l7t2207r59b2258],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_144	[p8l136t2204r280b2258],
2	JG	NNP	O	JG	_	0	SENT_144	[p8l291t2204r392b2271],
3	,	,	O	,	_	0	SENT_144	[p8l291t2204r392b2271],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_144	[p8l407t2205r590b2267],
5	PA	NN	PERSON	pa	appos	2	SENT_144	[p8l607t2204r707b2271],
6	,	,	O	,	_	0	SENT_144	[p8l607t2204r707b2271],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_144	[p8l729t2205r835b2258],
8	JC	NNP	PERSON	JC	appos	2	SENT_144	[p8l845t2204r939b2271],
9	,	,	O	,	_	0	SENT_144	[p8l845t2204r939b2271],
10	et	FW	O	et	nn	11	SENT_144	[p8l961t2212r1019b2258],
11	al.	FW	O	al.	appos	2	SENT_144	[p8l1033t2199r1103b2258],
12	.	.	O	.	_	0	SENT_144	[p8l1033t2199r1103b2258],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_145	[p8l1125t2204r1320b2262],
2	mutations	NNS	O	mutation	_	0	SENT_145	[p8l1330t2200r1653b2258],
3	in	IN	O	in	_	0	SENT_145	[p8l1672t2200r1733b2257],
4	lung	NN	O	lung	nn	5	SENT_145	[p8l1750t2199r1897b2275],
5	cancer	NN	O	cancer	prep_in	2	SENT_145	[p8l1912t2218r2136b2258],
6	:	:	O	:	_	0	SENT_145	[p8l1912t2218r2136b2258],
7	correlation	NN	O	correlation	dep	2	SENT_145	[p8l9t2296r355b2354],
8	with	IN	O	with	_	0	SENT_145	[p8l369t2296r512b2355],
9	clinical	JJ	O	clinical	amod	10	SENT_145	[p8l530t2295r756b2354],
10	response	NN	O	response	prep_with	7	SENT_145	[p8l773t2314r1058b2371],
11	to	TO	O	to	_	0	SENT_145	[p8l1076t2308r1135b2354],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_145	[p8l1154t2295r1421b2371],
13	therapy	NN	O	therapy	prep_to	10	SENT_145	[p8l1439t2295r1685b2371],
14	.	.	O	.	_	0	SENT_145	[p8l1439t2295r1685b2371],

1	Science	NNP	O	Science	_	0	SENT_146	[p8l1708t2296r1944b2354],
2	2004	CD	DATE	2004	num	1	SENT_146	[p8l1961t2300r2136b2367],
3	;	:	O	;	_	0	SENT_146	[p8l1961t2300r2136b2367],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_146	[p8l9t2396r469b2450],
5	—	CD	NUMBER	—	dep	1	SENT_146	[p8l9t2396r469b2450],
6	500	CD	NUMBER	500	dep	5	SENT_146	[p8l9t2396r469b2450],
7	.	.	O	.	_	0	SENT_146	[p8l9t2396r469b2450],

1	3	LS	NUMBER	3	_	0	SENT_147	[p8l8t2494r59b2545],
2	.	.	O	.	_	0	SENT_147	[p8l8t2494r59b2545],

1	Weinstein	NNP	PERSON	Weinstein	nn	2	SENT_148	[p8l135t2487r455b2545],
2	IB	NNP	O	IB	_	0	SENT_148	[p8l482t2491r568b2545],
3	.	.	O	.	_	0	SENT_148	[p8l482t2491r568b2545],

1	Cancer	NN	O	cancer	_	0	SENT_149	[p8l601t2491r840b2545],
2	:	:	O	:	_	0	SENT_149	[p8l601t2491r840b2545],
3	addiction	NN	O	addiction	nsubj	6	SENT_149	[p8l871t2486r1170b2545],
4	to	TO	O	to	_	0	SENT_149	[p8l1199t2499r1258b2545],
5	oncogenes	NNS	O	oncogene	prep_to	3	SENT_149	[p8l1289t2505r1628b2562],
6	—	VBP	O	—	dep	1	SENT_149	[p8l1655t2520r1737b2526],
7	the	DT	O	the	det	8	SENT_149	[p8l1762t2486r1859b2545],
8	Achilles	NNPS	MISC	Achilles	nsubj	9	SENT_149	[p8l1885t2486r2139b2545],
9	heal	VBP	O	heal	ccomp	6	SENT_149	[p8l8t2581r139b2640],
10	of	IN	O	of	_	0	SENT_149	[p8l158t2581r234b2640],
11	cancer	NN	O	cancer	prep_of	9	SENT_149	[p8l239t2600r458b2640],
12	.	.	O	.	_	0	SENT_149	[p8l239t2600r458b2640],

1	Science	NNP	O	Science	_	0	SENT_150	[p8l483t2582r718b2640],
2	2002	CD	DATE	2002	num	1	SENT_150	[p8l737t2586r1219b2652],
3	;	:	O	;	_	0	SENT_150	[p8l737t2586r1219b2652],
4	297:63	CD	NUMBER	297:63	number	5	SENT_150	[p8l737t2586r1219b2652],
5	—	CD	NUMBER	—	dep	1	SENT_150	[p8l737t2586r1219b2652],
6	4	CD	NUMBER	4	dep	5	SENT_150	[p8l737t2586r1219b2652],
7	.	.	O	.	_	0	SENT_150	[p8l737t2586r1219b2652],

1	4	LS	NUMBER	4	_	0	SENT_151	[p8l6t2685r59b2736],
2	.	.	O	.	_	0	SENT_151	[p8l6t2685r59b2736],

1	Shah	NNP	O	Shah	nn	2	SENT_152	[p8l139t2677r295b2737],
2	NP	NNP	ORGANIZATION	NP	_	0	SENT_152	[p8l311t2682r416b2749],
3	,	,	O	,	_	0	SENT_152	[p8l311t2682r416b2749],
4	Tran	NNP	PERSON	Tran	nn	5	SENT_152	[p8l436t2682r584b2736],
5	C	NNP	PERSON	C	appos	2	SENT_152	[p8l601t2682r664b2749],
6	,	,	O	,	_	0	SENT_152	[p8l601t2682r664b2749],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_152	[p8l685t2683r791b2736],
8	FY	NNP	O	FY	appos	5	SENT_152	[p8l808t2683r897b2749],
9	,	,	O	,	_	0	SENT_152	[p8l808t2683r897b2749],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_152	[p8l919t2677r1085b2737],
11	P	NN	PERSON	p	appos	5	SENT_152	[p8l1101t2682r1150b2749],
12	,	,	O	,	_	0	SENT_152	[p8l1101t2682r1150b2749],
13	Norris	NNP	ORGANIZATION	Norris	nn	14	SENT_152	[p8l1170t2678r1374b2737],
14	D	NNP	ORGANIZATION	D	appos	5	SENT_152	[p8l1392t2682r1459b2749],
15	,	,	O	,	_	0	SENT_152	[p8l1392t2682r1459b2749],
16	Sawyers	NNP	ORGANIZATION	Sawyers	nn	17	SENT_152	[p8l1482t2682r1733b2752],
17	CL	NN	ORGANIZATION	cl	appos	5	SENT_152	[p8l1752t2682r1854b2737],
18	.	.	O	.	_	0	SENT_152	[p8l1752t2682r1854b2737],

1	Overriding	JJ	O	overriding	amod	3	SENT_153	[p8l1876t2677r2138b2737, p8l7t2774r112b2849],
2	imatinib	NN	O	imatinib	nn	3	SENT_153	[p8l135t2773r403b2832],
3	resistance	NN	O	resistance	_	0	SENT_153	[p8l430t2774r747b2832],
4	with	IN	O	with	_	0	SENT_153	[p8l770t2773r913b2833],
5	a	DT	O	a	det	9	SENT_153	[p8l939t2793r972b2832],
6	novel	JJ	O	novel	amod	9	SENT_153	[p8l997t2774r1166b2833],
7	ABL	NN	ORGANIZATION	abl	nn	9	SENT_153	[p8l1189t2778r1324b2832],
8	kinase	NN	O	kinase	nn	9	SENT_153	[p8l1348t2773r1552b2833],
9	inhibitor	NN	O	inhibitor	prep_with	3	SENT_153	[p8l1577t2773r1871b2832],
10	.	.	O	.	_	0	SENT_153	[p8l1577t2773r1871b2832],

1	Science	NNP	O	Science	_	0	SENT_154	[p8l1903t2774r2139b2832],
2	2004	CD	DATE	2004	num	1	SENT_154	[p8l8t2874r610b2941],
3	;	:	O	;	_	0	SENT_154	[p8l8t2874r610b2941],
4	305:399	CD	NUMBER	305:399	number	5	SENT_154	[p8l8t2874r610b2941],
5	-401	CD	NUMBER	-401	dep	1	SENT_154	[p8l8t2874r610b2941],
6	.	.	O	.	_	0	SENT_154	[p8l8t2874r610b2941],

1	5	CD	NUMBER	5	_	0	SENT_155	[p8l9t2973r59b3024],
2	.	.	O	.	_	0	SENT_155	[p8l9t2973r59b3024],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_156	[p8l137t2965r474b3040],
2	S	NNP	LOCATION	S	_	0	SENT_156	[p8l497t2970r549b3037],
3	,	,	O	,	_	0	SENT_156	[p8l497t2970r549b3037],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_156	[p8l574t2970r829b3041],
5	T	NN	O	t	nn	6	SENT_156	[p8l848t2970r933b3037],
6	]	NN	O	]	appos	2	SENT_156	[p8l848t2970r933b3037],
7	,	,	O	,	_	0	SENT_156	[p8l848t2970r933b3037],
8	Dayaram	NN	ORGANIZATION	dayaram	nn	9	SENT_156	[p8l958t2970r1247b3040],
9	T	NN	ORGANIZATION	t	appos	2	SENT_156	[p8l1266t2970r1322b3037],
10	,	,	O	,	_	0	SENT_156	[p8l1266t2970r1322b3037],
11	et	FW	O	et	nn	12	SENT_156	[p8l1348t2978r1407b3024],
12	al.	FW	O	al.	appos	2	SENT_156	[p8l1424t2965r1496b3024],
13	.	.	O	.	_	0	SENT_156	[p8l1424t2965r1496b3024],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_157	[p8l1520t2970r1683b3025],
2	mutation	NN	O	mutation	_	0	SENT_157	[p8l1700t2966r1998b3024],
3	and	CC	O	and	_	0	SENT_157	[p8l2019t2965r2138b3024],
4	resistance	NN	O	resistance	conj_and	2	SENT_157	[p8l8t3062r326b3120],
5	of	IN	O	of	_	0	SENT_157	[p8l350t3061r425b3120],
6	non	JJ	O	non	amod	12	SENT_157	[p8l434t3061r910b3120],
7	—	JJ	O	—	amod	12	SENT_157	[p8l434t3061r910b3120],
8	small	JJ	O	small	amod	12	SENT_157	[p8l434t3061r910b3120],
9	—	NN	O	—	nn	12	SENT_157	[p8l434t3061r910b3120],
10	cell	NN	O	cell	nn	12	SENT_157	[p8l434t3061r910b3120],
11	lung	NN	O	lung	nn	12	SENT_157	[p8l932t3061r1078b3137],
12	cancer	NN	O	cancer	prep_of	2	SENT_157	[p8l1099t3080r1306b3120],
13	to	TO	O	to	_	0	SENT_157	[p8l1327t3074r1386b3120],
14	geﬁtinib	NN	O	geﬁtinib	prep_to	2	SENT_157	[p8l1410t3061r1695b3137],
15	.	.	O	.	_	0	SENT_157	[p8l1410t3061r1695b3137],

1	N	NN	O	n	nn	3	SENT_158	[p8l1720t3067r1776b3121],
2	Engl	NNP	O	Engl	nn	3	SENT_158	[p8l1796t3062r1983b3137],
3	]	NNP	O	]	nsubj	4	SENT_158	[p8l1796t3062r1983b3137],
4	Med	VBD	O	med	_	0	SENT_158	[p8l2000t3061r2140b3120],
5	2005	CD	DATE	2005	dobj	4	SENT_158	[p8l8t3162r566b3228],
6	;	:	O	;	_	0	SENT_158	[p8l8t3162r566b3228],
7	352:786	CD	NUMBER	352:786	number	8	SENT_158	[p8l8t3162r566b3228],
8	—	CD	NUMBER	—	dep	5	SENT_158	[p8l8t3162r566b3228],
9	92	CD	NUMBER	92	dep	8	SENT_158	[p8l8t3162r566b3228],
10	.	.	O	.	_	0	SENT_158	[p8l8t3162r566b3228],

1	6	CD	NUMBER	6	_	0	SENT_159	[p8l8t3259r59b3311],
2	.	.	O	.	_	0	SENT_159	[p8l8t3259r59b3311],

1	Blencke	NNP	O	Blencke	nn	2	SENT_160	[p8l136t3252r387b3311],
2	S	NNP	O	S	nsubj	19	SENT_160	[p8l409t3257r461b3324],
3	,	,	O	,	_	0	SENT_160	[p8l409t3257r461b3324],
4	Ullrich	NNP	PERSON	Ullrich	nn	5	SENT_160	[p8l486t3252r704b3311],
5	A	NNP	O	A	appos	2	SENT_160	[p8l722t3258r787b3324],
6	,	,	O	,	_	0	SENT_160	[p8l722t3258r787b3324],
7	Daub	NNP	PERSON	Daub	nn	9	SENT_160	[p8l811t3252r980b3311],
8	H.	NNP	O	H.	nn	9	SENT_160	[p8l1002t3258r1074b3311],
9	Mutation	NN	O	mutation	appos	2	SENT_160	[p8l1096t3253r1391b3311],
10	of	IN	O	of	_	0	SENT_160	[p8l1412t3252r1487b3311],
11	threonine	NN	O	threonine	prep_of	9	SENT_160	[p8l1495t3252r1803b3311],
12	766	CD	NUMBER	766	num	11	SENT_160	[p8l1824t3257r1939b3311],
13	in	IN	O	in	_	0	SENT_160	[p8l1960t3253r2021b3310],
14	the	DT	O	the	det	18	SENT_160	[p8l2042t3252r2139b3311],
15	epidermal	JJ	O	epidermal	amod	18	SENT_160	[p8l9t3348r329b3424],
16	growth	NN	O	growth	nn	18	SENT_160	[p8l358t3349r587b3424],
17	factor	NN	O	factor	nn	18	SENT_160	[p8l616t3348r802b3407],
18	receptor	NN	O	receptor	prep_in	11	SENT_160	[p8l830t3361r1094b3424],
19	reveals	VBZ	O	reveal	_	0	SENT_160	[p8l1122t3348r1335b3408],
20	a	DT	O	a	det	21	SENT_160	[p8l1366t3368r1399b3407],
21	hotspot	NN	O	hotspot	dobj	19	SENT_160	[p8l1428t3348r1676b3424],
22	for	IN	O	for	_	0	SENT_160	[p8l1702t3348r1795b3407],
23	resistance	NN	O	resistance	nn	24	SENT_160	[p8l1822t3349r2139b3407],
24	formation	NN	O	formation	prep_for	21	SENT_160	[p8l8t3444r328b3503],
25	against	IN	O	against	_	0	SENT_160	[p8l352t3445r585b3520],
26	selective	JJ	O	selective	amod	29	SENT_160	[p8l606t3444r870b3504],
27	tyrosine	NN	O	tyrosine	nn	29	SENT_160	[p8l895t3445r1147b3520],
28	kinase	NN	O	kinase	nn	29	SENT_160	[p8l1171t3444r1375b3504],
29	inhibitors	NNS	O	inhibitor	prep_against	24	SENT_160	[p8l1399t3444r1729b3503],
30	.	.	O	.	_	0	SENT_160	[p8l1399t3444r1729b3503],

1	J	NNP	O	J	nn	3	SENT_161	[p8l1751t3450r1779b3512],
2	Biol	NNP	O	Biol	nn	3	SENT_161	[p8l1801t3445r1928b3503],
3	Chem	NNP	O	Chem	_	0	SENT_161	[p8l1951t3445r2140b3503],
4	2003	CD	DATE	2003	num	3	SENT_161	[p8l8t3545r650b3612],
5	;	:	O	;	_	0	SENT_161	[p8l8t3545r650b3612],
6	278:15435	CD	NUMBER	278:15435	number	7	SENT_161	[p8l8t3545r650b3612],
7	-40	CD	NUMBER	-40	dep	3	SENT_161	[p8l8t3545r650b3612],
8	.	.	O	.	_	0	SENT_161	[p8l8t3545r650b3612],

1	Copyright	NN	O	copyright	_	0	SENT_162	[p8l10t3627r249b3692],
2	©	CD	NUMBER	©	num	6	SENT_162	[p8l271t3632r324b3686],
3	2005	CD	DATE	2005	num	6	SENT_162	[p8l349t3630r475b3676],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_162	[p8l495t3627r857b3676],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_162	[p8l878t3627r1077b3676],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_162	[p8l1095t3629r1278b3691],
7	.	.	O	.	_	0	SENT_162	[p8l1095t3629r1278b3691],

1	POSTING	VBG	O	post	csubjpass	35	SENT_163	[p9l814t85r930b103],
2	PRESENTATIONS	NNS	O	presentation	dobj	1	SENT_163	[p9l946t85r1161b103],
3	AT	IN	O	at	_	0	SENT_163	[p9l1173t86r1204b102],
4	MEDICAL	NNP	O	MEDICAL	nn	5	SENT_163	[p9l1218t85r1335b103],
5	MEETINGS	NNP	O	MEETINGS	nsubj	9	SENT_163	[p9l1349t85r1485b103],
6	ON	IN	O	on	_	0	SENT_163	[p9l1498t85r1537b103],
7	THE	DT	O	the	det	8	SENT_163	[p9l1551t86r1603b102],
8	INTERNET	NNP	O	INTERNET	prep_on	5	SENT_163	[p9l1617t86r1748b102],
9	Posting	VBG	O	post	prepc_at	1	SENT_163	[p9l749t137r844b166],
10	an	DT	O	a	det	12	SENT_163	[p9l852t144r882b160],
11	audio	JJ	O	audio	amod	12	SENT_163	[p9l891t137r961b160],
12	recording	NN	O	recording	dobj	9	SENT_163	[p9l971t137r1093b166],
13	of	IN	O	of	_	0	SENT_163	[p9l1102t137r1132b160],
14	an	DT	O	a	det	16	SENT_163	[p9l1135t144r1165b160],
15	oral	JJ	O	oral	amod	16	SENT_163	[p9l1175t137r1223b160],
16	presentation	NN	O	presentation	prep_of	12	SENT_163	[p9l1232t137r1390b166],
17	at	IN	O	at	_	0	SENT_163	[p9l1400t142r1423b160],
18	a	DT	O	a	det	20	SENT_163	[p9l1431t144r1444b160],
19	medical	JJ	O	medical	amod	20	SENT_163	[p9l1453t137r1551b160],
20	meeting	NN	O	meeting	prep_at	9	SENT_163	[p9l1560t137r1664b166],
21	on	IN	O	on	_	0	SENT_163	[p9l1672t144r1704b160],
22	the	DT	O	the	det	23	SENT_163	[p9l1713t137r1752b160],
23	Internet	NN	MISC	internet	prep_on	20	SENT_163	[p9l749t178r856b204],
24	,	,	O	,	_	0	SENT_163	[p9l749t178r856b204],
25	with	IN	O	with	_	0	SENT_163	[p9l866t176r922b200],
26	selected	VBN	O	select	amod	27	SENT_163	[p9l931t176r1031b199],
27	slides	NNS	O	slide	prep_with	23	SENT_163	[p9l1041t176r1111b199],
28	from	IN	O	from	_	0	SENT_163	[p9l1121t176r1182b199],
29	the	DT	O	the	det	30	SENT_163	[p9l1192t176r1230b199],
30	presentation	NN	O	presentation	prep_from	27	SENT_163	[p9l1239t177r1405b206],
31	,	,	O	,	_	0	SENT_163	[p9l1239t177r1405b206],
32	will	MD	O	will	aux	35	SENT_163	[p9l1415t176r1461b200],
33	not	RB	O	not	neg	35	SENT_163	[p9l1471t181r1513b199],
34	be	VB	O	be	auxpass	35	SENT_163	[p9l1521t176r1549b199],
35	considered	VBN	O	consider	_	0	SENT_163	[p9l1559t176r1696b199],
36	prior	RB	O	prior	prep	35	SENT_163	[p9l1705t177r1769b206],
37	publication	NN	O	publication	pobj	36	SENT_163	[p9l749t216r899b245],
38	.	.	O	.	_	0	SENT_163	[p9l749t216r899b245],

1	This	DT	O	this	nsubj	3	SENT_164	[p9l909t216r964b239],
2	will	MD	O	will	aux	3	SENT_164	[p9l973t216r1019b239],
3	allow	VB	O	allow	_	0	SENT_164	[p9l1028t216r1097b239],
4	students	NNS	O	student	dobj	3	SENT_164	[p9l1105t216r1211b239],
5	and	CC	O	and	_	0	SENT_164	[p9l1220t216r1267b239],
6	physicians	NNS	O	physician	dobj	3	SENT_164	[p9l1275t216r1407b246],
7	who	WP	O	who	nsubj	9	SENT_164	[p9l1416t216r1470b239],
8	are	VBP	O	be	cop	9	SENT_164	[p9l1480t224r1517b239],
9	unable	JJ	O	unable	rcmod	4	SENT_164	[p9l1526t216r1611b239],
10	to	TO	O	to	aux	11	SENT_164	[p9l1620t221r1644b239],
11	attend	VB	O	attend	xcomp	9	SENT_164	[p9l1653t216r1732b239],
12	the	DT	O	the	det	13	SENT_164	[p9l1741t216r1779b239],
13	meeting	NN	O	meeting	dobj	11	SENT_164	[p9l749t256r852b285],
14	to	TO	O	to	aux	15	SENT_164	[p9l861t261r884b279],
15	hear	VB	O	hear	infmod	13	SENT_164	[p9l894t256r949b279],
16	the	DT	O	the	det	17	SENT_164	[p9l958t256r996b279],
17	presentation	NN	O	presentation	dobj	15	SENT_164	[p9l1005t256r1164b285],
18	and	CC	O	and	_	0	SENT_164	[p9l1173t256r1219b279],
19	view	VB	O	view	infmod	13	SENT_164	[p9l1227t256r1285b279],
20	the	DT	O	the	det	21	SENT_164	[p9l1293t256r1331b279],
21	slides	NNS	O	slide	dobj	19	SENT_164	[p9l1341t256r1419b279],
22	.	.	O	.	_	0	SENT_164	[p9l1341t256r1419b279],

1	If	IN	O	if	mark	3	SENT_165	[p9l1430t255r1454b278],
2	there	EX	O	there	expl	3	SENT_165	[p9l1458t256r1521b279],
3	are	VBP	O	be	advcl	12	SENT_165	[p9l1530t263r1568b279],
4	any	DT	O	any	det	5	SENT_165	[p9l1577t263r1621b285],
5	questions	NNS	O	question	nsubj	3	SENT_165	[p9l1629t256r1750b285],
6	about	IN	O	about	_	0	SENT_165	[p9l749t295r821b319],
7	this	DT	O	this	det	8	SENT_165	[p9l829t295r875b318],
8	policy	NN	O	policy	prep_about	5	SENT_165	[p9l884t295r963b325],
9	,	,	O	,	_	0	SENT_165	[p9l884t295r963b325],
10	authors	NNS	O	author	nsubj	12	SENT_165	[p9l974t295r1069b319],
11	should	MD	O	should	aux	12	SENT_165	[p9l1080t295r1165b319],
12	feel	VB	O	feel	_	0	SENT_165	[p9l1174t295r1219b318],
13	free	JJ	O	free	acomp	12	SENT_165	[p9l1228t295r1275b318],
14	to	TO	O	to	aux	15	SENT_165	[p9l1284t300r1308b318],
15	call	VB	O	call	xcomp	13	SENT_165	[p9l1317t295r1360b318],
16	the_Iaumal	JJ	O	the_iaumal	poss	19	SENT_165	[p9l1369t295r1518b325],
17	’s	POS	O	’s	_	0	SENT_165	[p9l1369t295r1518b325],
18	Editorial	NNP	O	Editorial	nn	19	SENT_165	[p9l1528t295r1636b319],
19	Offices	NNS	O	office	dobj	15	SENT_165	[p9l1645t295r1741b319],
20	.	.	O	.	_	0	SENT_165	[p9l1645t295r1741b319],

1	832	CD	NUMBER	832	num	4	SENT_166	[p9l149t441r206b464],
2	N	NN	O	n	nn	4	SENT_166	[p9l880t443r894b459],
3	ENGLJ	NN	O	englj	nn	4	SENT_166	[p9l909t443r993b465],
4	MED	NN	O	med	_	0	SENT_166	[p9l1008t443r1061b458],
5	352	CD	NUMBER	352	num	7	SENT_166	[p9l1073t437r1139b465],
6	;	:	O	;	_	0	SENT_166	[p9l1073t437r1139b465],
7	8	CD	NUMBER	8	dep	4	SENT_166	[p9l1073t437r1139b465],
8	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	9	SENT_166	[p9l1174t443r1385b465],
9	FEBRUARY	NNP	DATE	FEBRUARY	dep	4	SENT_166	[p9l1425t443r1552b459],
10	24	CD	DATE	24	num	9	SENT_166	[p9l1564t443r1602b465],
11	,	,	DATE	,	_	0	SENT_166	[p9l1564t443r1602b465],
12	2005	CD	DATE	2005	num	9	SENT_166	[p9l1615t443r1678b465],

1	The	DT	O	the	det	4	SENT_167	[p9l936t540r987b564],
2	New	NNP	O	New	nn	4	SENT_167	[p9l996t541r1058b564],
3	England	NNP	O	England	nn	4	SENT_167	[p9l1067t540r1178b571],
4	Journal	NNP	O	Journal	_	0	SENT_167	[p9l1187t540r1284b564],
5	of	IN	O	of	_	0	SENT_167	[p9l1294t540r1323b564],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_167	[p9l1330t540r1455b564],

1	Downloaded	VBN	O	download	_	0	SENT_168	[p9l378t581r548b604],
2	from	IN	O	from	_	0	SENT_168	[p9l557t581r621b604],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_168	[p9l630t581r748b611],
4	at	IN	O	at	_	0	SENT_168	[p9l759t585r782b604],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_168	[p9l790t581r973b604],
6	on	IN	O	on	_	0	SENT_168	[p9l982t588r1015b604],
7	January	NNP	DATE	January	prep_on	1	SENT_168	[p9l1023t581r1126b611],
8	5	CD	DATE	5	num	7	SENT_168	[p9l1136t581r1159b608],
9	,	,	DATE	,	_	0	SENT_168	[p9l1136t581r1159b608],
10	2014	CD	DATE	2014	num	7	SENT_168	[p9l1170t581r1242b604],
11	.	.	O	.	_	0	SENT_168	[p9l1170t581r1242b604],

1	For	IN	O	for	_	0	SENT_169	[p9l1252t581r1299b604],
2	personal	JJ	O	personal	amod	3	SENT_169	[p9l1307t581r1419b611],
3	use	NN	O	use	pobj	1	SENT_169	[p9l1428t588r1472b604],
4	only	RB	O	only	advmod	3	SENT_169	[p9l1482t581r1546b611],
5	.	.	O	.	_	0	SENT_169	[p9l1482t581r1546b611],

1	No	DT	O	no	det	3	SENT_170	[p9l1557t581r1597b604],
2	other	JJ	O	other	amod	3	SENT_170	[p9l1607t581r1675b604],
3	uses	NNS	O	use	_	0	SENT_170	[p9l1683t588r1739b604],
4	without	IN	O	without	_	0	SENT_170	[p9l1749t581r1850b604],
5	permission	NN	O	permission	prep_without	3	SENT_170	[p9l1859t581r2011b611],
6	.	.	O	.	_	0	SENT_170	[p9l1859t581r2011b611],

1	Copyright	NN	O	copyright	_	0	SENT_171	[p9l728t622r863b653],
2	©	CD	NUMBER	©	num	6	SENT_171	[p9l872t622r896b646],
3	2005	CD	DATE	2005	num	6	SENT_171	[p9l906t622r970b646],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_171	[p9l980t622r1171b646],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_171	[p9l1181t622r1289b646],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_171	[p9l1300t622r1405b653],
7	.	.	O	.	_	0	SENT_171	[p9l1300t622r1405b653],

1	All	DT	O	all	det	2	SENT_172	[p9l1416t622r1457b646],
2	rights	NNS	O	rights	nsubj	3	SENT_172	[p9l1466t622r1541b653],
3	reserved	VBN	O	reserve	_	0	SENT_172	[p9l1551t622r1670b646],
4	.	.	O	.	_	0	SENT_172	[p9l1551t622r1670b646],

